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Hamlet: Do you see yonder cloud that's almost in shape of a camel? 
Polonius: By the mass, and 'tis like a camel, indeed. 
Hamlet: Methinks it is like a weasel. 
Polonius: It is backed like a weasel. 
Hamlet: Or like a whale? 
Polonius: Very like a whale. 
William Shakespeare, Hamlet. Act 3 scene II 
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Abstract 
Design, development and implementation of a new Ion Mobility capable Mass 
Spectrometer - the MoQToF - is presented. The instrument is a Micromass Q-ToF 
modified to include a temperature regulated drift cell. Initial testing of the instrument to 
measure cross sections of well characterised proteins (cytochrome C, ubiquitin and 
lysozyme) in a range of charge states is described, showing the apparatus to perform well 
in comparison with values reported by others on analogous instruments. 
Ion mobility data are presented on a number of novel systems from small peptides to 
large proteins. The largest volume of work focuses on the study of -defensins and 
related peptides. -defensins are small anti-microbial peptides that form a vital part of 
the innate immune system of all mammals, they are characterised by the presence of six 
conserved cysteine residues connected via disulphide bonds. Characterisation of these 
bonds (number and topology) using mass spectrometry based techniques is presented. 
The ion mobility data presented here probes the influence of these disulphide bonds on 
:1.:1:-... 
..JL1IJA LL1a1%Ji&ai IlcAlUIltLy. 
The mode of action of 3-defensins is not known, two techniques designed to further 
understanding of this are described here. Firstly a mass spectrometry based technique in 
which the interaction between a defensin, DEFB 107, and an artificial membrane is 
studied using hydrogen deuterium exchange revealing the N-terminal section of the 
peptide to interact favourably with the lipid bilayer. Secondly, a heparin binding assay is 
described revealing a relationship between heparin binding strength and anti-microbial 
activity. This interaction is further studied using the MoQToF and molecular modelling. 
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Genome mapping projects, such as the human genome project, have provided an 
enormous amount of genetic information for proteome (PROTEin complement to a 
genOME) characterisation - known as proteomics. While genetic information gives a 
wealth of primary structure information, it can tell us nothing about the higher order 
protein structures which give rise to their function. The characterisation of these 
structures has been traditionally carried out in the condensed phase using x-ray 
crystallography' and multi-dimensional NMR 2 . 
The reasons for using these experiments are two-fold: firstly the condensed phase has 
greater molecular density and hence larger signals are obtained; secondly the condensed 
phase is thought to more closely resemble biologically relevant conditions 3 . While the 
first reason is undoubtedly valid, the second is perhaps less so. For example, it is not 
clear that the crystalline environment required for x-ray diffraction experiments can be 
directly related to the in vivo environment; proteins are often extremely flexible 
molecules and their conformations can be extremely sensitive to their environment 
(solvent, T, pH, salt conc. etc.) which can change dramatically throughout the body 4 . 
Similarly, it is often extremely difficult to perform NMR experiments in biologically 
relevant conditions. 
Researchers have also been studying biological molecule conformations in solvent free 
environments - the gas phase' 567. Again, it is not clear how comparable this 
environment is to the natural environment of a protein but these studies can often provide 
complementary information to condensed phase studies, especially with regard to 
conformational flexibility. Optical spectroscopy techniques are commonly used to 
determine molecular conformations 89. however, the techniques are currently limited to 
comparatively small molecules (a nucleotide base pair, an amino acid...) leaving them 
lagging behind condensed phase techniques. 
I. Introduction 
Until the mid 1980s, mass spectrometry (MS) methods struggled to analyse large 
molecules. This changed , however, with the advent of new, more advanced MS 
instruments and more importantly through the development of two new ionisation 
techniques: Matrix Assisted Laser Desorption lonisation (MALDI)' ° ' 1 ' and Electrospray 
lonisation (5)l23  These soft ionisation techniques allow the transfer of extremely 
large, intact biomolecules into the gas phase with relative ease. ESI is particularly useful 
as it generates highly charged ions which appear in a mass spectrum at low mlz and can 
be analysed on an MS with a relatively small mass range. The application of ESI to 
biomolecules was first shown by Fenn who received the 2002 Nobel Prize in chemistry 
along with Tanaka - who pioneered soft desorption ionisation a precursor of MALD1 - 
and Wuthrich, an NMR spectroscopist 14 . 
While it is clear that MS can be used to study the mass of a protein, it is not necessarily 
clear how MS can be used to study protein conformation. One, quite indirect method is 
to use charge state analysis whereby the degree of foldedriess' of a protein can be 
estimated by studying the distributions of charge states' 5 ; more highly charged protein 
ions tend to be more unfolded than lower charged protein ions. By analysing the 
abundances of higher and lower charged ions it is often possible to characterise gas phase 
unfolding transitions. Another, more direct method of analysing conformation by MS is 
hydrogen/deuterium exchange mass spectrometry' 6, a technique which probes the solvent 
accessibility and hence structure of proteins in both the solution phase and the gas phase. 
These measurements , however, require some prior knowledge of the structure if they are 
to be useful. Therefore, they are mostly used to confirm the retention/loss of higher order 
structure in the gas phase. 
A more direct method to study gas phase conformation is ion mobility spectrometry 
(IMS). The technique was developed by Cohen and Karasek in 1970 as a sensor' 7 . It has 
since been used to detect illegal drugs, chemical warfare agents, explosives and 
environmental pollutants' 8-19 . Ion mobility is a measure of how quickly a gas phase ion 
moves through a buffer gas under the influence of an electric field. this depends on two 
things: the rotationally averaged collision cross section of the ion and the charge present 
2 
1. Introduction 
on it. By measuring the drift time of an ion through a known distance it is possible to 
determine its collision cross section which can then be used, in conjunction with 
computational studies, to obtain conformational information. 
The use of IMS to elucidate structural information was pioneered by the groups of 
Bowers 20  and Jarrold2l who used it to study conformations of gas phase atomic clusters. 
These methods have since been developed to provide structural information on 
biomolecules. in this work a new ion mobility mass spectrometer (JMMS) is developed 
in order to analyse gas phase conformation of biomolecules. 
3 
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1.1 Mass Spectrometry 
A mass spectrometer is a device that analyses ions by mass-to-charge (m z) ratio. The 
technique was first developed by J.J. Thomson in 1912 to determine elemental masses 22 . 
Over a short period of time mass spectrometry progressedgreatly, allowing larger 
molecules to be analysed more easily with each innovation. However, much MS has 
changed since the days of Thomson and his fellow pioneers, the basic elements of an MS 
experiment remain unchanged, namely: a source in which gas phase ions are produced; a 
mass analyser where ions are separated by nvz and a detector with which to record 
spectra. One useful addition to most spectrometers since the early days is a computer 
with which the data can be more easily recorded and analysed. The major innovations 
associated with each of the three main elements will be discussed in the next three 
sections. 
1.1.1 lonisation Sources 
The first mass spectrometers used electron ionisation (El) sources 24. El requires 
volatile samples which can be transferred to the gas phase by heating. Once the sample is 
volatilised it is subjected to bombardment by a beam of electrons; these electrons ionise 
the analyte molecules by electronic interaction. The electrons used in El are typically 
around 70 eV 2 . Of this energy, 10-20 eV is transferred to the molecule during the 
ionisation process , however,, 10eV is enough energy to ionise most molecules and there 
is therefore up to 10 eV excess energy per molecule. This excess energy leads to the 
formation of fragment ions (useful for structure determination of small molecules) and is 
therefore termed a hard' ionisation technique. 
Chemical ionisation (C!) 26 , or more commonly atmospheric pressure chemical ionisation 
(APCI), is a related technique in which firstly a carrier gas - usually methane - is ionised 
by El. the resultant ions then interact with the analyte molecules causing them to ionise 
via a proton transfer reaction. CI is a much softer ionisation technique than El and 
4 
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therefore causes less fragmentation; it does , however, still require a volatile sample and 
is therefore only useful for small molecules. 
For larger and less volatile samples, it was necessary to develop techniques in which less 
volatile samples could be transferred to the gas phase easily and ionised with the 
minimum amount of fragmentation. The resulting techniques fall loosely into two 
categories: desorption techniques in which a sample is desorbed from a surface by a laser 
or molecular beam; and techniques where samples are ionised directly from solution. Of 
these categories by far the most important techniques are matrix assisted laser 
desorption/ionisation (MALDI) ii  and electrospray ionisation (ES 1)12  respectively. 
MALDI will be briefly described in the next section, while ESI - the ionisation method 
used in most of this work - will be discussed in depth in the subsequent section. 
1.1.1.1 MALDI 
In the 1960s an ionisation process known as laser desorption (LD) was first described 2 '. 
This technique involved the ablation of a sample (usually solid) from a surface with a 
pulsed laser to create gaseous ions. This technique was extremely efficient but due to the 
energies required for the process, extensive fragmentation was seen for larger molecules 
(>500 Da). This problem was first overcome by Hillenkamp and Karas" when they 
successfully demonstrated that the addition to the experiment of a small organic molecule 
- known as a matrix - which absorbs strongly in the wavelength of the laser used, allows 
much larger molecules to be ionised intact. This work, along with work on an analogous 
technique soft laser desorption (SLD) by Tanaka 1° (for which he won the 2002 Nobel 
Prize for Chemistry), led to the development of MALDI. 
A basic MALDI experiment is performed as follows: a solution of analyte molecule(s) is 
mixed with a saturated solution of the matrix molecule. The resulting mixture is spotted 
onto a target plate and allowed to dry - the resulting spot is said to be a solid solution' 
i.e. the matrix is in such excess that the analyte molecules are isolated from each other as 
if they are solvated by the matrix. The target plate is then placed in the source region of 
5 
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the mass spectrometer - this can be at atmospheric pressure or more commonly at 
relatively low vacuum - where it is irradiated by a pulsed laser to produce ions. 
The matrix is chosen based on a number of criteria but must possess two key features: it 
must firstly absorb strongly in at the wavelength of the chosen laser (almost always a UV 
laser); secondly it must be easily sublimable. Most matrices are therefore small aromatic 
compounds. 
The mechanism of MALDI is not fully understood but it is thought to involve two basic 
steps 2 29 O 
Matrix Excitation: the LASER beam is focussed onto the sample-matrix 
mixture causing clusters of analyte and matrix molecules to be ablated from the 
surface. Most of the laser energy is transferred to the matrix molecules (not the 
analyte molecules) which are photoionised by the laser. 
Analyte Ionisation: the subsequent ionisation of the analyte molecules is not 
fully understood but may involve a combination of processes including proton 
transfer, photoionisation. desorption of preformed ions and ion molecule 
reactions. The most widely accepted mechanism is gas phase proton transfer 
from matrix to analyte to produce protonated analyte molecules. 
The resulting cluster of analyte ions (and residual matrix ions) is then be extracted into 
the mass spectrometer for analysis. 
MALDI tends to produce low charge states i.e. ions carrying few charges (z = 1. 2, 3) 
and therefore requires a mass spectrometer with a large mass range to be useful for the 
analysis of large molecules (rn!z > 10 kDa). While MALDI can be used with virtually 
any mass spectrometer the requirement for a large mass range coupled with the pulsed 
nature of the ion source means it is most effective when coupled with a time of flight 
(T0F) mass analyser as they have (theoretically) an infinite mass range and require a 
pulse of ions. 
on 
1. Introduction 
The great advantage of MALDI over standard LD is that the amount of energy 
transferred to the analyte molecules is low, meaning there is little or no evidence of 
fragmentation allowing MS analysis of molecules with molecular mass of up to 300,000 
Da28 . 
While whole protein MALDI on such large systems is extremely interesting, it is often 
difficult to identify an unknown protein by mass alone and it is in the identification of 
proteins (often from complex mixtures of several proteins/peptides) that MALDI has 
come into its own. A typical experiment might involve the extraction of a number of 
proteins from an organism and a subsequent enzymatic digestion (i.e. cleaving the 
proteins at specific point to form peptides using an enzyme such as trypsin) of those 
proteins. Analysis of the resulting mixture by MALDI-MS will produce an extremely 
complex mass spectrum, often containing several hundred different peaks, but due to the 
large amount of proteins identified by genome mapping projects it is possible - with the 
aid of bio-informatics - to assign the peptides to specific proteins and therefore identify 
them 31 . The reasons MALDI is so well suited to this type of analysis are manifold but it 
is primarily due to the sensitivity of the technique; often only a few femtomoles of the 
peptide are required to be present for a successful analysis by MADLI-MS. 
1.1.1.2 ESI 
The electrospray phenomenon has been known about for several hundred years but it was 
not until the late 1960s that its potential as to be used in ionisation was realised when 
Dole invented electrospray ionisation (ES 1)32.  It took almost twenty more years for the 
technique to be applied to biornolecules through the pioneering work of John Fenn ' 213 , 
the co-recipient of the 2002 Nobel Prize for Chemistry for his work on ESI. 
A quick search of the literature - or indeed a quick look around any modern mass 
spectrometry laboratory - reveals many different styles of ESI source 33; the main 
components . however, remain unchanged. The sample of interest is introduced into the 
source in a solution at a low flow rate (1-10 .il min') from a syringe pump or from an 
7 
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HPLC. It passes through the electrospray needle, to which a high potential difference (2-
4 kV with respect to the counter electrode) is applied. This leads to the formation of a 
'Taylor cone' at the end of the needle (see figure 1.1) from which a spray of highly 
charged droplets appears. The spray is often accompanied by a co-axial now of inert gas 
(usually nitrogen) which helps to confine the spray within the source chamber. 
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: Schematic diagram of the ESI process. A potential difference is applied between 
the spray needle (capillary) and cone leading to the formation of a Taylor cone from which highly 
charged, analyte containing droplets are produced. The solvent evaporates, shrinking the droplet 
until the'Rayleigh' limit is reached and coulombic explosion occurs. This process continues 
until free analyte ions are produced. 
As the droplets are ejected from the needle the solvent contained in them begins to 
evaporate (this is usually assisted by filling the source region with a heated nitrogen) thus 
reducing the size of the droplet. This brings the charge on the surface of the droplet 
closer together therefore increasing the coulombic repulsion between the charges. 
Eventually the coulombic repulsion becomes so great the droplet fissures into a number 
of smaller. charged droplets of sample solution. The point at which this fission occurs is 
determined by the size of the droplet, the surface tension of the solvent and the charge on 
its surface - the relationship between these factors can be easily described by the 
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Rayleigh equation  (equation 1.1) which can be used to reveal the diameter at which a 
droplet of given charge and solvent will fissure - the so called Rayleigh limit, in this 
equation q is the charge on the droplet, 80 is the permittivity of the environment, 'y is the 
surface tension and D is the diameter of the droplet. 
q 2 = 87r 2 e0 yD 3 	 Equation 1.1 
The use of this equation falls down , however, when you consider it relies on the droplets 
being spherical in nature. Gomez and Tang showed this not to be the case when they 
obtained photographs of the ESI process and showed them to be deformed thus reducing 
the effective diameter of the droplets in places, allowing fission to occur before the 
droplet has reached the Rayleigh limit. 
The droplets that result from the fission go through the same process until only 
desolvated, charged analyte molecules are present. Figure 1.1 shows is a schematic 
representation of the ESI process. The charged ions produced by ES1 are of the same 
polarity as the needle and are therefore repelled from it and attracted towards the counter 
electrode (typically a skimmer or a capillary) through which they are drawn into the mass 
spectrometer. 
Initially two mechanisms were put forward for the final stage of the ESI process i.e. the 
production of a 'naked ion. The first mechanism, known as the charged residue model 
(Dole et a1 32), postulates that the droplet fission process occurs until there is no solvent 
remaining, leaving only a charged gas phase ion. The second mechanism. the ion 
evaporation model (Iribarne et a1 36), proposed that once the droplets reached a certain size 
analyte ions were ejected from the droplet due to coulombic repulsion. It was initially 
thought that ions of molecular mass <2000 Da were produced by ion evaporation whilst 
those of mass > 2000 Da were produced by the mechanism described by Dole. However, 
the ion evaporation model has now largely been discredited thanks to the research of 
Williams and all ions produced by ESI are believed to be formed via the charge residue 
mechanism37 . 
1. Introduction 
The true beauty of ESI is its ability to produce highly charged ions of low m!z meaning 
large molecules can be analysed easily even on instruments with small mass ranges. This 
is what makes ESI particularly useful for the study of biomolecules. A small protein such 
as ubiquitin has a mass of —8,500 Da; with only one charge present this would be 
undetectable on a large number of mass spectrometers (e.g. most quadrupole 
instruments). However, ubiquitin has 11 basic residues (i.e. lysine and arginine) which 
can be protonated (i.e. charged positively) in positive ionisation mode; the large amount 
of charge present on a droplet produced by ESI means that it is possible to charge some 
or all of these basic residues thus reducing the mlz of the ions, meaning they are now 
detectable on almost any MS. 
Another feature of ESI that makes it particularly useful for the analysis of biomolecules is 
that it is an extremely soft ionisation process; little or no fragmentation is seen for even 
the largest of molecule. This has led to the use of ESI-MS for the analysis not only large 
proteins but also large complexes of biomolecules of up to several MDa molecular mass. 
The advent of ESI has revolutionised mass spectrometry and opened up whole new field 
of study for MS users - this will he discussed in more detail in section 1.3. 
Nanoelectrospray ionisation (nano-ES1) 8 is a related technique which allows much lower 
volumes of sample to be used in the course of an experiment. In nano-ESI the sample 
solution is sprayed from a glass capillary which has been pulled out into a fine point of 
only a few micrometers diameter. The voltage (1-1.5 kV) can either be applied directly 
to the solution via a platinum wire or to the glass capillary itself by coating it in an inert 
metal (e.g. Pt, Au). The sample flow rate used for nano-ESI is at least an order of 
magnitude lower than that required for standard ESJ (5 1.il in a capillary can often last an 
hour or more). Aside from the obvious benefit of lower sample consumption, nano-ESI 
is also thought to be more sensitive (the droplets produced are smaller than for ESI and 
therefore require less desolvation) and more salt and contaminant tolerant than ESI. For 
these reasons, nano-ESI is the technique of choice for much of this work. 
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1.1.2 Mass Analysers 
The mass analyser is the heart of any MS experiment; it is where the ions are separated 
by miz such that they can be detected. There are many different types of mass analyser 
from the relatively simple and cheap quadrupole, to the complicated and extremely 
expensive Fourier Transform Ion Cyclotron Resonance Mass Spectrometer (FTICR). 
Different types of mass analyser offer different features and each has its advantages and 
disadvantages that must be weighed up. Factors that may affect the choice of mass 
analyser include: 
Resolution - the ability to differentiate between two ions with a small rnlz 
difference 
Mass accuracy - how well the m/z can be assigned 
Mass range 
Sensitivity - essentially a measure of how well the analyser transmits ions 
Ease of use 
Additional features - e.g. can it be used to trap ions? 
Cost 
While the choice of mass analyser is often dependent on what is available, given a free 
choice, it is usually a play-off between the quality of data required and the cost of 
analysing a sample. In general high resolution, high sensitivity instruments are more 
expensive - in terms of initial purchase and day to day running - than low resolution, low 
sensitivity instruments. 
This section will focus on the three different types of mass analyser used in this work 




Quadrupoles are probably the most common type of mass analyser in use today, due in no 
small part to their relatively low price and comparatively simple operation. They were 
developed by Wolfgang Pau1 39 (in tandem with his Nobel Prize winning work on the 
development of the quadrupole ion trap) in the early 1950s. They consist of four parallel 
(usually circular) rods to which a fixed DC potential (or offset) is applied along with an 
alternating RF potential. The rods are paired such that directly opposite rods are in phase 
with each other with regard to the RF, while adjacent rods are 180° out of phase i.e. when 
one rod is positive w.r.t the RF ground, the rods next to it are negative and vice versa. 
The trajectory of an ion passing through a quadrupole is complex: it is dependent on the 
spacing of the rods (a fixed parameter), the amplitude of the applied potential and the 
frequency of the RF. The total electric field experienced by an ion travelling in the x-
direction through a quadrupole is described in equation l.22  where 00 is the total 
potential on the rods, U is the DC potentival, V is the zero-to-peak RF voltage and co is 
the angular frequency of the RF where w = 27rv, where v is the RF frequency. 
= 	+ V cos w) and - cI t, = -(u + V cos wt) 	Equation 1.2 
Figure 1.2 is a schematic diagram of a quadrupole, the first potential described is applied 
to one pair of rods (labelled ±) while the second is applied to the other pair (labelled -). 
From the equations it is clear to see that the potential applied to the rods varies 
sinusoidally with time t. This varying potential causes ions to pass through the 
quadrupole with an oscillating trajectory; for an ion of a given mlz there is a set of values 
of U, V and w that give rise to a stable trajectory allowing transmission of the ion. These 
values are specific to that mlz and ions of all other mlz to have unstable trajectories 











Figure 1.2: Schematic diagram of a quadrupole mass analyser. The red ion has a stable trajectory 
through the device and is therefore transmitted. The blue ion has an unstable trajectory and 
collides with the rods. 
For most situations, quadrupoles will be set up to transmit ions within a given mlz range; 
this is usually achieved by scanning the RF amplitude (V). By detecting ions at the end 
of the quadrupole and relating their detection time to the applied potential it is possible to 
determine the m/z and therefore produce a mass spectrum. 
Another common use of quadrupoles is as mass filters where they are set to transmit only 
ions of one specific m./z. This is particularly useful for tandem MS instruments in which 
an ion is selected in order to dissociate e.g. by CID. 
1.1.2.2 Time of Flight 
The concept of time of flight (ToF) mass analysis was first described by Stephens in 
l946 ° but it was not demonstrated practically until 1955 when Wiley and McLaren 
published their design of a ToF instrument which went on to become the first commercial 
ToF mass spectrometer 41 . 
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In a ToF experiment, ions are accelerated over a short distance by a potential difference; 
they then enter a field free region through which they drift at a velocity dependent on the 
ions m./z. The time taken for an ion to pass through a set distance (flight time, t1) can 
therefore be used to find its m/z. Equations 1 .3. 1.4 and 1.5 describe the effect of the 
acceleration potential on the ions and how it is related to time of flight where: Ek is 
kinetic energy. m is mass, v is velocity, q is charge, e is the charge on an electron, z is the 
number of charges on an ion, V is potential (voltage), d is distance and tf is the flight 
time. 
EK = Y2 17?,V -' 	 Equation 1.3 






From equation 1.3 it is clear that for a given kinetic energy 	veocty of an ion i  s 
dependent on its mass. From equation 1.4 it can be seen that the kinetic energy given to 
an ion in the acceleration region (pusher) varies linearly with charge i.e. a +2 ion will 
receive twice as much kinetic energy as a ±1 ion. Combining these two expressions and 
solving for time gives equation 1 .5. This shows how measuring tf can yield rnlz 
information. 















flight distance, d 
Figure 1.3: Schematic diagram of a linear ToF where the green, red and blue circles are low, 
medium and high mJz ions respectively. 
The far left of the diagram shows the pusher region where the ions are accelerated, the 
potential difference needed to cause this acceleration is brought about by periodically 
pulsing the far left plate with a high voltage. This accelerates a pulse of ions into the 
field free region where they separate by miz before being detected at the far end. Once 
all the ions have been detected, the pusher can be pulsed again to start the next ToF 
experiment. 
The potential experienced by an ion in the pusher will be dependent on its position within 
the pusher region; an ion adjacent to the first pusher plate will pass through a greater 
potential difference than an ion a few millimetres away. This difference in kinetic energy 
will result in two ions of the same m/z will result in them having slightly different flight 
times causing a loss in resolution. 
To overcome this problem. two different methods can be used: (i) delayed extraction - 




Reflectrons were first described by Mamyrm in the mid-1970S 42 . It is a series of grids 
and ring electrodes used to create a retarding field. In ToF MS a reflectron is positioned 
at the opposite end of the flight tube from the pusher/source and is used to reflect ions 
back through the flight tube to a detector near the source. The depth an ion will penetrate 
into a reflectron (and hence the time it will spend within the reflectron) is dependent on 
its kinetic energy - an ion with high energy will penetrate the reflectron further than one 
with lower Ek.  By tuning the reflectron voltage correctly it is possible to bring ions of 
the same rn!z with slightly different Ek into focus at the detector. Figure 1.4 shows a 
schematic of this process. 
Source 	




Figure 1.4: A refiectron ToF instrument. The filled square and open square represent ions of the 
same rnz with different Ek (filled square - high, open square - low). The high energy ion has a 
greater velocity and reaches the reflectron first: it spends longer in the reflectron then the low 
energy ion, exiting later (but with higher Ek).  If the reflecnon voltage is correctly, both ions 
reach the detector simultaneously giving higher mass resolution. 
1.1.2.3 Fourier Transform Ion Cyclotron Resonance 
Fourier Transform Ion Cyclotron Resonance Mass Spectrometry (FTICR-MS) was 
developed in the 1970s by Comisarow and Marsha11
444 . It works on the principle that in 
the presence of a magnetic field, ions will be subject to the Lorentz force which will 
cause them to process in a circular path perpendicular to the magnetic field in a direction 
dependent on the ions polarity. Figure 1.5 shows this motion for positive and negative 
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charges and equation 1.6 describes the Lorentz force where F is the force, q is charge. v 
is velocity and B is magnetic field strength. 
9161W4I~  
Figure 1.5: The effect of a magnetic field on positive and negative charges. 
F = qvxfi 	Equation 1.6 
The ions process at a frequency - known as the cyclotron frequency, w - dependent on 
their rniz as described by equation 1 
w =q/ 	
Equation 1.7 
This frequency is the same for all ions of the same mj'z.regardless of their kinetic energy 
It is this cyclotron motion that is exploited in FTICR. 
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Figure 1.6: An FTICR cell showing the tapping plates (blue), excitation plates (green) and 
detection plates (yellow). 
In an FTICR experiment, ions are injected into the cell through the front trapping plate 
and trapped within it  by rapidly raising the voltage on the trapping plates. 
The ions are detected on a pair of detection plates on opposite sides of the cell; when an 
ion passes a detection plate it induces an image charge on the plate and therefore sets up a 
potential difference between the two detection plates. The difference in charge between 
the plates produces a current which oscillates with the same frequency as the cyclotron 
motion. Measuring the frequency current will therefore allow the m/z of the ions to be 
determined. The magnitude of the current seen is dependent on the distance the ion is 
from the plate, the charge on the ion and the abundance of that ion. 
Upon entering the cell the ions begin to exhibit cyclotron motion, however, the motion of 
ions of any one miz is incoherent i.e. the ions are distributed randomly about their orbit 
and are therefore undetectable. Further to this, the radius of the ions on entering the cell 
is too small to allow detection - the ions must be excited to a greater radius in order for 
them to be detected. This excitation is achieved by applying a resonant frequency (i.e. a 
frequency equal to the cyclotron frequency of the ions of interest) to the pair of excitation 
plates. The excitation pulse has the added function of bringing all ions with the same niiz 
into resonance with each other creating a packet of ions precessing together. After the 
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excitation the ions are therefore in a coherent packet at a detectable distance from the 
detection plate S45. 
Early ICR experiments used single frequency excitation, exciting one mlz at a time; this 
was an inefficient method of obtaining mass spectra as separate scans are required for 
every mlz resulting in a loss of resolution. By using broadband excitation (i.e. exciting a 
wide range of mlz simultaneously) it is possible to measure an entire spectrum in one 
experiment. The data output from the detection plates in this case is a superposition of 
the signals obtained for all ions present. To convert this complex, frequency scale data 
into discreet mlz data, a Fourier transform is performed. 
The primary advantage of FTICR-MS over any other MS technique is its unsurpassed 
mass resolution 45 . The main reason for the high resolution is the extreme stability of the 
magnets used; their fields vary by only very small amounts over a long period of time 
(reportedly parts-per-billion over many hours). Secondly, the orbital motion of the ions 
averages out any inhomogeneity in the magnetic field (c.f. spinning samples in NMR). 
This means that the magnetic field strength is known to an extremely high accuracy and. 
as the frequency can be measured to an equally impressive accuracy, the m!z of species in 
the cell can be calculated to extremely accurately. More importantly, there is little peak 
broadening hence the high resolution and mass resolving power. 
1.1.2.4 Tandem Mass Spectrometry 
Tandem mass spectrometry (MS) describes any MS method involving at least two stages 
of mass analysis, usually in conjunction with a dissociation process. This can involve 
the combination of two mass analysers (MS/MS) - using the first to isolate an ion of 
interest (parent ion) and the second to analyse product ions - such as quadrupole and time 
of flight: or the use of a single trapping mass analyser (Paul trap or FTMS) in which ions 
can be stored, dissociated and re-analysed a number of times. 
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The most common dissociation technique used in these experiments is collision induced 
dissociation (CID). In this process a portion of the kinetic energy of the ions is 
converted to internal energy by collision with neutral molecules. The excess internal 
energy brings about fragmentation of the ions. For proteins and peptides this 
fragmentation occurs at the amide bond producing well defined fragment ions which can 
be used to sequence the molecule. 
Other dissociation techniques used include surface induced dissociation (SID) 47 - a 
technique that uses ion-surface collisions to induce fragmentation; electron capture 
dissociation (ECD)48 - where dissociation is mediated by interaction with a beam of 
electrons: and infrared multi-photon dissociation (IRMPD) 49 - where dissociation is 
brought about through excitation with an IR laser. 
1.1.3 Detectors 
Clearly FTICR mass analysers also function as ion detectors, other mass spectrometers 
however, require a separate detector after the analyser. Most MS detectors use the 
incident ions to generate secondary electrons which are further amplified to create a 
detectable current. The three most common detectors are: (i) electron multiplier; (ii) 
photomultiplier: (iii) microchannel plate (MCP). These will be discussed in turn. 
i. 	Electron multiplier' : these consist of a series of dynodes held at sequentially 
increasing potential. Ions from the mass analyser are incident on the first (lowest 
potential) dynode causing the release of secondary electrons; these secondary 
electrons are incident on the next dynode where further electrons are produced. 
This process continues along to the end of tube by which point the signal has been 
amplified by 106.  The electrons are then detected as a current. Figure 1.7 is a 
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Figure 1.8: Electron multiplier. 
Photornultiplier tube 46 : this works on a similar principle to the electron multiplier. 
The ions are incident on a conversion dynode and generate electrons. These 
electrons are then incident on a phosphor screen causing the generation of photons 






Figure 1.9: Photornultiplier detector 
Microchannel plate: ToF instruments often use microchannel plate (MCP) 
detectors: these consist of a glass plate with many channels each similar to an 
electron multiplier. An ion incident on one channel will produce over 1000 
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Figure 1.10: Schematic representation of a microchannel plate 
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1.2 Ion Mobility Spectrometry 
This section will discuss the theories and concepts behind ion mobility spectrometry 
(IMS) and the types of instrumentation used, concentrating on the relatively recent 
development of ion mobility mass spectrometry (IMMS). 
1.2.1 Theories and Concepts 
The behaviour of ions moving through gases was thoroughly described by Mason and 
McDaniel in their excellent book "Transport Properties of Ions in Gases" 51 . Much of the 
theory described here is adapted from that work. 
In IMS. an electric field is used to separate ions in a buffer gas based on their mobility in 
that gas. A typical IMS experiment requires the injection of a pulse of ions into a 
chamber filled with a known gas at a known pressure; an electric field is then applied 
across the chamber and the time taken for the ions to pass through the chamber is 
measured. Upon injection into the chamber (drift cell), the ions experience an 
electrostatic force pulling them through the cell; this force is counteracted by collisions 
between the ions and the buffer gas. The velocity of the ion quickly reaches a constant 
known as the drift velocity, Vd which can be determined by measuring the time taken for 
an ion to pass through the drift cell, td. 
The behaviour of an ion moving through a gas under the influence of an electric field is 
dependent on its energy which is determined by the ratio of electric field strength to 
buffer gas number density, E/N 2147 . At low E/N the ions are said to be in the low field 
limit, under this regime the ions have low velocities which are independent of the field 
strength. At higher E/N the ions may align in the field and their motion becomes 
dependent on the field strength. In the low field limit, the motion of the ions can be 
described in more simple terms and most ion mobility measurements are therefore 
performed below the low field limit. 
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Under these conditions it is possible to define the low field mobility, K, as the constant of 
proportionality between drift velocity, Vd,  and electric field, E as shown by equation 1.8. 
Vd = ATE 	Equation 1.8 
Drift velocity of an ion depends on gas pressure, electric field, the charge on an ion and 
its shape. The mobility, K, must therefore contain terms relating to molecular shape, 
charge and buffer gas pressure. In the limit of vanishing electric field and ion 
concentration, the mobility of an ion can be described by Nernst-Townsend-Einstein 
relation, which is obtained as follows: 
Firstly, the ion flux density, J, of an ion is stated using Fick's law of diffusion: 
J = DVfl 	Equation 1.9 
Where D is the diffusion coefficient and n is the number density of the buffer gas. J can 
also be described in terms of drift velocity: 
J = flVd 	 Equation 1.10 
Allowing Fick's law to be stated in the following form: 
V  = _
(D 
 )V11 	Equation 1.11 
11 
Combining equations 1. 8, 1.9 and 1.10 gives: 
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J = nKE - DVn 	Equation 1.12 
To find an expression for Vn we take the equilibrium case where J = 0 and the ion 
distribution as described by a Boltzmann exponential: 
+ zeE . r 
ii = n exp 	
kl?T 	J Equation 1.13 
Where z is the integer number of charges on the ion, e is the charge on an electron, r is 




11 	k b T)  
Which combined with expression 1.11 at J = 0 gives: 
(zeD_\\ 
) 	
Equation 1.15 k , T  
Or: 
K = ZeD 
k/)T 	 Equation 1.16 
Chapman-Enskog theory 52  allows mobility of an ion to be related to its rotationally 







Where t is the reduced mass of the buffer gas and ion of interest, and N is the number 
density of the buffer gas. 
From equation 1.17 it is clear that, in the low field limit, the mobility of an ion is 
dependent on its charge, cross section, temperature and mass, along with the pressure of 
buffer gas used in the experiment, but independent of the electric field as stated 
previously. For large molecules, such as peptides and proteins, the reduced mass 
approaches the mass of the buffer gas and the mobility is therefore essentially mass 
independent. 
In an ion mobility experiment, all parameters apart from rotationally averaged cross 
section. can be determined directly. The mobility of the ion is therefore a measure of its 
collision cross section. For any one species, a compact ion with a small cross section 
(e.g. a folded protein) will have higher mobility than a more extended ion with a larger 
cross section (e.g. a denatured protein). 
In order to make comparison across different instruments, where temperature and 
pressure may vary greatly, the mobility of an ion is usually expressed in terms of the 
reduced mobility, K0 as shown in equation 1. 18 2("21 where p is the pressure in mmHg and 
T is the temperature in Kelvin. 
K =  0 	
760 	T 	 Equation 1.18 
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1.2.2 Experimental Set-up 
Traditionally. IMS was used as a stand alone technique to monitor the gaseous 
environment in a variety of locations. The instruments used vary in size from the small, 
hand-held instruments used in the defence industry to detect the use of chemical weapons 
to the large scale instruments used in the semiconductor industry to monitor contaminant 
level. More recently, IMS devices have been coupled to mass spectrometers to allow 
simultaneous collection of mobility and mass data via ion mobility mass spectrometry 
(IN'IIMS)2021 . 
Stand-alone IMS instruments can operate at a wide range of pressures but experiments 
are often performed at atmospheric pressure for ease of operation. Mass spectrometers, 
however, function at pressures below atmosphere (10 -4 to 10" mTorr); IMS devices 
coupled with mass spectrometers are therefore usually housed within a vacuum chamber. 
Several different types of IMS device have been described in the literature and each of 
these will be discussed in turn: the basic experimental set-up , however, is common to all 
IMS devices. Much like MS. IMS devices require three basic components: (i) an ion 
source: (ii) the mobility chamber (drift cell); and (iii) a detector. 
Ion sources and detectors have been covered in detail in section 1. 1 the different types of 
IMS will be covered in the following sections. Discussion of specific instruments will be 
restricted to IMMS instruments. 
1.2.2.1 Linear Ion Mobility 
This is the most common and the most well understood type of ion mobility 
spectrometry. A typical experimental set-up requires a drift cell which can be held at 
some elevated pressure relative to the vacuum chamber; the cell must also be designed 
such that a linear electric field can be applied to it. Providing the low pressure limit is 
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observed (EN < 2 Td), ions in such a device will behave according to the equations 
outlined in section 1.2.1. 
Figure 1.11 shows the linear ion mobility cell used in the Bowers group at UCS13 53 . 
Figure 1.11: Linear ion mobility cell used in the Bowers group. (a) cooling line, (b) cell body, 
(c) buffer gas inlet, (d) cell end cap, (e) drift guard ring, (1) ion entrance hole, (g)  ion focusing 
lens, (h) ceramic ring, (i) ion exit hole, (j) ceramic rod holding guard rings. (k) ceramic rods 
holding cell assembly. 
The cell is constructed from a copper block, a copper end cap and a ceramic ring to 
separate the two. The block can be heated by electrical heaters and cooled with a flow of 
liquid nitrogen, the end cap has a separate temperature control. The drift field is provided 
by a set of ring electrodes connected by a set of precision I MQ resistors. The total drift 
length is 4.503cm, the cell temperature can be varied between 80 K and 800 K. Typical 
buffer gas pressure is 4-5 Ton allowing for drift voltages of 2 to 20 V/cm. Higher 
temperature and pressure is possible with some modification to the cell. 
W. 
1. Introduction 
This cell design has a resolution of around 20 and has been used in a number of 











Figure 1.12: (Top) Cross-sectional view of entire instrument as viewed from the top. (Bottom) 
Perspective cross-sectional view of source, funnel and cell. (a) and (b) vacuum chambers, (c) 
pump ports, (d) source flange, (e) ion funnel, (f) drift cell, (g) quadrupole mass analyser, (h) 
conversion diode. (i) detector, (j) capillary heating block, (k) insulator, (I) funnel first section. (m) 
funnel second section, (n) funnel third section, (o) funnel flange, (p) hat flange, (q) second pump 
stage. (r) cell body, (s) cell end cap, (t) ceramic ring, (u) guard rings, (v), (w) and (x) ion optics. 
This instrument consists of an ESI source, ion funnel and drift cell followed by a 
quadrupole mass analyser. The ion funnel is a high transmission RF ion guide which has 
o functions: firstly, it compresses the divergent stream of ions produced by the source 
into a small diameter; secondly, it transports the ions from the source to the cell at low 




In a typical experiment, the ions are created in the ESI source and pulled through the ion 
funnel towards the drift cell; they are then trapped in the final section of the ion funnel 
and pulsed into the drift cell to start an ion mobility experiment. The ions are then mass 
analysed by the quadrupole and detected on the detector - this detection event also stops 
the IMS experiment. 
Several similar instruments (IM followed by MS) have been described in the 
literature 55.56.57-58'  including those used in the Clemmer group at The University of 
Indiana. This group has been responsible for a number of exciting advances in the field 
of IMMS including the development of multidimensional ion mobility (IMS").They were 
the first group to demonstrate the use of a ToP MS as a back end for an IMS device 9 . 
The original instrument consisted of an IMS device followed by a ToF, it was 
subsequently improved upon by the addition of a quadrupole mass analyser followed by 
an octapole collision cell between the drift cell and the ToF 6° and finally the addition of 
an ion trap prior to the drift cell; this set up allows IMS-MS-MS experiments to be 
performed. A diagram of this instrument is shown in figure 1.1361. 
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Figure 1.13: (HPLC)-ESI-IMS-Q-o-ToF instrument. 
30 
1. Introduction 
The challenge of this technique is that drift times and mass spectra of several different 
ions must be measured simultaneously. This is possible because ToF flight times are 
very much shorter than drift times (ps as oppose to ms), therefore flight times can be 
nested' within the time windows of the ion mobility spectra. Ions are injected into the 
drift cell at a rate of 10-30 Hz and into the ToF flight tube at a rate of 104  Hz, or 
approximately 1000 times for every injection into the drift cell, therefore it is possible to 
observe all mlz present in a drift time window using a ToF MS. 
In this set-up 57 ions are produced by the ESI source and stored in the ion trap before 
being injected into the drift cell where they are separated. The ions then pass through the 
quadrupole to the ToF where they are sampled at a pre-defined rate, mass analysed and 
finally detected on the MCPs. The quadrupole is typically set to transmit, it can be 
Sparked' on an individual mass to allow a specific ion to be dissociated in the collision 
octapole. 
The arrival times, t a, measured on the MCPs are a composite of the time the ions spend in 
the drift cell. td , the flight time in the ToF.. Tf and the time spent in the rest of the 
instrument (ion optics etc.) - the dead time, t. By accurately measuring ta and tf it is 
possible to determine t and hence calculate td. 
Clemmer et al first reported this method as a technique to simultaneously measure 
conformations of different charge states of peptides, a technique also used by Hill and 
co-workers62 . The method has also been used to separate and analyse complex 
mixtures63 . 
The Clemmer group have recently reported a variation on this instrument using a new 
type of linear IMS device which uses a split-field drift tube to separate and fragment ions 
within the same device 65 . A schematic diagram of the instrument is shown in figure 
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Figure 1.14: Diagram of the Clemmer group split-field drift tube instrument. Ions are created in 
the ESI source and transferred to the linear trap from where they are pulsed into the drift tube and 
separated before detection using the ToF MS. Figure taken from reference 65. 
The drift cell differs from a standard mobility cell as the later portion of it can be 
operated at both high and low drift fields. With this portion at low drift field, the device 
is used as a standard IMS drift tube: with the latter part of the drift tube at high drift field, 
dissociation of the ions occurs causing the formation of CID type fragments. This set-up 
allows mobility separated conformers to be dissociated thus revealing difference in the 
covalent structure of the conformers studied. 
This technique has been furthered by the advent of multidimensional IMS in the same 
group6667 . In IMS-IMS, two drift cells are coupled together separated by an ion funnel 
and ion gate. An instrument schematic is shown in figure 1.15 66  
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Figure 1.15: Schematic diagram of the Clemmer IMS-IMS-ToF instrument. The drift regions 
(Dl and 1312), ion funnels (F1-F3). ion gates (Gi and G2), ion activation regions (IA1-1A3). and 
resolution (R) of specific components are labeled. 
This instrument offers four modes of operation: 
Both drift tubes are used together: ions are separated in the first drift nthe 
refocused by the ion funnels into the second drift tube where they are further 
separated. This allows high resolution (80-160) mobilities to be determined. 
IMS-IMS: ions are separated in the first drift tube but only a selected window 
of these ions is allowed to enter the second drift tube. This allows ions with a 
specific mobility to be selected for further analysis. 
Activation of mobility selected ions: ions are mobility selected in the first drift 
tube as in (ii) before activation/dissociation in the ion funnel (1A2). The 
resultant ions are then analysed in the second drift tube. 
Parallel dissociation: ions are dissociated in 1A2 as described in (iii): further 
dissociation is carried out after the second mobility separation in the post cell 
ion funnel (1A3). 
Clearly this development represents a new and exciting avenue for IMMS offering an 
extremely versatile instrument capable of performing a number of different experiments. 
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Not all groups use the IMS followed by MS set up used in the instruments described 
above. Several groups use MS-1MS 68 or MS-IMS-MS 9 set-ups. The MS-IMS-MS 
approach was pioneered by Bowers and Kemper 
70 
 who used a double focussing mass 
spectrometer (MSI) before the drift cell with a quadrupole mass analyser after the drift 
cell. Fiure 1.16 is a schematic diagram of the instrumen0' . 
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Figure 1.16: The Bowers and Kemper MS-IMS-MS instrument. 
The advantage of this sort of set-up over and IMS-MS set-up is the ability to mass select 
ions prior to IMS separation thus allowing greater experimental control. This sort of set-
up has since been used in conjunction with other mass analysers including FTICR, 
quadrupole, quadrupole ion trap and ToF. Weis et al.' 1 report an experimental 
configuration where a ToF is used to pre-select the ions this is a particularly useful front 
end as the ToF has no theoretical upper mass limit and it requires short (<l.xs), intense 
bundles of ions which are ideal for injection into the cell. 
One disadvantage of MS-IMS-MS (and MS-IMS) instruments is that they are generally 
restricted to relatively low pressure (3-10 Torr) ion mobility devices due the pumping 
requirements for the pre-cell MS. 
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1.2.2.2 High Resolution Linear Ion Mobility 
The resolution of an ion mobility measurement is limited by the diffusion of the ion 
packet as it passes through the tube. It is defmed by equation 1.1 972  where td is the drift 
time, t1 is the peak width at half height and Vd is the voltage drop across the cell (drift 
voltage). 
td 	11 ze 	V \ (a_)y 
1,v4kb 1n2) T 	
Equation 1.19 
Clearly, the resolution of an instrument can be increased by decreasing the temperature of 
the drift cell. This, as will be shown later, may have an effect on the conformations 
adopted by the ions being studied. It is therefore more practical to increase the drift 
voltage. In order to keep the ion motion within the low-field limit it is necessary to 
increase the number density of the gas (i.e. the pressure) along with the drift voltage. 
Increasing the buffer gas pressure presents a number of practical problems, most notably 
at high pressure it becomes more difficult to get the ions into the drift tube due to the 
quantity of buffer gas flowing out of the drift cell. To overcome this it is necessary to 
increase the ion injection energy, as some of this energy is converted to internal energy, 
increasing the injection energy too much can bring about fragmentation of the ions. In 
the set-up developed by Dugourd el a173 , this is overcome by housing the source and drift 
cell together allowing the ions to be transferred directly into the drift region. Figure 1.17 
shows a schematic of this instrument. 
The resolution of a drift tube is defined in equation 1.19 where Atd is the drift time spread 
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Figure 1.17: A schematic representation of the high resolution IMS instrument developed by the 
Jarrold group. It uses a laser vaporisation/desorption source to produce ions which are introduced 
directly into the drift cell via an ion gate. The drift cell is 63cm long and is typically held at 500 
Ton, at such pressure it can be used with voltage drops up to 15000V. The ions are then mass 
analysed and detected using a quadrupole MS. 
High resolution IMS-MS instruments have also been reported by the Hill group including 
an ESI instrument and an ambient pressure drift cell instrument 74 . 
1.2.2.3 Travelling Wave Ion Mobility 
A new ion mobility separation technique has recently been launched commercially by 
Waters Micromass Technologies (Manchester. UK) 7 . It uses an elevated pressure 
stacked ring ion guide (SRJG) 6 as a mobility cell 77 . A SRIG is an ion guide consisting of 
a stack of thin ring electrodes arranged in a sequence with opposite phase RF applied to 
consecutive electrodes as shown in figure 1.18,13  . The RE provides a potential well which 








Figure 1.18: An RF only stacked ring ion guide. 
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In order to propel the ions through the device, a travelling wave DC voltage is 
superimposed on top of the RF voltage. This voltage is applied sequentially to pairs of 
ring electrodes providing a potential which can push ions through the device as shown by 
figure 1.1973. 
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Figure 1.19: Pulse sequence for travelling wave SRIG mobility device. 
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At low pressure the travelling wave provides an effective method of transmitting ions 
through the SRIG. At elevated pressure (-1 rnBar) the ions can be separated based on 
their mobility: ions are pulsed into the cell and remain in the first region until they 
experience a travelling wave; the ions then 'surf on the wave as it passes through the 
cell. As in other ion mobility methods the progress of the ions through the cell is retarded 
by collisions with the buffer gas, because of this the ions will eventually fall off the back 
of the wave into the potential well behind it where they remain until they experience the 
next wave. The distance an ion travels before it falls off the wave is mobility dependent; 
a high mobility ion will 'surf on the wave for longer than a low mobility ion. The device 
can therefore be used to separate ions by mobility. 
It is not clear , however, whether mobility values (and hence cross sections) can be 
measured directly using this method. While the ions are reported to be in the low field 
limit in this device, their motion is complex and non-linear. The equations outlined in 
section 1.2.1 are therefore not applicable to this device. 
In order to obtain cross sectional information from this device, a calibration technique 
was described by Thalassinos et a1. They related the arrival times measured in this 
device to cross sections obtained from linear ion mobility measurements in order to 
provide a calibration equation; they showed good agreement with literature for a number 
of peptides. 
The main advantage of this device over a linear mobility device is its high transmission 
efficiency. The ions are very effectively constrained by the RF field and are efficiently 




High-field Asymmetric Waveform Ion Mobility Spectrometry (FAIMS) was developed 
in Russia in the 1980s798° and launched commercially by lonalytics Co. (Ottawa, 
Canada) as an atmospheric pressure mobility device for front end separation of ions prior 
to MS analysis 81 . 
It is a two electrode system that uses the difference in the mobilities of ions at high and 
low field to separate them. This is achieved by applying a square wave potential to one 
electrode consisting of a high positive voltage for a short time followed by a lower 
negative voltage for a longer time. The nature of the collisions with the gas at high field 
strength can affect the mobility of the ion making it either more of less mobile than at 
low field. In FAIMS the ions are carried through the device not by the electric field but 
by a flow of carrier gas; the applied electric field is perpendicular to this gas flow and it is 
in this direction they are separated. 
Figure 1.20 shows the waveform used in a FAIMS experiment. 




Figure 1.20: Waveform used in FAIMS experiments. DV is the dispersion voltage — the 
amplitude of the high field pulse. The waveform is set such that the voltage-time integral for the 
high field pulse is equal to that of the low field pulse. 
Figure 1.21 —  shows the paths of three different ions through a FAIMS device. The far 
left ion has higher mobility at high field than low field causing it to move towards and 
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eventually collide with the bottom electrode. The far right ion has higher mobility at low 
field than high field causing it to move towards and eventually collide with the top 
electrode. For the centre ion, the mobility high and low field is balanced such that the 
mobilities at high and low field resulting in the average ion position being unchanged for 
a cycle of the FAIMS pulse - this ion is therefore transmitted out of the FAIMS device. 
Ion Hits Lower Plate 
	 Ion Hits Upper Plate 
Ion in 'Balanced' Condition 
Figure 1.21: Passage of ions of different mobility through a FAIMS device. 
In order to select ions of different mobility, a weak DC field known as the compensation 
voltage (CV) is applied between the electrodes. CV can be used to compensate for an 
ion's drift towards either electrode, bringing it back to the centre of the device and 
allowing it to be transmitted. 
The commercial version of FAIMS does not use the linear geometry shown above but 
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Figure 1.22: Cylindrical geometry ESI-FAIMS-MS device. 
Several groups have shown this device to be useful for conformational selection of 
ions 85 , spectrum simplification 86 and background subtraction'. The device does not 
however, allow low field mobility values - and therefore cross sections - to be 
determined. 
1.2.3 Mobility Calculations 
Clearly, from linear mobility (and calibrated t-wave mobility) experiments it is possible 
to determine the mobilities of different ions. Equation 1.17 can then be used to obtain 
cross section values from these mobility values. It is not clear however, how these cross 
sections can be used to give structural information about the ions. 
This is not a simple process, requiring many complex computational calculations. The 
start point for these calculations is obtaining candidate structures for the ions of interest. 
For smaller molecules <50 atoms, it is possible to perform precise quantum mechanical 
calculations on the molecules using programmes such as Gaussian S8 . Large molecules 
such as proteins and peptides , however, are too complex for such high level calculations 
and candidate structures are normally generated using molecular mechanics techniques 
such as AMBER89 . 
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These calculations use force fields - tables of atom types, parameters (bond length, bond 
angles etc.) and equations - from which the energy and geometry of a molecule can be 
calculated. 
(Ar)= 	k1 (b-b0 ) 2 + 	 19  (~ )2 Ykjd- 
honds 	 angles
Cii 
+ 	k[Cos(n + o)+ i]+ 	[q,qj + 	- 
torsions 	 non -bonded ru 	ii 
Pairs 
Equation 1.20 
Where the first term describes the stretching of the bonds, the second term describes the 
bending of the bonds, the third term describes the twisting of the bonds and the final term 
describes the non-bonded interactions between atoms namely the electrostatic interaction 
and the van der \Vaals interaction. 
The molecular modelling programs use this equation to model the potential energy 
surface of the molecule of interest. Candidate structures are generated by sampling this 
surface and minimising the energies of the molecules in order to sample its minima. 
This can be done by a number of methods; in this work a technique called simulated 
annealing is used90. In a typical simulated annealing calculation, an initial candidate 
structure is built within the molecular modelling program either by simply joining amino 
acids in the correct order and minimising the energy or by using a previously published 
structure from NMR or X-ray crystallography studies. The molecule is then heated to a 
temperature at which the molecular structure is lost (e.g. 800 K): dynamics are performed 
at this temperature for a set time (e.g. 30 ns) before the molecule is cooled to 0 K and 
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minimised. This process is carried out a number of times to produce a library of low 
energy structures. 
These calculations can be carried out in a number of different environments but in the 
case of calculations for ion mobility they are generally calculated in the gas phase. 
Once a library of gas phase structures has been created, the rotationally averaged cross 
sections of each can be calculated. This can be done by three different methods: (i) the 
projection approximation (PA): (ii) exact hard spheres scattering method (EHSS): and the 
trajectory method (TM). Each of these will now be discussed in turn. 
i. 	The Projection Approximation: this method treats all the atoms within a 
polyatomic molecule as hard spheres and assumes the interactions between the 
molecule and the buffer gas are simple hard sphere collisions. The collision cross 
section of the molecule is obtained averaging the cross section of the molecule 
over all possible orientations. The method was developed by Mack in 1925' 
before the advent of computational techniques; the measurement was performed 
manually using  beeswax models of the molecule of interest and determining the 
cross section based on the shadow cast by the model. This technique has since 
been applied computationally by a number of groups. 
The method has been updated somewhat by Bowers et a192 who included a 
temperature dependent term into their hard sphere modelling equations to allow 
some approximation of the long range interactions involved in the collisions. 
Variations in temperature can cause fluctuations in atomic radii which can in turn 
affect the collision cross section. This can be accounted for by the use of a (12. 6, 
4) potential to model the ion-buffer gas interactions. The Bowers group have 
made available a program. Sigma, which will calculate collision cross sections for 
candidate structures using this method 93 . 
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ii. 	Exact Hard Spheres Scattering 94 : the collisions between the ions of interest and 
the buffer gas in IMS cannot be completely described by the hard sphere 
scattering alone; in reality the temperature of the interaction and the nature of the 
collisions must be taken into account. 
The method described above accounts well for temperature effects for small 
molecules (<200 atoms) but falls down for larger systems as it does not fully 
describe the nature of the collisions. In reality, the collisions between the ions 
and buffer gas involve a degree of scattering that is not described by PA. To fully 
describe these collisions, the trajectories of the ion and buffer gas must be 
described before and after collision. Shvartsburg and Jan -old have described a 
method to account for this: firstly, the momentum transfer integral is calculated 
by averaging a function of the scattering angle over the impact parameter and 
collision geometry. This collision integral is then calculated by averaging the 
momentum transfer cross section over the relative velocities of the ion and buffer 
gas. 
ill. 	Trajectory Method99 : the EHSS method must be further refined to fully consider 
the long range interactions between the ion and buffer gas. To achieve this a 
potential must be described that includes all the interactions between the buffer 	- 
gas and all atoms in the polyatomic ion including Lennard-Jones type interactions 
and ion-induced dipole interactions. 
Table 1.1 is a reproduction from the excellent ion mobility tutorial by Clemmer and 
Jarrold 97 . It shows theoretical cross sections obtained by each method for (C60)7. (C60)13 o  
bovine pancreatic trypsin inhibitor (BPTI) and cytochrome C. The trajectory method has 
been reported to be the most accurate method for calculating theoretical cross sections for 




Cross Section (2) 
Compound TM EHSS PA 
(C f,o )' 226(1.00) 225 (0.99) 216 (0.96) 
(C 60 ) 813 (1.00) 787 (0.97) 683 (0.84) 
BPTI 927(l.00) 935(l.01) 767 (0.83) 
Cytochrome c 1334 (1.00) 1339(l.00) 1075 (0.81) 
Table 1.1: Theoretical cross sections of four different polyatomic molecules obtained from three 
different calculation methods. Values in parenthesis indicate the collision cross section divided 
by the value obtained from the trajectory method. 
It can be seen that as the molecular size increases - ( C60)2 being the smallest, cytochrorne 
c the largest - the values obtained by TM and PA become more divergent with the 
projection approximation underestimating the value by nearly 20% for cytochrome c. 
The agreement between TM and EHSS is good for all molecules studied and is seen to 
improve marginally for the larger molecules. This suggests two things: firstly, the largest 
source of error in the PS approach is its failure to account for scattering effects; secondly, 
the long range interactions included in the TM are of less importance for larger 
molecules. 
The TM is , however, the most computationally expensive method and is therefore 
unsuitable for very large molecules due to the time taken for each calculation 93 . EHSS is 
a less demanding calculation and —as shown above - gives comparable values to TM; 
EHSS is therefore the most appropriate method for calculating collision cross sections of 
very large molecules. 
Once candidate geometries have been generated for a molecule, the theoretical cross 
section can then be determined for each geometry by the most appropriate method. By 
comparing the theoretical values with those obtained from experiment it is possible to 
propose likely gas phase structures for ions. 
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1.3 Studying Biomolecules by Mass Spectrometry & Ion Mobility 
The term biornolecule is a fairly loose way of characterising the myriad of molecules 
found in living organisms ranging from the small building blocks - amino acids, nucleic 
acids, mono-saacharides - to the very large - proteins, DNA, poly-saacharides and 
complexes of each. The structures formed by these molecules have long been of interest 
to scientist who use the information to gain insight into the function of biomolecules. 
This work will focus on the study of the structure of proteins and peptides using gas 
phase techniques. Proteins and peptides have four levels of structure: 
I. Primary Structure: the sequence of amino acids that form the polymer. 
Secondary Structure: regions of repetitive structure such as a-helix and 3-sheets. 
Tertiary Structure: the arrangement of the 2° structure 
Quaternary Structure: the arrangement of polypeptide chains (identical or 
different) to form oligomers (dirners, trirners etc.). 
As stated previously, protein and peptide structure has traditionally been studied in the 
condensed phase by techniques such as X-Ray crystallography (XRC)', circular 
dichroism (CD) 98 , fluorescence spectroscopy 94 and NMR2 . 




Technique Advantages Disadvantages 
Accurate structural Large sample volume. 
XRC infonriation. 	trusted difficulty growing 
technique crystals, slow 
Accurate structural Large sample volume. 
information, dynamic often require 'non- 
N MR 
probe of structure, biological' solvents. 
non-destructive slow 
Large sample volume, 
Non-destructive. 
only higher order 






IR spectroscopy analysis, absorption of 
dynamic probe 
JR by water 
Difficult to accurately 
Fluorescence Dynamic probe. high assign fluorescence, 
Spectroscopy sensitivity low resolution, 
structural probe 
No water interference. High signal-to-noise. 
Raman Spectroscopy - 
2 	and '1 3 information poor reproducibility 
Table 1.2: Advantages and disadvantages of traditional hiomolecu]ar structural probes. 
Clearly each technique has pluses and minuses; NMR and XRC provide greater structural 
detail about the molecules but require high volumes of sample and often require unusual 
solvent conditions; fluorescence on the other hand can be performed on very low 
volumes of sample (as little as one molecule!) but only provides structural inforniation on 
lower level structure e.g. folded or unfolded. 
47 
1. Introduction 
Mass spectrometry and ion mobility have only relatively recently been applied to 
biomolecules. The combination of these techniques can provide a wealth of structural 
information for biomolecules from primary to quaternary structure. The great advantage 
of these techniques is the low sample volumes required; using nano-el ectro spray 
ionisation it is possible to gain structural information from attomoles of sample. Both 
techniques, especially MS. are also extremely fast especially in comparison to XRC and 
NMR. 
As discussed above, early ionisation techniques such as El were too harsh to transfer 
intact biomolecules into the gas phase; similarly, early mass analysers had insufficient 
mass range to analyse biomolecules. The advent of MALDI, ESI and more advanced 
analysers has provided a means of observing intact biomolecules in the gas phase. 
This section will focus on the study of biomolecules using mass spectrometry and ion 
mobility mass spectrometry. 
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1.3.1.1 Primary Structure Determination 
In its simplest form, primary structure determination by mass spectrometry requires only 
an accurate mass measurement. If the sequence of a protein is known, the mass can be 
calculated accurately from the molecular formula of the ion. 
Determining the mass of an intact protein by mass spectrometry is a relatively simple task 
best performed by ESI-MS. ESI-MS typically produces a series of multiply charge ions, 
the rn/z ratio of an ion with n charges is related to its mass, M by equation 1.21 where 
mi is the mass of the charge carrier (e.g. a proton). 
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M + nin 
in 
Z 
	 Equation 1.21 
From a high resolution mass spectrum it is possible to determine the charge on an ion 
based on the spacing between the isotopes which is equivalent to liz i.e. for an ion 
carrying one charge the isotopes are separated by I mlz unit; for an ion carrying three 
charge the isotopes are separated by 1/3 mlz units. From a low resolution mass spectrum 
the spacing between consecutive charge states can be used in conjunction with equation 
1.21 to find the charge state of each ion. Once the charge on each ion is known the mass 
of the molecule can be determined. 
For unknown proteins, a more complicated procedure must be used whereby the 
molecule of interest is broken apart to determine its sequence. This can be achieved by 
either peptide mass mapping or tandem mass spectrometry. 
i. 	Peptide mass mapping' °° : in this so called 'bottom up' approach to primary 
sequencing. the protein of interest is digested using a proteolytic enzyme such as 
Glu-C, chymotrypsin or trypsin. These enzymes cleave proteins at specific points 
hence producing predictable peptides. Trypsin, for example. cleaves peptides at 
the c-terminus of lysine and arginine (unless followed by a proline). 
In a typical experiment a protein (or mixture of proteins) is digested for a set 
period of time to generate a set of peptides. The peptide mixture is then analysed 
by mass spectrometry - most commonly MALDI-MS but also ESI-MS. Genome 
mapping projects such as the human genome projects have produced large 
databases of gene sequences from which protein sequences can be predicted. The 
peptide masses obtained from the MS are characteristic of the protein(s); the 
masses obtained are therefore compared to the protein sequences obtained from 
genome mapping in order to identify the protein present. This is done on a 
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statistical basis using programs such as MASCOT (Matrix Science Ltd., UK) 
which assign a probability score based on a number of factors including number 
of peptides identified. sequence coverage and the presence of missed cleavages. 
ii. 	Top down sequencirg: in top down sequencing tandem mass spectrometry is 
used to determine the primary sequence of the protein of interest. The intact 
protein is introduced to the mass spectrometer via ESI-MS. One ion is then 
selected and dissociated by CID, SID, IRMPD, BIRD, ETD or ECD. Much like 
bottom up sequencing, the masses produced are characteristic of the protein 
sequence and can be used to identify it from an online database. 
1.3.1.2 Higher Order Structure Determination 
Determination of higher order structures (2D,  3 and 4) of proteins is most reliably 
performed by XRC and NMR spectroscopy. However, many proteins cannot be studied 
by these techniques due to difficulties in producing crystals, insufficient sample etc. 
These sorts of proteins are. however, often suitable for MS studies. 
Higher order structure determination by MS can be performed by four main methods: (i) 
chemical cross linking; (ii) hydrogen/deuterium exchange; (iii) controlled fragmentation; 
and (iv) charge-state analysis. 
Chemical cross linking uses small organic compounds - designed to bind to specific 
amino acid residues - in order to create proximity maps of proteins. The technique was 
first reported in the mid-1950s by Zahn and Meienhofer to identify the dimeric structure 
of insulin"" - "' 2 . The cross-linking reagents are used as molecular rulers to determine the 
distance between residues ranging from no separation to 20 A99 . In order for the cross 
linking to occur on a native structure the reaction(s) are carried out under non-denaturing 
conditions. The specific residues to which the cross linkers are attached can then be 
determined by a combination of proteolysis. LC separation. MS and MS/MS. 
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Once the cross-linked locations are assigned a distance map for the protein(s) can be 
created. A number of groups have used this technique to characterise the 3° and 4° 
structures of a number of proteins and complexes including scallop myosin 
subfragment' °3 and the 19s proteosome particl&° 4 . 
Hydrogenldeuterium exchange mass spectrometry (HDX) is a probe of solvent 
accessibility that can be applied in the solution or gas phase. Initial studies into the 
reaction between deuterium oxide (D 20) and organic molecules showed that certain 
hydrogen atoms on a structure would exchange preferably for deuterium' °5 . For 
heteroatoms (type I hydrogen: -OH. -SH etc) the exchange rate was shown to be rapid 
while hydrogens attached to carbon atoms (type III hydrogen) do not exchange. 
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Figure 1.22: Schematic diagram of a peptide with the three different types of hydrogen assigned. 
Type I - side chain hydrogen; type II - backbone hydrogen: and type III - aliphatic hydrogen. 
For proteins and peptides, a third type of hydrogen exists - the backbone amide hydrogen 
(type II hydrogrens). As with other heteroatoms, type II hydrogens exchange for 
deuterium rapidly. Figure 1.22 is a schematic of a segment of peptide (sequence FVN) 
with the three different hydrogen types labelled. 
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Solution protein structure can be probed by exposing the protein of interest to D20. The 
exchangeable hydrogens (types I and II) will then exchange for deuterium at a rate 
dependent on the solvent accessibility. Hydrogens involved in hydrogen bonding 
interactions are somewhat protected from exchange and hydrogens in regions of the 
protein sequestered from the solvent in the core of the proteins can be completely 
protected from exchange. The rates of exchange of different hydrogens can therefore 
indicate how well folded a protein is' 6 . This can be monitored by MS as the exchange of 
one hydrogen for one deuterium results in a mass increase of approximately 1 Da. 
The kinetics of the HDX process can be monitored by time course experiments where the 
mass of the sample is measured at different times after exposure to D20, the degree of 
exchange with time can give information about the structure of the molecule. The sites of 
exchange can be identified by proteolytic digest with pepsin and MS/MS experiments. 
The type of experiment described above is known as direct infusion HDX. specific 
assignments of exchange sites and the exact amount of exchange is difficult to determine 
precisely by this method due to a combination of back exchange to hydrogen and 
deuterium scrambling (movement of the deuterium from one site to another). 
Gross and co-workers have recently described a new method which probes only the 
exchange of backbone hydrogens' 06 . The method is called protein ligand interaction by 
mass spectrometry titration and hydrogen/deuterium exchange or PLIMSTEX. This 
method exploits two factors of H/D exchange rates. Figure 1.23107  shows the exchange 
rate of backbone amide hydrogens at different pH and temperature. The room 
temperature exchange rate at pH 2.7 can be seen to be four orders of magnitude slower 
than that at pH 7.0, reduction of the temperature to 0 °C produces a further order of 
magnitude reduction in the exchange rate. 
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Figure 1.23: Amide backbone exchange rates and exchange half-life (t1 :) at different 
temperatures and pHs. 
In PLIMSTEX, the protein is exposed to D:O as before, after a chosen time an aliquot of 
the sample is removed and the exchange is quenched with acid and placed on ice. This 
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Figure 1.24: Relative exchange rates of side chain and backbone hydrogens at different pHs. 
Figure 1.24107  shows the relative exchange rates of backbone hydrogens and side chain 
hydrogens (type 1). It can be seen that the exchange rate of type I hydrogens is higher 
than that of type II hydrogens. 
In PLIMSTEX the quenched sample is loaded onto a reversed phase guard column - C18 
for peptides, C8 or C5 for proteins - and washed with low pH. low temperature aqueous 
solution, this back exchanges the side chain groups from deuterium to hydrogen but 
leaves the backbone hydrogen exchanged i.e. backbone exchange remains quenched. 
The sample is then eluted from the column into a mass spectrometer where it is mass 
analysed. As the wash stage has back exchanged the side chain hydrogens but left the 
backbones exchanged, any mass increase is only due to backbone exchange. This is a 
more sensitive probe of peptide structure primarily because the data obtained are easier to 
analyse as only one hydrogen can exchange per residue. The dynamics of exchange are 
also probed more easily by this method as shorter time scales are available due to the 
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quenching process. In PLIMSTEX quenching can be performed almost instantly; in 
direct infusion HDX the shortest time scale available is approximately 1 minute. This 
method has been used to study calcium binding to porcine calmodulin' °8 . 
HDX can also be employed in the gas phase using ion trap type mass spectrometers 
(quadrupole ion traps and FTICR). These experiments can be used to probe the structure 
of gas phase ions by exposing trapped ions to D 20 vapour. Monitoring mass increase 
with time can give insight into the 'foldedness' of the gas phase ions' 09110 . 
Controlled fragmentation employs dissociation techniques such as CID and ECD to probe 
the structure and stoichiometry of protein assemblies i.e. quaternary structure. A large 
number of groups have shown that it is possible to transfer non-covalent complexes to the 
gas phase intact using ESI-MS. This is possible because the interactions that hold these 
complexes together - ionic, hydrophobic, hydrogen bonding and van der Waals - are. 
with the exception of hydrophobic interactions, preserved in the gas phase if the right 
experimental conditions are used" 1.112 
By employing mass spectrometry - and knowing the masses of the species studied - it is 
possible to determine the stoichiometry of protein complexes on mass grounds alone. 
However, a loss of mass accuracy has been reported when studying large complexes due 
to poor desolvation: the species observed contain solvent and buffer molecules along with 
the protein complex ions'' -'. This lack of mass accuracy can make absolute confirmation 
of stoichiometry difficult. This can be overcome by the use of harsher desolvation 
conditions (higher cone voltage etc.) to bring about the dissociation of the complex. This 
allows accurate analysis of the components of the entire system' 04 . 
Robinson and co-workers report the use of dissociation methods to characterise the 
quaternary structure of complexes'14 115-116  In these experiments they have been able to 
use CID to bring about the stepwise dissociation of extremely large complexes such as 
intact ribosomes" . antibody: complexes' 6  and GroEL' 1 '. The dissociation 
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products obtained can be used to build up a contact map for the complex and hence give 
information on its quaternary structure. 
Charge state analysis of proteins has been used by a number of groups to estimate the 
solvent accessible area of a protein or protein complex 99118119" 20 . Under standard ES! 
conditions (49:49:2 H 2O:MeOH:CHCOOH) the mlz values of most proteins fall on the 
region of 800-2500 rn/z regardless of mass. Under 'native' conditions (e.g. 10 mM 
ammonium acetate) a shift to the lower charge states is often observed. Kaltashov and 
co-workers 99  report a method whereby the solvent accessible surface of a protein can be 
estimated using the charge observed on the protein. Using this method it has been 
demonstrated that protein surface area increases with charge in a fairly consistent manner 
i.e. the ion unfolds with increasing charge. By comparing the surface areas calculated 
using this method with those observed for solved structures it is possible to gain 
information on the gas phase structures adopted by protein ions. The method reveals that 
the lower charge states observed in native ESI experiments give solvent exposed surface 
areas similar to that calculated for solution and crystal structures. This indicates the 
conformations seen under these conditions are native-like. 
1.3.2 Ion Mobility Mass Spectrometry 
In section 1.2 it was demonstrated that ion mobility spectrometry can be used to 
determine collision cross sections of ions and that, with the aid of computational 
techniques, gas phase structures of ions can be determined 
This application of ion mobility was pioneered by the groups of Bowers and Jarrold with 
their work on determining the structure of atomic clusters such as carbon 
clusters' 2122" 23 ' 14 . silicon clusters' and sodium chloride crystals 16 . The technique has 
since been used to study a range of biomolecules from small peptides to large 
bimolecular complexes. This section will summarise the work done in this area. 
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1.3.2.1 Cytochrome C 
Cytochrome C is perhaps the biomolecule that has been most widely studied by JMMS 
having been studied on a variety of instrumentation by a number of 
6 78 Y'7 1'8 P91'O 11 authors............................. . Much of the important work on this peptide was performed 
by Jarrold and coworkers 127 . Figure 1.25 shows the arrival time distribution (ATD - a 
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Figure 1.25: Drift time distribution recorded for the +7 charge state of bovine cytochrome c with 
nominal injection energy of 130 eV. Arrows show the expected drift times for a variety of 
cytochrome c conformations: (a) the native structure (-1100 Ps): (b) a partially unfolded structure 
with an open haem crevice (l68Ops): (c) an unfolded coil that retains the cc-helices (20701cs); (d) 
a typical random coil with no secondary or tertiary structure (-2880 ps); and (e) a near-linear 
conformation (-3425 ps). 
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The ATD shows three clear peaks: a small, narrow peak at —1600 its; a more intense 
broad peak at --1800 ts; and an intense, sharp peak at —2000 ts. The figure also shows 
the computed drift times for a number of candidate geometries ranging from the compact 
native structure (a) to the near-linear conformation (b). It can be seen that none of the 
geometries adopted by +7 are as compact as the NMR structure; a degree of unfolding 
has occurred. Neither are the conformations adopted as extended as the computed near-
linear structure. In other words, +7 cytochrome c retains some degree of higher order 
structure with the most intense peak in good agreement with computed structure c, an 
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Figure 1.26: Drift time distributions recorded for the +7 charge state of cytochrome c as a 
function of drift tube temperature. The drift time scale has been converted into a cross section 
scale so that distributions recorded at different temperatures can be easily compared. The dashed 
line shows the distribution recorded at high injection energy (2100 eV). The other distributions 







The work also shows the influence of temperature on the conformations adopted by 
cytochrome c. Figure 1.26 shows the drift times of +7 cytochrome c at different 
temperatures ranging from 28 °C to 300 c(' 
It can he seen that drift time. and hence collision cross section, increases with 
temperature indicating an unfolding with temperature. At lower temperatures, the ATD 
peak is broad indicating the presence of a number of unresolved conformations. At 
higher temperature (200 °C upwards) the peak is far sharper indicating the presence of a 
single conformer. 
Bowers and co-workers' ' 2 have shown that by carefully measuring the temperature of the 
drift cell it is possible to use this type of experiment to calculate energy barriers between 
conformers. If two distinct conformations exist at a given temperature, it can be said that 
the energy barrier between the two conformations is higher than the thermal energy of the 
system: if the conformations then merge into one at some higher temperature it is clear 
that the energy barrier has been overcome. Accurate determination of the temperature at 
which this occurs allows the barrier height to be determined. Examples of systems 
studied using this technique are di- and tri-nucleotides and the trimer of PET. 
Increasing the temperature of the experiments increases the thermal energy of the system 
and hence the energy of the ions. The energy of the ions can also be increased by raising 
the injection voltage. Figure 1.27 shows the drift times of +7 cytochronie c at various 
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Figure 1.27: Drift time distributions recorded for the +7 charge state of bovine cytochrome c as a 
function of injection energy. The dashed line shows the expected distribution for native 
conformation cytochrome c. 
The dotted line on the figure corresponds to the calculated drift time of the NMR 
structure. At low injection energy, the drift time of the ion is slightly less than expected 
for solution phase native conformation of cytochrome c. In the solution phase, the side-
chains extend out into the solvent to maximise their interactions; in the gas phase, 
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intramolecular interactions dominate and the side-chains collapse onto the protein surface 
resulting in a collapsed native conformation. As the injection energy is gradually 
increased, the drift time of the ions increases indicating an unfolding of the peptide due to 
collisional heating. 
The data discussed so far have only shown the ±7 charge state of cytochrorne c. In 
section 1.3.1, it was shown that charge state analysis can be used to determine the solvent 
exposed surface area of a protein revealing an unfolding with charge. The data available 
from this data are low resolution and rather indirect. As IMS gives a direct measure of 
conformation, the data obtained from IMMS are of higher quality than that obtained from 
MS alone. Figure 1.28 shows the experimental collision cross sections obtained for +3 to 
±20 cytochrorne c. 
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Figure 1.28: Plot of the collision cross sections for the features observed in the drift time 
distributions for the ±3 to +20 charge states of cytochrome c. The dashed lines show cross 
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sections calculated for the native conformation and an extended string. Filled circles show cross 
sections obtained at high injection energy while open circles show cross sections obtained at low 
injection energy. 
As expected, there is an increase in cross section with charge. Low charge states (z<6) 
exist in collapsed native conformations. As the charge is increased, the structure 
becomes more unfolded; this is attributed to increased Coulombic repulsion (due to the 
charging protons) overcoming some of the intramolecular interactions which keep the 
peptide folded. 
At high injection energy (filled circles) two conformations are observed for the +6, ±7 
and +8 charge states; all other charge states exhibit a single cross section. The region 
from +5 to +9 corresponds to the steepest increase in cross section with charge, indicating 
a shift of conformation from the compact native and collapsed native conformations 
observed at +3  to +6 to the more extended conformation seen for +9 onwards. 
1.3.2.2 Bradykinin Dimer 
If an ion is undergoing a reaction from one species to another during the course of its 
flight through the drift tube then, providing there is a change in cross section from A to B 
(where A~B),  the kinetics of the reaction can be studied by IMS. The ensemble of 
reacting ions gives a cross section distribution ranging from A (no reaction) to B (early 
reaction). An example of such a reaction is the dissociation of a dimer. 
Singly protonated peptides have been shown to have a propensity for the formation of 
non-covalently bound aggregates of the form [nJvI ± nH]n±. The rni'z of a singly 
protonated monomer is the same as that of a doubly protonated dimer and so on; 
therefore these oligomers will appear as one peak in a mass spectrum. IMS can be used 
to separate and study these species. 
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Bowers and co-workers 132 used IMS-MS to study the bradykinin dimer. Figure 1.29 
shows IMS data for bradykinin at different temperatures. At 441K two distinct species 
are present, the monomer and the dimer; at 463K the area between the peaks begins to 
fill-in indicating the occurrence of a reaction; at 510K the only the monomer is present. 
An Arrhenius plot of the data can be used to find the dimer binding energy. 
Bradykinin 
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Figure 1.29: Arrival time distributions measured for hradvkinin at different cell temperatures. 
The dirner present at lower temperatures dissociates into two monomer units as the temperature is 
raised. (a) 441K shows singly protonated monomer and doubly protonated dimer, (b) 463K shows 
dissociation of dimer into two monomer Units (filling in between peaks), (c) 520K shows all 
dimer dissociated to monomer. 
1.3.2.3 GnRH 
Barran and co-workers' 134 have used a combination of IMMS. molecular modelling 
and ECD to demonstrate the influence of minor sequence changes on the gas phase 
structures adopted by the small peptide GnRH. Four different species are studied: the 
mammalian form: the Cional form; and two variants thereof. One of the more 
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interesting mutations was the substitution of L-Ala for the D enantiomer in the Cional 
form. This subtle change allows the peptide to form a 111  -turn in a manner similar to the 
mammalian GnRH. This suggests the L-Ala fonn imparts some steric hinderance on the 
structure. 
1.3.2.4 Amyloid a-Protein 
Bernstein et al have recently used IMIVIS to probe the aggregation propensity of the 
peptide AP, a neuropathic agent involved in Alzheirner's disease 135 ; aggregation of this 
peptide to form amyloid plaques' in the brain tissue is believed to be the cause of the 
disease. The peptide exists in various forms but is most commonly found in its 40 and 42 
amino acid forms (A40 and A42) the latter of which has been shown to be the 
predominant species in the plaques'. 
Figure 1.30 1  shows the ATDs obtained from nano-ESI studies of A1342.  At low 
injection energy A342 aggregates to form hexamers and di-hexamers. At higher injection 
energy the hexamer can he discociated to fhrrn tetramers and dimerc The heamers re 
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Figure 1.30: Arrival time distributions for the peptides [Pro l9]A42 (a-c) and A342 (d-e) for the 
-5/2 charge states at the injection energies indicated. The letter designations given for the features 
are D = dimer, Te = tetramer, and H = hexamer. 
The authors report that the hydrophobic core of the protein is an important factor in the 
aggregation process. To study this. a central phenylalanine residue was substituted for a 
proline in order to disrupt the hydrophobic core of the peptide. The aggregation 
propensity of this peptide, [Pro' 9]A1342, was then studied by IMMS. Figure 1.30 also 
shows the ATDs obtained for this peptide. 
While some aggregation is evident the largest oligomer seen is a tetramer, even at low 
injection energy: this is consistent with the fact that [Pro' 9]A42 does not form amyloid 
fibrils. This underlines the assertion that the hydrophobic core of the peptide is an 
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important feature in the formation of the higher order aggregates needed to form the 
amyloids. 
1.3.2.5 Complexes by IMMS 
Some groups are now beginning to use ion mobility to study large non-covalent 
complexes. 
Guo et al report the use of a modified triple quadrupole instrument to measure the cross 
sections of the metallothionein MT-2A with heavy metals and As(III) containing 
molecules' 6 . Metallothioneins have been shown to be induced in the liver by the 
presence of heavy metals and have been shown to bind to Cu(I), Ag(I), Zn(II), Cd(II), 
Hg(II) and As(III) in the form of arsenite, monomethylarsonous acid (MMA) and 
dimethylarsonous acid (DMA). Through this work they were able to show that the 
binding of these species to MT-2A stabilises the peptide. Sequential binding of MMA to 
MT-2A for example shows a decrease in collision cross section of the 6± species with 
increasing numbers of MMA bound. With 0 MMA bound the cross section is 1090 A2 , 
with 10 MMA hound the cross section is 900 A 2 . a decrease of —19 0,/n- This is internreted 
as a stabilisation of the structure through increased cross-linking between cysteine 
residues. 
Joseph Loo and co-workers have used a ion mobility technique known as GEMMA (gas 
phase electrophoretic mobility macromolecule analyser) to characterise the 28 subunit 
20s proteosome cornplex 37 . They first characterised the stoichiometry of the complex by 
ESI-MS and CID. The GEMIMA experiment uses an ESI source followed by a charge 
neutralisation chamber (which uses a-radiation to reduce the charge on the droplets 
produced by ESI) then a differential mobility analyser (DMA - essentially linear FAIMS) 
to separate the ions prior to detection. This technique gives so-called electrophoretic 
mobilities (EMs) for the ions which are interpreted as an EM diameter. 
Fiure 1.3 1 1 g 	37  shows the measured EM diameters for the full complex and one 7 subunit 
ring of the full complex along with the crystal structure of the full complex. 
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The EM diameters obtained for each of these species are in good agreement with the 
dimensions of the crystal structure suggesting a general retention of the solution phase 
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Figure 1.31: ESI-GEMMA of the cz7 and a7f377a7 20S proteasome complexes from M. 
thermophila. The structure (right) shows the dimensions as measured by X-ray crystallography. 
Thomas et al138 have reported the use of GEMMA to analyse the EM mobilities of intact 
viruses 
Ruotolo et al. have recently reported the use of travelling wave ion mobility to study the 
Trp RNA binding protein TRAP" 9 . Using MS techniques they were able to show that 
the protein exists as an I 1-mer. The combination of molecular modelling and ion 
mobility allowed them to identify the structure of this oligorner to be ring like at low 
charge (+19, ±20), this structure was then seen to collapse to a more compact oligomer at 
higher charge (±21, ±22). Figure 1 .32 shows the structures assigned different charge 
states of this complex at different activation energies. 
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Figure 1.32: Cross sections obtained for the TRAP I 1-mer complex at +19, +21 and +22 as a 
function of activation energy (175, 125, and 50 V) applied in the high-pressure, sampling-cone 
region of the instrument. The dashed lines (green and blue) represent the collision cross sections 
for the calculated collapsed and ring structures. 
Woods et al report the use of a MALDI-IM-ToF-MS instrument to analyse 
phosphorylated and non-phosphorylated angiotensin II with acetylcholine 
140 . While the 
authors do not make any attempt to assign structures to the species seen they do report 
that the JMS stage allows simplification of the mass spectra seen; by looking at trends in 
the mobility of different species (e.g. phosphorylated vs. non-phosphorylated) it is 
possible to assign adduct peaks effectively increasing the sensitivity of the measurement. 
1.3.2.6 Nucleotides 
Bowers and co-workers have recently used IMMS to study the interactions of DNA 
nucleotides 1442" 43 . In one study they look at the structure of deoxyguanosine 
complexes 141 . G-rich areas of DNA have been shown to form structures known as 
quadruplexes, structures comprised of stacked G-quartets (subunits of four co-planer 
guanines). 
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In these experiments the deoxy form of guanosine, dG, was prepared in aqueous solution 
and allowed to anneal at 80 °C in order to allow aggregation to occur. The solutions 
were then analysed by nano-ESI-IMS-MS. The predominant species seen in the mass 
spectra produced correspond to 4 and 6 mucleotides with evidence of less abundant 
higher oligomers (11, 14. 16, 17 and 23 dG with differing amounts of ammonium 
adducts). 
Analysis of the 4 dG containing peak by IMMS revealed the presence of three species: 
[4dG ± NH4] -.  [8dG ± 2NH4 ] 2 ; and [12dG ± 3NH 4 ]. This again shows the ability of 
IMMS to identify the presence of oligomers that are unresolvable by MS alone. 
Molecular modelling of these three species shows the theoretical structures that 
correspond to the measured cross sections. The structures correspond to quadruplex 
structures (stacked rings with interstitial ammonium ions) as oppose to globular 
structures. 
Analysis of the 6dG peak reveals the presence of 6, 12. 18 and 24 dG 'under' the peak. 
For 6 dG, the cross sections obtained correspond to a globular type structure. The cross 
sections for the 12, 18 and 24 dG ions , however, correspond to G-quadruplex type 
structures. 
1.3.2.7 Analysis of Complex Mixtures 
A common technique in analytical chemistry is the coupling of a separation device (e.g. 
HPLC) to a mass spectrometer. The separation device essentially 'cleans up' the mass 
spectrum of a complex mixture, allowing each component to be mass analysed 
individually. IMS can be similarly used to separate complex mixtures of molecules in the 
gas phase before MS analysis. This technique was first reported by Guevremont et al'44 
but it has been pioneered for biomolecules by the group of Clemmer who coupled IMS to 
TOF MS'9 . 
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Clernmer and co-workers have since added an LC (or nano-LC) separation stage prior to 
the IMIMS instrument, thus providing an extra degree of separation 67 . The technique has 
been applied to a number of systems including a combinatorial library of tetrapetides' 4 
and the proteome of drosophila melanogaster63 . 
The benefit of using  IMMS over MS alone is the extra separation stage; a complex 
mixture of ions obtained from a protein digest, for example, can be separated by IMS 
yielding more simplified spectra. This is of course analogous to pre-fractionation of 
mixtures using liquid phase separations such as HPLC and CE. The great advantage of 
using a gas phase separation is the time scale of the separation. For a complex mixture of 
peptides HPLC separation times range from minutes to hours, EMS separation times 
range from jts to ms allowing much higher sample throughput. 
IMMS is, however, limited by poor sensitivity due to the poor ion transmission often 
seem for IM cells. It is also limited by low peak capacity, essentially a measure of the 
separation power of a technique. McLean et 	report a peak capacity of their MALDI- 
IM-TOF instrument to be 5.5 x iø as compared to 6 x 	for an LC-FTICR experiment; 
they do however, report the peak capacity production rate of the IMMS experiment to 
be two orders of magnitude higher than that obtained for LCMS. The combination of 
HPLC with IMMS gives an increased peak capacity of 4 x 105  but demonstrates a four 
orders of magnitude drop in peak capacity production rate as compared to the MALDI-
IM-TOF experiment. 
Much of the fundamental studies in this area have been carried out by the Russell group 
at Texas A&M University (TX, USA). They have demonstrated the influence of field 
strenth' 47 , solvent ' 48 , buffer gas 149  and instrument design on ion separation '°. 
Tang et al have reported the combination of a FAIMS separation with a linear [MS 
separation for complex mixture analysis''. With this set up they report a peak capacity 
of-5 x 106,  this is comparable with that reported for LC/MS by McLean et al but has the 
advantage of being a much more rapid separation. 
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The recently launched Synapt instrument (Waters Micromass Technologies, Manchester. 
UK) 7 may have a significant impact in this area. The TWIG mobility device used in this 
instrument has very good transmission efficiency and its availability on an "off the shelf' 
commercial instrument will open make mobility separation available to many more 
research groups. 
1.3.2.8 Ligand Binding Studies 
It is possible to use IMS-MS to determine thermochemical parameters relating to an 
equilibrium providing the reactants and products have different rnlz. A typical type of 
equilibrium studied is a ligand binding equilibrium such as ligation of metal ions and 
solvation of ions20 . The experiments are performed by injecting ions into a drift tube in 
which neutral ligand molecules are present at a known pressure. By varying the 
temperature of the cell and studying the abundance of reactant and product ions using 
MS, LH0 and AS° values can be obtained. To ensure equilibrium has been reached, the 
drift voltage is varied and the ratio of product to reactant is studied, if this ratio is found 
to be constant then it can be said that equilibrium has been reached. 
This method has been applied to the hydration of protonated arginine methyl ester 
[(argOMe) + H] - . In the experiment, the ions are formed by ESI and injected into a cell 
filled with a known pressure of water (0.1-2 Ton). An equilibrium is established of the 
type shown in equation 1.23. 
(argOMe)H ± H-,O (argOMe)H • H7 0 	 Equation 1.23 
The product and reactant ions are analysed by MS at the exit of the drift cell. The 
equilibrium constant for the reaction is obtained at a number of temperatures using 
equation 1.24 (where p(H 2 0) is the water pressure). A van't Hoff plot is then generated 
and used to calculate the reaction energies. 
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1(arg OMe)H .(H2O)] 
1(arg OMe)H . (H,o)_, ~(HO) Equation 1.24 
The plot for the addition of the first water molecule to [(argOMe)+H] yields values of 
AHO = -9 kcal mol' and AS ° = -17 cal K - 1 rnoF 1 for the reaction. 
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2. The MoQToF - a new ion mobility mass spectrometer 
Coupling of ion mobility to mass spectrometry is fast becoming the technique of choice 
for gas phase structure determination of molecules. The number of papers citing the use 
of ion mobility mass spectrometry (IMMS) in its various forms has increased more than 
five fold in the last ten years*.  This has been partly due to the launch of commercial 
systems such as FAIMS which can easily be coupled to most mass spectrometers; 
however, most IMMS instruments - and all linear mobility IMMS devices - currently in 
use are home built. In line with this, we have developed a new linear ion mobility mass 
spectrometer known as the M0QT0F (Mobility Quadrupole Time of Flight). This project 
has been carried out in collaboration with Dr. Robert Baternan's group at Waters 
Micromass MS Technologies (Manchester, UK) and Prof. Mike Bowers' group at The 
University of California, Santa Barbara (UCSB; Santa Barbara, CA, USA). 
Source: Scifinder Scholar search for "ion mobility mass spectrometry" 
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2.1 Design and Construction 
2.1.1 Micromass QToF 
The starting point for the design of the apparatus was a Micrornass QToF I mass 
spectrometer (Micromass. Manchester, UK). This instrument was originally launched in 
the late 1990s as part of the first wave of commercial tandem mass spectrometers. A 
schematic of the instrument is shown in figure 2.1. The apparatus has three major 
components: a z-spray ion source; MS 1, a quadrupole mass analyser and MS 2, a time of 
flight (ToF) mass analyzer. Each of these components will now be described in turn. 
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Figure 2.1: Micromass Q-T0F I schematic - (I) z-spray ion source: (2) first vacuum chamber 
containing source hexapole: (3) second vacuum chamber containing: (4) quadrupole mass 
analyser; (5) hexapole collision cell and (6) pre-T0F hexapole; (7) third vacuum chamber (T0F 
flight tube) containging: (8) pusher; (9) point detector; (10) reflectron and (11) MCP detector. 
(i) 	Z-spray ion source: the z-spray system was developed by Micromass in the 
late 1990s as an improvement to their on-axis ESI source. The basic design is 
shown in figure 2.2. The source consist of a sample capillary (APCI, ESI, 
nanospray etc.), a sample cone with a 4 mm diameter aperture orthogonal to 
the capillary, an extractor cone orthogonal to the first cone (located within the 
source block) followed by a 20 cm hexapole ion guide (located in the first 
vacuum chamber). The ion guide consists of two parts; the hexapole itself and 
a DC only stop hat' lens at the end of the rods. The top hat serves two 
v1] 
2. The M0QT0F - a new ion mobility mass spectrometer 
functions namely to act as an electrostatic lens to aid extraction from the 
hexapole and to aid the vacuum - the top hat seals the hole between chambers, 
with only a 6 mm orifice between the chambers through which the ions can 
pass. For electrospray operation a high voltage (3-4kV for the ESI, 1-2kV for 
nanospray) is applied to the capillary setting up a potential difference between 
the capillary and the cone. Sample is passed through the capillary and ions 
are pulled into the mass spectrometer by this potential difference. The sample 
cone is held at 30-lOOV higher than the extractor cone; this voltage 
determines the kinetic energy of the molecules on entering the MS, this is one 
of the more important parameters when tuning for signal using this source 
(higher cone voltages are required for larger molecules but tend to fragment 
smaller molecules). The extractor is held at, or close to, the DC offset of the 
hexapole which is also applied to the top hat. Each of these voltages 'float' 
(i.e. rise and fall with) on top of the voltage applied to the collision cell 
(effectively the ground voltage for all supplies upstream' of the collision cell) 
and therefore the actual applied voltage varies depending on the experiment 
being performed. 
MS I - quadrupole mass analyser: the quadrupole is located in the second 
vacuum chamber along with the hexapole collision cell. 
The quadrupole can be used in transmission mode for normal MS 
experiments - where the quadrupole is set to scan across a fixed m!z range 
- and in mass selected range for MS/MS experiments - where the 
quadruple is set to transmit a chosen rnz. In the original design of the Q-
ToF I the upper limit of the quadrupole was set to 4000, however, our 
instrument has been modified to allow transmission of ions up to 32,000 
mlz. As with the elements described above, the DC offset applied to the 
quadrupole floats on top of the collision cell voltage. 
The quadrupole is followed by a short transmission hexapole leading to 
the hexapole collision cell. This is an 12.5 cm hexapole enclosed in 
aluminium to allow the pressure inside to be raised with an inert buffer gas 
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(usually to 10-15 PSI with Ar. He or N 2 ) in order toperform CID 
experiments without greatly affecting the background pressure of the 
vacuum chamber. CID experiments can be performed on a range of mlz 
ions by using the quadrupole in transmission mode or on a single miz ion 
by using the quadrupole in mass selective mode. The ions are fragmented 
by increasing the collision voltage until fragmentation occurs. The 
collision cell is followed by a further short hexapole to focus the ions into 
the final vacuum chamber. 
(iii) 	MS 2 - Time of Flight mass analyser: the final vacuum chamber is the ToP 
flight tube it consists of four main components: the point detector; the pusher; 
the reflectron and the MCP detectors. It is positioned orthogonal to the two 
other vacuum chambers in the vertical plane. 
The point detector is a photomultiplier tube used as the detector for the 
quadrupole when in tune mode and when acquiring quadrupole spectra. It 
is located at the top of the flight tube, in line of sight of the ions entering 
from the quadrupole chamber. 
The pulse of ions required for the ToF experiment is provided by a pusher, 
an electrostatic device which in this case accelerates the ions through 7.2 
kV over 10 mm. The pusher is pulsed at a set frequency (dependent on the 
mi'z range required) with each pulse starting a new ToF experiment. 
The ToF has a v-geometry reflectron. 
The ToF detector is a set of micro-channel plates (MCP) 
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2.1.2 Instrument Layout 
From the literature it can he seen that an ion mobility cell can be placed in a number of 
positions within a mass spectrometer before' and after' -' the mass analyser, between mass 
analysers on tandem MS instruments 3 , before  and after  a collision cell. The positioning 
of the cell, along with the types of mass analyser used will partially determine the types 
of experiments that can be performed on an instrument. Returning to figure 2.1 it is clear 
that there are two places a drift cell can be easily accommodated: (i) in place of the 
hexapole collision cell or (ii) in a new vacuum chamber between the source hexapole 
and the quadrupole. 
Each of the positions has certain advantages over the other e.g. placing the cell after the 
quadrupole mass analyser would allow mass selection prior to IMS separation. 
Ultimately it was decided that the cell should be housed in a new chamber between the 
source hexapole and the quadrupole. The reasons for this were manifold but included: 
The pre-cell hexapole can be used to store ions prior to pulsing them into the IMS 
cell. 
Housing the cell separately from the quadrupole (and away from the ToF) will 
allow the instrument to operate at near normal pressures. 
The hexapole collision cell and hence MS/MS capability can be retained. 
Designing a new vacuum chamber rather than modifying an existing one means 
the dimensions are less constrained. 
Figure 2.2 shows one of the first design drawings for the apparatus. In order to ease the 
transition back into the original instrument, a short hexapole has been included in the 
chamber, this will transmit and focus the ions exiting the drift cell and also provide a 
vacuum seal via the top hat. 
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Figure 2.2: Design drawing of MoQT0F including new chamber and post cell hexapole. 
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2.1.3 The Cell 
Of the three types of ion mobility described in chapter 1. only linear ion mobility 
provides absolute conformational information as described by equation 1.1 7. Our interest 
in ion mobility stems from a wish to measure gas phase conformations of molecules and 
therefore linear ion mobility was chosen for our apparatus. As outlined previously there 
are two different categories within linear mobility; the low resolution mobility of 
Bowers' and others and the high resolution mobility of Clemmer and co-workers 6 . The 
development of our instrument is part of a collaboration with the Bowers group at UCSB, 
their experience is in the design and construction of low resolution drift cells which can 
be temperature controlled. 
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Figure 2.3: Cell Drawings for M0QToF drift cell. (I) 3D section through cell; (H) section through cell 
viewed from side: (III) front elevation; (IV) rear elevation. Parts are labelled as follows: A - baratron 
connection: B - Gas in: C- Drift rings: D - Exit lens (1-4): E - End cap (C2): F - Cell body (C I); G - 
Einzel lens (L I. L2 and 1-3): H - Heater terminal block: I - Mounting brackets; J - Heaters: K - Cooling 
line inlets: L - Feedthrough to drift rings; M - Molybdenum orifice; N - Thermocouple mounting; 0 - 
Cell screws 
The cell chosen was based on the design used in the Bowers group as shown in figure 
.11. In order to incorporate the cell into the apparatus some significant redesigning of 
2. The MoQToF - a new ion mobility mass spectrometer 
the ion optics (see section 2.14), cell mounting and feedthroughs (power and gas supplies 
etc.) was required. Figure 2.3 shows the final cell design. The figure shows two cross 
section views of the cell (I and II) and the front and rear elevations of the cell. 
The cell is made from a copper block and a copper end-cap separated by a ceramic ring 
giving a cell of the following dimensions: 65.5 mm x 88.9 mm x 88.9 mm (L x W x H). 
The cell contains five drift rings (30.5 mm o.d. x 15.2 mm i.d. x 3.2 mm) spaced 5.2 mm 
apart. separated by ceramic spacers. The drift field is achieved by applying a potential 
difference between the cell body and the end cap; the field is kept linear using six 1 M 
resistors connected in series along the drift rings (the first resistor between the cell body 
and the first drift ring, the second resistor between the first and second drift rings and so 
on). The cell orifices are cut into molybdenum discs (30.5 mm o.d. x 1.27mm); the 
orifice size can be chosen at the discretion of the user but is typically 1mm in diameter 
for the work shown here. The two orifices are held in place by copper retainer rings 
(30.5 mm o.d. x 15.2 mm i.d. x 1.6 mm). 
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Figure 2.4: Cell end cap and drift ring stack. A - End cap cooling lines (1/4" Swagelok VCR fitting): B 
- Exit lens (1-4): C - Cell screw external insulator;  D - End cap; E - Drift ring mounting ceramics: F - 
Cell screw internal insulator: G - Drift ring separating ceramics: H - Drift ring; I - Orifice retaining 
ring: J - Molybdenum orifice. 
Figure 2.4 shows how the drift ring (H) stack is built up from the end cap (D) on a set of 
6 ceramic rods (E). The figure also shows how the cell exit lens (1-4 - B) mounts from 
the exterior of the end cap. 
I . The MoQT0F - a new ion mobility mass spectrometer 
Figure 2.5: Cell body (C 1). A - feedthrough for baratron (1/4" Swagelok VCR): B - Gas 
inlet (1/8" Swagelok VCR): C - Ceramic spacer ring: D - Orifice retainer ring (orifice not 
shown): F - Cell body: F - Ceramic mounting rods: G - Cell mounting brackets: H - Heater 
terminals; I - Cell cooling line feedthroughs (1/4" Swagelok VCR). 
Figure 2.5 shows the cell body construction. The retainer ring (D) is used to keep the 
front orifice in place, once this is in place the end cap and drift ring stack can be inserted 
through the ceramic spacer ring (C) and located in the retainer ring (D). The end cap is 
then kept in position by a set of 12 hex-screws insulated from the end cap by a set of 
ceramics (Figure 2.X - C & F). Each ceramic heater is attached in series to the heater 
terminals (H) - the end cap and cell heater voltages are supplied separately. 
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The cell and end cap can be heated via a set of ceramic heaters. These consist of 71 mm 
ceramic rods threaded with Tantalum wire. The cell body contains 10 of these rods (five 
either side) while the end cap contains two shorter ceramic rods (50 mm). Applying a 
potential to the heaters causes the wire to resitively heat and hence heat the cell. The cell 
body and end cap can be cooled using a stream of nitrogen gas which can be passed 
though cooling channels in the copper. The cell temperature can be monitored via a set 
of three thermocouples - one on the cell body, two on the end cap. 
The cell entrance lens (see section 2.1.4 for design details) is mounted on a set of ceramic 
rods from the front of the cell body (figure 2.X - F). A detailed drawing of the lens stack 
is shown in figure 2.6. The three lenses (LI - A, L2 - B & C and L3 - D) are stainless 
steel discs with the following dimensions: 40.6 mm o.d. x 22.4 mm i.d. x 3.8 mm. L2 (B 
& C) is split into four sections to allow x-y steering of the ions - voltages are supplied 
separately to each lens and each pair of lenses (x and y) can be biased relative to each 
other using a variable resistor. The final lens (1-3 - D) is tapered to a final i.d.of 7.6 mm 






Figure 2.6: Cell entrance lens stack. A - Li: B - L2Y: C - L2X: D - L3; E - Ceramic spacers. 
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In the Bowers instrument 7, the cell is mounted on a set of horizontal bars, employing this 
in our instrument would have made removal of the cell an extremely time consuming 
activity requiring the removal of the source and first vacuum chamber to gain access to 




Figure 2.7: Cell with mounting rods and gas feedthroughs attached. A - 
Plastic supports: B - Mounting rods: C - Cell body: D - End Cap: E - L4 
The cell is mounted on four vertical, stainless steel rods attached to brackets on each 
corner of the cell body (figure 2.3 - 1: figure 2.5 - G) and to two plastic supports at the 
other end; the plastic supports are in turn attached to the top of an aluminium vacuum 
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mounting rods (B) attached. N.B. In the hose attachments for the various gas 
feedthroughs are attached. 
Figure 2.8 shows the cell vacuum chamber (E & F), cell (I, J. K, L) mounted from the top 
flange (E) and post cell hexapole (H2 H, TH2 - G). The chamber has an iso-160 flange 
to the bottom allowing the mounting of a 500 Is - ' Pfeiffer TMH520 turbomolecular pump 
(Pfeiffer Vacuum Ltd., Newport Pagnell, UK). 
F' 	 J 
Figure 2.8: Cell chamber, cell and post-cell hexapole. A - Gas inlet: B - Cooling lines; C - Baratron 
feedthrough: D - Voltage feedthroughs: E - Cell chamber top flange: F - Cell chamber bottom flange: G - 
Post cell hexapole top hat (T112); H - Post cell hexapole (1-12); I - 1_4: J - End cap; K - Cell body: L - 
Einzel lens; M - Pre cell top hat (TH1); N - Cell mounting rods 
Mc 
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The voltages applied to the cell and the pre-cell hexapole (HI) and top hat (TH1) are 
supplied via the voltage feedtrhoughs (D). The top flange contains three voltage 
feedthroughs; one for applying voltage to the cell components, one for supplying voltage 
to the heaters and one for connecting thermocouples. Figure 2.9 shows the final design 
drawing of the cell and cell chamber and its location in the instrument (N.B. the ToF has 
been removed from the drawing). 
Figure 2.9: M0QT0F final design drawing. 
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Figure 2.10 shows the MoQToF thstrument schematic. 





Figure 2.10: The M0QT0F. A - Z-spray ion source: B - HI: C - THI: D - einzel 
1-n P - flnft 11 P - I 4. ( - T4 14 - TI-Ti I - m drurr1 vrni1r11 hhsr I - 
- 	 - .--. - -... - 	 -.. 	 ---.-- ----,- 	 --..- 1-.- 
ToF vacuum chamber 
2.1.4 Einzel Lens Design and SIMION Modelling 
In order to obtain the best possible ion transmission - and therefore sensitivity - the ions 
must be efficiently and tightly focussed into the cell. In order to achieve this it was 
necessary to design some ion optics for the front of the cell in the form of an einzel lens. 
An einzel lens is a three element electrostatic lens used to focus ions without increasing 
their energy 8 . The first and last lenses are held at the same potential with the central lens 
biased positive (acceleration) or negative (deceleration) with respect to these lenses. The 
decree of focussing seen is dependent on the lens geometry and the potentials applied. 
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The lens system was designed and tested using the electrostatic modelling program 
SIMION a package developed by David Dahl; the program and its capabilities have been 
extensively reviewed by him9 . 
The elements modelled were the pre-cell hexapole top hat (TH1), the three einzel lens 
components (LI, L2 and L3), the cell body and drift rings (Cl) and the cell end cap (C2). 
The geometries of the lens elements were adjusted and optimised to give the potential 
arrays shown in figure 2.11 wherein the top panel shows the array used to model the drift 
cell and the bottom panel shows the array used to model TH 1, the einzel lens and the cell 
entrance; the cell entrance is featured in both potential arrays so that they can be 
modelled separately or together. 
93 






Figure 2.11: SIMION arrays for Drift Cell and Einzel lens. A - 3D 
representation of drift cell: B - Cell Entrance (CI); C - Drift Rings: D - 
Cell Exit (C2); E - 3D representation of einzel lens; F - Pre-cell hexapole 
top hat (TH1): G - Lens 1 (L 1): H - Lens 2 (L2): I - Lens 3 (1-3): J - Cell 
Entrance (C2). 
Figure 2.12 shows the potential energy view of the lens. The centre lens, L2, is held at a 
lower potential than the other lenses. This creates a potential well that focuses the ions; 
the degree of focussing is dependent on the potentials placed on each lens element. The 
black lines through the centre of the lens show the trajectories of a group of 51 parallel 
ions (mlz = 100, 50 eV, starting 0.1 mm apart) passing through the cell. It is clear that 
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Figure 2.12: Potential energy view of Einzel lens. A - THl B - L1 C-
1-2: D-L3:E-C1 
The cell array was set such that the potential varies linearly across the elements from Cl 
to C2 with C2 at ground. Combing the two potential arrays gives the potential energy 
representation of the system as shown in figure 2.13. This combined potential array was 
used to estimate the transmission efficiency of the lens and cell. To achieve this a 
program was written to simulate the presence of gas in the drift cell part of the array. The 
program allowed for the mean free path of the ions to be varied along with the mass of 
the collision gas. Upon collision the ions randomise their trajectory and the trajectory 
line changes colour. The simulation was carried out at various mean free paths (and 
hence cell pressures) and the transmission efficiency was calculated by counting the 
number of ions passing out of the cell. Figure 2.14 shows the trajectories of a group of 
51 parallel ions (100 miz, 50 eV. starting 0.1mm apart) passing through the cell with a 
mean free path of 4 x 10' mm. The inset images show a magnified view of the cell exit 
and an end on view of the cell which shows the divergent trajectories of the ions when 
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Drift 
Figure 2.13: Potential energy view of einzel lens and drift cell. 
aperture at the cell exit but do not exit the cell. This is because they collide at or just 
before the exit of the cell where they are essentially in a field free region (see figure 
2.13). These ions therefore stop at this point and are not transmitted. In practice this will 
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the ions out. However, it was decided that an exit lens (1-4) should be included in order 
to accelerate the ions out of the cell into the post-cell heaxapole (H2). 
Figure 2.15 shows a plot of the number of ions transmitted as a function of mean free 
path (for clarity the number of ions that collided with the cell, lenses and drift rings and 
were not transmitted is also plotted). The total number of ions included in each study 
was 2050 from 50 simulations of 51 ions (100 ni'z. 50 eV). 
As expected, the simulations show almost complete transmission at high mean free path 
and reducing transmission at lower mean free path (corresponding to higher pressure in 
the cell). This is due to collisions with the gas causing the ions to be deflected off axis 
away from the exit orifice. At around I x 10 -3 mm mean free path, there is a slight 
increase in transmission efficiency. This is thought to be due to collisional focussing; in 
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Figure 2.14: Simulation of ion paths through lens stack and cell at 4 
x 10' mm mean free path 
this regime, the ions are kept on axis by collision with the gas, thus increasing the number 
of ions transmitted, at higher pressure than this the increased number of collisions 
occurring reduces the influence of this effect. The mean free path of a 600 A2 ion in the 
cell at 5 Torr is approximately I x 10.2  mm corresDondinQ to a transmission efficiency of 
—25%. 
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Plot of Ion Transmission vs. Mean Free Path 
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Figure 2.15: Plot of ion transmission as a function of mean free path 
obtained from SIMION modelling 
It should be noted that SIMION has been reported to model collisions poorly", it does 
not take into account effects such as diffusion which will cause the ion packet to spread 
out in all directions and therefore reduce ion transmission and it does not allow ions to 
gain energy from a collision. The transmission efficiency reported here will therefore be 
an over estimate and in practice the transmission efficiency of the device will be lower. 
In the final design the lens L2 was split into four sections to allow x-y steering of the 
ions 
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2.1.5 Power Supply Design 
A bespoke DC power supply was designed and constructed in-house by the School of 
Physics Electronic Workshop. The elements that require a voltage supply are: HI, Ti-Il, 
Ll. L2 (four inputs), L3. Cl, C2 and L4. The post-cell hexapole and top hat (H2 and 
TH2) are supplied via the instrument. The required voltages and their grounds are shown 





4 ... • .4.. • • 
H2 TL1L2L31 	C2L4H1 THI 	CV 
Figure 2.16: Schematic of Voltages. Horizontal lines indicate the ground for each 
voltage i.e. for THI the ground voltage is C\ (the collision voltage). Voltages 
indicated in blue are supplied from the instrument and controlled via the software. 
As can be seen from the figure, each voltage in the supply is set with reference to the 
collision voltage (the voltage applied to the hexapole collision cell with respect to 
ground); all other voltages float on top of this value i.e. increasing the collision voltage 
by 5 Volts will cause all other voltages to increase by 5 Volts. Further to this L4 is 
referenced to the end cap voltage (C2) and all voltages to the source side of the cell body 
are referenced to Cl. Table 2.1 shows the voltage ranges of each supply and the total 
voltage applied. 
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Element Voltage Range Output Voltage 
CV -07 to 200 V CV 
TH2 0Vto-5V CV-rTH2 
H2 OVto-5V CV 	H2 
L4 ±50Vto-50V CV±C2±L4 
C2 0Vto75V CV±C2 
Cl 0Vto200V CV±Cl 
L3 + 50V to -50V CV + Cl +L3 
1-2 0Vto-350V CV+C1±L2 
Li 0Vto-350V CV+C1±Ll 
THI 0Vto200V CV -- Cl+THI 
Hi 0Vto200V CV-Cl+Hl 
Table 2.1: Voltage requirements for drift cell power supply. 
The power supply was constructed such that these voltages could be supplied in both 
negative and positive polarity. This was achieved by using two different PCB boards. 
one for supplying negative voltages, the other for supplying positive voltages. 
Circuit diagrams for the power supply can be found in appendix I. 
2.1.5.1 Lens 2 - X-Y Steering 
As discussed previously, L2 is split into four segments to allow x-y steering of ions (1-2 
right, 1-2 x I eft, L2 0 and 1-2 y bonom ). To achieve this, the voltage applied to the lens has to 
be split between the four segments. This is achieved as follows: the voltage on L2 is set 
via a resistor pot, this voltage is then applied to two circuits - one for the X segements, 
one for the Y segements; the voltage is then split on each pair of lenses using a variable 
resistor; the sum of the voltages on any pair of lens segments is equal to the value of L2 
but value on each may be varied by as much as ±50 V e.g. for L2 = 50 V and 1-2 1- = 
100 
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30 V, L2xiefi = 20 V. By changing the voltages applied to each of these segments, the 
centre point of the potential can be shifted thus allowing some steering of the ions. 
2.1.6 Pulser Design 
As described in chapter 1, an ion mobility experiment requires a pulse of ions but as an 
electrospray source is a continuous ion source, it is necessary to trap ions somewhere in 
front of the cell and pulse them out of the trapping region into the cell. Returning to the 
instrument schematic (figure 2.10) it is clear that the ions can only be trapped in the pre-
cell transfer hexapole HI. This is achieved by placing a stopping voltage on the top hat 
lens (TH 1). To pulse ions out of the hexapole it is necessary to apply a pulsed voltage to 
TH1 which will allow the stopping potential to be rapidly lowered for short periods of 
time at a set frequency. 
A pulser unit was therefore designed and built in house to allow the TH 1 to be pulsed. 
The unit requires two inputs: THI from the lens power supply described above and a 
TTL pulse from a signal generator. The signal generator is used to define the pulse 
frequency and width; the amplitude of the stopping potential is controlled via the pulser 
unit. A circuit diagram for this unit can be found in appendix 1. 
2.1.7 Pressure Measurement 
The pressure in the drift cell is measured using a MKS Baratron attached to the cell via a 
¼" Swagelok VCR fitting. 
2.1.8 Temperature Measurement 
The temperature of the cell is monitored using three K-type thermocouples. one on the 
cell body and two on the cell end cap. The thermocouples are read on a Omega 
CN 1001 TC thermocouple controller. 
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2.1.9 Gas Inlet 
Figure 2.17 is a schematic of the gas inlet system used to pressurise the drift cell. The 
system includes a gas filter used to remove oxygen, water and hydrocarbons from the 
buffer gas. It has been designed for use with one or two buffer gases (e.g. He or He and 
H20). 
r G= I 
Figure 2.17: Drift cell gas inlet system. Where I are Swagelok ¼ shut off valve 
and the arrows are 1/4" needle valves used to fine tune the cell pressure. 
By opening and closing the correct combination of valves it is possible to accurately 
control the pressure in the drift cell using the needle valves. When not in use the inlet 
system is kept dry and clean by pumping it out using a 70 Ls - 'turbomolecular pump 
(Pfeiffer Vacuum Ltd.. Newport Pagnell, UK). 
2.1.10 Cell Hexapole 
The drift cell often requires some maintenance (e.g. cleaning) for which it needs to be 
removed from the instrument. Without the cell in position the instrument can no longer 
function (or even be pumped down) and lengthy maintenance will therefore leave the lab 
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down one instrument. To overcome this, Micromass provided a short hexapole to replace 
the cell. The hexapole mounts off a top vacuum flange and is supplied the same DC and 
RF as H2. 
Figure 2.18 shows the hexapole (10 cm) and vacuum flange. 
4 L 	L 	 _________ • 
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Figure 2.18: Cell hexapole and vacuum flange. 
2.1.11 Quadrupole Upgrade 
On a standard Q-ToF I the quadrupole has a maximum isolation mz of 4000. While this 
is sufficient for most applications, it will not be suitable for large biornolecular 
complexes - such as those studied by Robinson and co workers'' - which can often 
appear at above 4000 miz on a mass spectrum. With this in mind, the quadrupole has 
been modified to have a mass range of up to 32.000 mlz. This was achieved by replacing 
the quadrupole RF driver with one capable of lower frequency operation. 
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2.2 Experiment Set-up 
In order to take mobility data (i.e. measure arrival times) on the MoQToF, the Masslynx 
software was redesigned by Waters Micromass Technologies (Manchester, UK). The 
new software allows for two modes of operation: (i) MS(IMS) mode - collection of mass 
spectra only (on point detector or MCPs); (ii) IMS mode - collection of mass spectra 
with mobility data (MCPs only). 
2.2.1 MS Mode 
The basic operation for MS mode has not changed greatly, the only significant software 
change has been to two of the source voltages, those applied to the extractor cone and the 
sample cone. 
The extractor cone voltage is referenced to the collision voltage and prior to the 
instrument modifications it was typically held at 0 V to 5 V above the collision voltage 
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several tens of volts higher than the collision voltage (typically —110 V), the extractor 
must therefore be held at 0 V to 5 V higher than this value, to achieve this the software 
was altered allowing a greater range of voltages to be applied. 
The sample cone is referenced to the extractor cone and therefore the software also 
required some modification to allow the desired voltage to be applied to it. The 
maximum voltage that can be applied to the sample cone (sample cone voltage ± 
extractor cone voltage) is 204 V + CV, this can be prove to be a limiting factor in 
examining high miz species and some further modification is still required. 
MS mode is typically used when tuning for signal the drift cell is filled with buffer gas to 
the desired pressure, the drift voltage and injection energy (defined as the difference 
104 
2. The M0QT0F - a new ion mobility mass spectrometer 
between the voltages applied to CI and HI) are set and the source voltages are tuned until 
the best possible signal is obtained. 
2.2.2 IMS Mode 
For mobility operation significant changes have been made to the software so it can 
record mobility data (arrival times) along with mass data. In ToF-MS mode the 
instrument measures the time taken for ions to pass from the pusher to the detector. 
These times are then converted to mlz values as described in chapter 1. In IMS mode 
each ion has an associated arrival time (the time it takes to pass through the drift cell ± 
dead time) that must also be recorded. 
In the MoQT0F software the ion arrival time is the time taken to pass from THI to the 
pusher. This is measured as follows: 
THI pulsed to allow packet of ions into drift cell (10 to 40 .ts wide, 50 to 100 
Hz). The signal generator sends a simultaneous pulse to the instrument TDC 
card which signals the software to start the TMS experiment 
The first pulse of the pusher (push) after this start signal is scan 1, the second 
push is scan 2 and so on up to 200 scans. The width of each scan is equivalent 
to the pusher period being used. 
The software records a mass spectrum for each scan to build up a 200 scan total 
ion count (TIC) chromatogram. The 200 scans can then be summed to give a 
mass spectrum for the experiment. 
The software allows any single miz or mlz rang to be selected. It then builds up 
a chromatogram for the selected m!z with a peak after n scans corresponding to 
that ion's arrival at the pusher. 
	
V. 	Multiplying the scan number of the peak by the pusher frequency gives the 
arrival time. 
In practice a single set of 200 scans provides insufficient data and the software is set to 
sum over a number of seconds (10 to 25 s) to obtain a single set of 200 scans. Further to 
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this it necessary to sum the data over a number of scan sets to obtain good arrival time 
data. For every set of 200 scans there can be only one pulse of ions into the drift cell, the 
frequency of the period of this pulse must therefore be greater than 200 x pusher period. 
Figure 2.19 shows the pulse sequences of the pusher and IMS pulse. The upper trace 
shows the pulse sequence used to control the ion mobility pulse while the lower trace 
shows the ToF pusher pulse. The pulses in red indicate the first push after the IMS pulse 
i.e. the start of the experiment. 
I 
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Figure 2.19: Pulse sequence for IMS pulser and ToF Pusher 
Although the figure indicates the IMS pulse and pusher pulse are synchronised, they are 
in fact asynchronous (the consequences of this on the measurements will be discussed 
later). In order for the software to start an IMS experiment, it must see an input pulse 
whilst it is pushing, for this reason the input pulse to the TDC card must be at least one 
pusher period in width (thus ensuring the input pulse and pusher pulse are concurrent). 
Figure 2.20 is a schematic representation of how the data are presented in the software 
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Figure 2.20: Schematic representation of IMS data obtained from Masslynx. A set of TIC arrival 
time distributions (ATDs) is obtained: the data are combined to give a mass spectrum: from the 
mass spectrum individual ions are selected and a corresponding ATD is created. 
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2.3 From ATDs to Drift Times to Mobilities 
The ATDs obtained by following the procedure outlined in section 2.2.2 give the time 
ions take to pass from THI to the pusher i.e. the drift time (td time spent in the cell) + 
dead time (tdead time spent outside the cell). To calculate the drift time accurately, it is 
necessary to determine the dead time or manipulate the data so that the dead time is not 
needed to calculate the mobility. In reality, both of these conditions can be satisfied by 
plotting the arrival time (t a) of an ion against P/V as shown by equations 2.1 and 2.2 
where L = cell length. T 0 = 273.15 K, 1(0 = reduced mobility, P o = 7.6 x lO Torr, T = 
cell temperature in Kelvin, P = cell pressure in Torr and V = drift voltage (the difference 
between Cl and C2). 
t a = td + tdead 	 Equation 2.1 
L2 T0 P 
td 
= KPAT v 	Equation 2.2 
VU 
By substituting equation 2.2 into equation it is clear that a plot of arrival time as a 
function of P/V for any one ion should give a straight line of gradient inversely 
proportional to the reduced mobility. For any experiment the values of T and L are well 
known so by performing the measurement at several different PiV values, K0 can be 
easily calculated from the plot. The y-intercept of this plot will give the dead time for the 
ion of interest. 
To obtain different values of P/V it is possible to change one or both of the parameters 
however, the cell pressure can take several seconds to stabilise when it is changed while 
the drift voltage stabilises almost instantly. It is therefore more practical to perform the 
measurements at a range of drift voltages with constant cell pressure. Figure 2.20 shows 
a plot obtained for +14 cytochrome C. 
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Fi2ure 2.20: Diot of arrival time vs. P/V + 14 for Cytochrome C. 
2.3.1 Obtaining Good ATDs 
As the software only allows the ions to be sampled once every pusher cycle the resolution 
of the data is relatively poor e.g. for data where the maximum mlz = 1000, the pusher 
period is set to 63 .is;  the ions are therefore only sampled once every 63 j.ts. To try and 
counteract this low resolution, it is necessary to sum a number of distributions (n ? 10) 
and fit a Gaussian distribution to the peak in order to obtain an accurate arrival time. 
Summing the data in this manner also allows low abundance peaks to be better sampled. 
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2.4 Initial Testing 
In order to make tuning the instrument as easy as possible, the cell orifices were added in 
stages. Initial tuning was carried out with no orifices present - using the drift cell as an 
ion guide only. testing was then carried out with only a 2 mm aperture diameter front 
orifice in place; a rear 1.67 mm aperture diameter orifice was then added and eventually 
both orifices were swapped for 1 mm diameter aperture orifices. 
2.4.1 No Orifices 
SIMION modelling of the einzel lens suggests TH1 and Li should be held at 
approximately the same voltage with L2 held 50 to 90 V lower and L3 held 5 to 20 V 
lower; TH 1. Li and L3 are all required to be at the same or greater potential as Cl. 
However, the construction of the power supply is such that LI and L2 must be biased in 
the same polarity i.e. both positive wrt Cl or both negative wrt Cl; this clearly changes 
the capabilities of the lens stack. 
Returning to the SIMION modelling it was obvious that the best focussing was achieved 
with L2 biased negative wrt Cl, therefore forcing LI to be biased —ye wrt Cl. In the 
modelling discussed above, L2 was required to be the minimum of the lens potential, 
however, as TH1 is required to be positive wrt CI, it seemed obvious to set L  as the 
minimum with TH I and L2/L3 as the high potential points on the lens. 
A solution of NaCsI in 50150 IPA/H 20 was used to tune for ion signal on the ToF with no 
orifices in place. The following optimum values were obtained for each lens: HI = 35 
(75) V; THI = 25 (65) V; LI = -40 (0)V; L2 = -28 (12) V; L3 = 28 (68) V; CI = 40 (40) 
V; C2 = 20 (20) V; L4 = 0 (20) V; H2 = TH2 = CV = 20 (18.9) V. Where the values in 
parentheses indicate the applied voltage relative tog round. 
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The values applied to Hi, L2, Cl, C2 and L4 are less crucial those applied on TH1. Li 
and L2 but they must meet the following criteria: Hi > THI; HI > 1-3; Cl > L2 > LI; CI 
> C2; C2 ? L4 > H2. 
With the values indicated above, the ion transmission efficiency was approximately 75% 
(as compared with ion transmission with the cell hexapole in place). 
2.4.2 Front Orifice 2 mm Aperture 
The tuning experiment was repeated with the front molybdenum orifice in place with a 2 
mm aperture. 
The presence of this orifice requires a much tighter focus for the ions to enter the cell. 
This is achieved by varying the potentials applied to the einzel lens. Figure 2.21 shows a 
plot of (normalised) ion intensity at different values of LI, L2 and L3 with all other 
voltages held constant (HI = 37 V. TH1 = 30 V, Cl = 35 V. C2 = 20 V, L4 = 0 V, H2 = 
TH2 = CV =20 V). 
From the figure it is immediately apparent that there a number of peaks in the ion 
intensity, the maxima generally occur for L2 = L  ± 20V. Looking left to right along the 
graph, the amplitude of the peaks increases up to L  = -50 V then decreases (marginally) 
again. Looking in the area of experiments 40 to 60, the value of L3 is altered 
significantly here. The ion intensity is seen to be fairly insensitive to this lens until L3> 
Hl where the ion intensity drops off entirely only returning at L3 = 30 V = THI. The 
greatest ion intensity is achieved for 3 0 V? L3 ? -40 V (for TH 1 = 30V). 
This work therefore provides two more tuning criteria, namely L2 z LI ± 20V and L3 
THI. 
The transmission efficiency in this configuration was approximately 60% 
0 
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Tuning Data (Front Orifice Only) 
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Figure 2.21: Normalised ion intensity data (blue line) for different values of Li, L2 and L3 
2.4.3 Front Orifice 2 mm Aperture, Rear Orifice 1.67 mm Aperture 
The addition of a rear orifice allows gas to be added to the cell: with these apertures in 
place the maximum achievable cell pressure (i.e. the highest pressure possible without 
straining the pumps) was 1.75 Torr. The tuning experiment was therefore repeated with 
0.5 Ton He in the drift cell. 
To obtain good ion transmission, a drift voltage (Cl - C2) of 40 V was required with HI 
? 15 V. Tuning the einzel lens, maximum signal was achieved at LI = -70 V. L2 = -55 
V. L3 = 15 V. 
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The presence of two orifices and gas in the cell greatly reduces the transmission 
efficiency of the instrument to approximately —10% at 40 V across the cell 
2.4.4 Front and Rear Orifices 1mm Apertures 
The two larger orifices were then replaced with two 1mm aperture orifices. In this 
configuration it is possible to maintain good pressure in the rest of the instrument (< 10 
rnBar in the quadrupole chamber. < 10. 6  rnBar in ToF chamber) with up to 4.5 Torr of He 
in the drift cell. In practice , however, good ion transmission was only possible at 3.5 
Ton. 
Very little tuning of the lens voltages was required to obtain good transmission efficiency 
in this configuration. At 3.5 Torn the drift voltage was required to be? 20 V with HI ? 





Hi ?CiI-V 30 (105)V 
TH1 Hi—WV 20(95)V 
Li Ci-75V -75(0)V 
12 +20 -60 
L3 C1I-15V 15(90)V 
C   65(75)V 
C2 s Cl - 	V 5(15)V 
LA c2-4V -4(11)V 
112 CV 1O(tO)V 
TB2 CV 10(tO)V 
Cv CV 10(I0)V 
Table 2.2: (iptiniuni voltages for MoQToF with cell at 3. Ton 
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Table 2.2 lists optimum voltages for good transmission efficiency in this configuration 
with 3.5 Torr of He in the drift cell. Once more, values in parentheses indicate the 
applied voltage. 
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2.5 Mobility Experiments on Standard Compounds 
With the instrument tuned as described above, a set of test experiments were carried out 
to check the accuracy and consistency of mobility measurements made using the 
MoQToF and use for calibration if necessary. 
The experimental cross sections of the proteins Cytochrome C 12 , lJbiquitin 13 and 
Lysozyme 14 have been widely reported in the literature. As these compounds are cheap 
and easily available they were ideal test/calibration compounds. 
2.5.1 Cytochrome C 
Cytochrome C is probably the protein most widely studied by IMS (see section 1.3.2.1). 
It has been widely used as a test compound for new instruments 15,16  and as a calibrant 
molecule for some mobility measurements 118 . It is a 104 residue haem-containing 
protein of mass 12,360 Da. 
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Figure 2.22: M0QT0F ESI mass spectrum of Cytochrome C from 
49:50:1 MeOH:HO:CHCOOH 
Figure 2.22 shows a mass spectrum of 40 .tM Equine Cytochrome C (Sigma Aldrich, 
Milwaukee, WI) flown from 49:50:1 MeOH:H 2O:CHCOOH with p = 3.5 Ton, T = 305 
K, Injection Voltage = 35.6 V. Measurements were also taken for cytochrome C flown 
from 30:70 MeOH:H 20 at the same pressure in order to sample higher charge states. 
Measurements were taken at Vd = 60, 55. 50, 45, 40, 35 and 30 V with 60 .is and 72 j.ts 
pusher frequency. 
Arrival times for each ion at each Vd were determined and mobilities were calculated as 
described above. Figure 2.23 shows a plot of arrival time as a function of P/V for the +7 
charge state. Note the excellent R 2 value for the best fit line. The least squares fit error 
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Arrival Time vs. PN for Cyt C
+7 
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This value gives a mobility of 2.926 cm 2 V's' which translates to a cross section of 1268 
A. The cross section of this ion reported by Shelimov et a112  is 1247 A 2 in good 
agreement with the value measured here. Table 2.3 lists measured cross sections of 
Cytochrome C versus literature values from the same work. 
117 
- 2. The MoQToF - a new ion mobility mass spectrometer 
Measured Cross Section 
Charge State 
(A) 
Literature Cross Section 
(A) 
7 1268±38 1247 
8 1855±56 1845 
9 1927±58 1964 
10 2223±67 2226 
11 2182±65 2303 
12 2298±69 2335 
13 2350±70 2391 
14 2486± 75 2473 
15 2613±78 2579 
16 2647± 79 2679 
17 2782± 83 2723 
Table 2.3: Table of measured cross sections and literature values from Sheliinov ci al 
for equine Cytochronie C. Reported errors are based on a 3% standard error. 
It can be seen that there is excellent agreement between the cross sections measured here: 
all measure values are within 6% of those reported in the literature and most are within 
2 1,,6. The large change in cross section between ±7 and +8 indicates an unfolding event 
brought about by coulombic repulsion, the position of this is consistant with studies of 
Cyt C reported elsewhere. 
Shelimov et a112 and others 19 report the presence of multiple resolvable conformations for 
the ±5 to +8 ions of Cyt C. The data obtained here shows only single resolvable 
conformers for each charge state. There was , however, some evidence of a more 
extended conformation for the +8 charge state of Cyt C. 
Figure 2.24 shows the ATD obtained for this charge state at Vd = 60 V. The shoulder on 
the peak in this distribution represents a lower mobility conformation than the main peak. 
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of too low intensity at all other voltages to obtain accurate arrival times. The mobility of 
this species cannot therefore be determined via the previously outlined method. 
However, as the more compact species was observable at all drift voltages, the 
experiment dead time for this charge state was able to be determined accurately. It is 
reasonable to assume that the dead time for any one charge state should be independent 
of collision cross section and therefore the drift time for the more extended species at Vd 
= 60 V could be determined. The mobility - and hence collision cross section - of this 
species can therefore be determined without the need for measurement at multiple drift 
voltages. 
ATDof+8 CytC 
Arrival Time (Scans) 
Figure 2.24: Arrival time distribution of Cyt C ±8 at Vd = 60 V. The arrival times of the two 
species (obtained from Gaussian fitting in Origin) are indicated. 
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The arrival time of the lower mobility species is 1504 .ts and the dead time for the +8 
species was determined to be 654 l.ts.  This gives a drift time of 850 ps for this species. 
Using equation 1.8 the mobility was therefore determined to be 1.977 cm 2V's' (c.f. 
2.285 cm2V 1 s' for the more abundant conformer) corresponding to a collision cross 
section of 2144 A 2 . This compares well - within 5% - with the cross section of 2061 A2 
reported by Shelimov et al. This agreement is especially pleasing as the mobility was 
only obtained using one arrival time, this suggests the assumption made about the dead 
time is indeed a valid one. 
2.5.2 Ubiquitin 
Ubiquitin is a small protein (76 residues, 8564 Da) found in all eukaryotic cells. It has 
been widely studied by TM-MS. 
Mobility measurements were taken were taken on 20 1iM lJbiquitin (Sigma Aldrich, 
Milwaukee, WI) flown from 49:50:1 H20:MeOH:CH3COOH with 3.5 Ton He in the cell 
at 305 K. Measurements were taken at Vd = 60 V 50 V. 40 V. 5 V and 10 V with 10 V 
injection voltage and 65 s pusher frequency. Figure 2.25 is a plot of measured cross 
section as a function of charge state for Ubiquitin (plotted in black) along with literature 
values for Ubiquitin from Valentine et a1 1 ' and Li et a!20 . 
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Figure 2.25: Ubiquitin cross-sections from M0QT0F (black) and literature 
Once more there is excellent agreement between the cross sections measured on the 
MoQToF and those measured by others (all values are within 3% of the literature values). 
2.5.3 Lysozyme 
Lvsozyrne is a 129 amino acid protein (-14 kDa) which contains 4 intermolecular 
disulphide linkages. The presence of these disulphide bonds has been shown to have a 
stabilising effect on the gas phase conformations adopted by the protein. Here it will be 
studied in its fully disulphide intact (oxidised) form. 
Figure 2.26 shows a mass spectrum of chicken egg white lysozyme (Sigma Aldrich, 
Milwaukee, WI) flown from 49:59:1 H70:MeOH:CH3COOH with the 3.5 T He in the 
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drift cell at 305 K. Mobility measurements were taken at Vd = 60 V. 50 V, 40 V and 30 
V with 30 V injection energy with 87 is pusher period. 
FM+9HI 9 
1! 
Figure 2.26: Chicken egg lysozyme mass spectrum. 
Collision cross sections were determined as described previously. Figure 2.27 shows a 
plot of cross sections measured in this work for the observed charge states (+5 to +10). 
Once more only single conformations were observed for each charge state. 
Valentine et a 11 , however, report the presence of a number of conformations for +7 to 
+11. They categorise these conformations as either highly-folded, partially-unfolded or 
unfolded (with the latter category only evident for fully disulphide reduced lysozyme); 
the ±5 and +6 charge states of lysozyme exist as only single conformers categorised as 
highly-folded. The cross-sections observed in this work for the three lowest charged 
species (+5, ±6 and +7)  agree well with the values from Valentine et al. assigned as 
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well with the reported values for partially-folded lysozyme. The conformational change 
can be seen clearly on figure 2.28. 
Lysozyme Cross Sections 
1200 
5 	6 	7 	8 	9 	10 
L#I Idi 
Figure 2.28: Collision cross sections of lysozyme at different charge states. 
It is worth noting that Valentine et a114 only report the partially-unfolded species at high 
injection voltage (120 V) and not at the 30 V used here. The reason the partially-
unfolded conformation is sampled here is not clear but it may be due to RF heating of the 
ions whilst they are being stored in the pre-cell hexapole. 
123 
I . The MoQT0F - a new ion mobility mass spectrometer 
2.6 Issues Affecting Operation of M0QT0F 
While it is clear that the instrument is performing well and is capable of reproducing 
measurements made by other groups, there are still a number of issues effecting the 
operation of the apparatus that need to be overcome. In this section these problems will 
be discussed and some solutions suggested. 
2.6.1 Source Issues 
During the course of making the initial measurements it became clear that the 
characteristics of the source had changed somewhat since with the addition of the drift 
cell. Prior to the modification it was relatively simple to obtain mass spectra containing 
high mlz species flown from native' conditions (e.g. 10 mM ammonium acetate) and 
non-native conditions (methanol/water/acid). Since the upgrade, however, observing 
high mhz species has proved to be extremely difficult and further to this it has been 
..,.,i,, 	 ._.,.. -----;.-.- ci,-...., 	'....+. .' 
¼flL1 ¼.111¼.1J ...LiLJfl¼.¼&1t 1¼J JU¼.S 'V ¼. USA) 31C.1IU1 I¼31 F1¼11¼.1123 Lit) V'V ii lit)!)) LIVAL1 'V ¼. ¼,t'ii*..LiLSJii.. 
While there have been no physical changes to the source itself, there has been a change to 
the voltages applied in the source area. The total voltage that may be applied to the 
sample cone (i.e. collision voltage + extractor voltage + cone voltage) is 204 V + 
collision voltage. In the original configuration the extractor was typically set to 0 V 
giving a maximum cone voltage of 204 V. For most experiments in the new 
configuration the extractor is set to 117 V, this gives a maximum cone voltage of 87 V. 
The cone voltage effectively determines the kinetic energy given to the ions as they are 
transferred from the source to the hexapole. High miz ions require more kinetic energy 
than low mlz ions ion order to be transmitted efficiently from the source to the hexapole. 
High cone voltage therefore aids the transmission of high mlz ions. However, high cone 
voltage tends to bring about in-source fragmentation of ions and can therefore lead to a 
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drop in overall ion intensity, especially for higher charged, low mlz ions. The cone 
voltage can therefore be viewed as an mlz filter that can be tuned to give the desired ion 
distribution. 
It is clear therefore that the limiting of the cone voltage brought about by the 
modifications to the apparatus, has led to reduced transmission of high mlz ions by 
reducing the tuning range of the instrument. This will be overcome by providing the 
cone voltage externally using a stabilised power supply. 
The poor performance of the ion source with regard to proteins analysed from 'native' 
solutions is less easy to explain. The cone voltage limiting may have some effect this - 
native ESI tends to produce lower charged species than non-native ESI it therefore 
follows that the ion intensity will be lower for some 'native' experiments - but the source 
conditions are thought to be more relevant. 
The presence of gas in the drift cell causes the pressure in the instrument to increase. 
With 3.5 Ton He in the cell, the pressure in the cell chamber typically increases by 3 
orders of magnitude (I 0 ° rnBar to 10 — mBar), the quadrupole chamber pressure increases 
by an order of magnitude (1 06  to 10-5 ) and the temperature in the ToF chamber increases 
by approximately three times (2 x 10 - 'to 6 x 10). While there is no simple way of 
measuring the pressure in the source hexapole chamber and source it follows that there 
will be an increase in the pressure in these regions when gas is introduced to the drift cell. 
It has been shown that having increased pressure in a hexapole can improve ion 
transmission. Indeed the groups of Robinson 21  and Heck 22  have shown that introducing 
argon to the source hexapole can greatly improve the performance of a Q-ToF with 
regard to the transmission of large, high mlz biomolecules and complexes. They do 
however, have to carefully control the pressure in the source chamber and source block 
(containing the source and sample cones) to achieve good ion signal. It is our belief that 
the increased pressure in these regions is suppressing the ion signal and that this is 
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particularly apparent for 'native' ESI due to desolvation effects - aqueous solvent being 
les volatile than organic solvent. 
To overcome this it is proposed that additional pumping be provided to the source in the 
form of a higher capacity rotary pump and that the source pressure should be monitored 
and optimised for different solvents. 
It is hoped that by making these changes, the instrument will be capable of analysing 
higher mlz ions and molecules flown from more native conditions. 
2.6.2 Software Issues 
As stated previously, the software used for data collection and analysis is a modified 
version of Masslynx. While the software has some unique elements, it was originally 
designed to operate an instrument fitted with a travelling wave ion mobility (t-wave) 
device and is therefore optimised for this type of system. Some modifications to the 
software and/or electronics are required in order for to optimise it for the MoQT0F. 
2.6.2.1 Data Resolution 
Typical drift times for a t-wave experiment are of the order of 3 to 10 ms whereas drift 
times for a MoQToF experiment are of the order of I to 3 ms. Additionally, ATDs 
obtained from the MoQToF are far narrower than those obtained from a t-wave device. 
Figure 2.29 shows typical ATDs for ±8 Ubiquitin obtained from the MoQToF (blue 
trace) and a t-wave instrument (red line). 
The trace from the MoQToF has a centre at —1240 [is with a full width of —235 us while 
the trace from the t-wave has a centre at —2735 us with a width of —2050 us - nearly nine 
times as wide. Both measurements were taken using a pusher period of 65 us thus the 
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Essentially this means ATDs from the MoQToF are sampled far less than t-wave ATDs 
and are therefore the MoQT0F data are of lower resolution (in a data sense - from here 
on the number of times a peak is sampled will be referred to as data resolution). 
ATDs of +8 Ubiquitin on MoQToF and -Wave 
I.) uuu 	 '-fUUU 
Drift Time (ps) 
Figure 2.29: .ATDs for ±8 ubiquitin from the MoQToF (blue line) and a t-wave 
instrument (red line). Ion intensities were normalised to the top of each peak. 
For species of containing a single conformation the lack of data resolution has not proved 
to be an issue in assigning cross sections. However, for species with multiple 
conformations - especially those with similar cross sections - the lack of data resolution 
may prove problematic. Returning to figure 2.24, the two peaks are not completely 
resolved and accurate assignment of the arrival time of the second peak proved difficult. 
If the data resolution had been higher (i.e. the peak was sampled more often) it may have 
been possible to fully resolve this peak. 
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To improve the data resolution, there must be a change to the way it is acquired. In the 
current set up the ion distribution is sampled once every time the pusher is pulsed. The 
frequency of the push is determined by mass range being studied - the pusher period is 
set to be slightly longer than the flight time of the highest mlz being studied. If the 
pusher period is set to a shorter time than this the pusher pulse appears as a set of noise 
spikes in the mass spectrum that swamp the ion signal. Changing the pusher frequency is 
therefore not an option for improving data resolution. 
The solution to improving the data requires the ability to delay the ion mobility pulse 
relative to the pusher pulse or vice versa. This can be achieved in two ways: 
Delaying the pusher pulse relative to the ion mobility pulse: this requires 
taking control of the pusher away from the instrument software and 
synchronising it with the IMS pulse. The leading edge of the IMS pulse will 
feed a simultaneous trigger pulse to the pusher circuit triggering the first pulse in 
the set of 200 required to make up a mobility experiment. The circuit will be set 
up such that it the trigger pulse can be delayed by some time (e.g. 5 p.$) thus 
effectively sampling the mobility separated peaks that time later. The entire 
mobility peak can then be sampled by sequentially increasing the delay. The 
complete ATD can then be formed by summing all the data collected (including 
the relevant delays). 
ii. 	Delaing the mobility pulse relative to the pusher: this involves triggering the 
mobility pulse with the pusher pulse. A circuit will be set up that includes a 
digital counter to count the pusher pulses, after a set number of pulses (>200) the 
circuit will send a trigger pulse to the IMS pulse signal generator, triggering the 
mobility pulse. The circuit will be set such that the IMS pulse can be delayed 
relative to the trigger pulse allowing the ions to be sampled in much the same 
way as described above. 
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Of these two possibilities the latter solution is the simplest and safest to implement as it 
does not require major changes to the instrument circuitry. Appendix 1 shows a circuit 
diagram for the proposed new pulse set-up based on scheme ii. 
2.6.2.2 Pulse Synchronisation 
In section 2.2.2, the pulsing sequence used in a typical IMS experiment is outlined. 
Within this it is made clear that the pusher pulse and the IMS pulse are asynchronous. 
The pusher pulse is controlled by the instrument and when an acquisition begins, the ToF 
pushes at the defined frequency. While the frequency of the IMS pulse is determined by 
the pusher frequency (i.e. T 1 45 = * 200) it is not triggered by it and therefore is 
likely to be offset relative to the pusher pulse. This means the start time of the ion 
mobility pulse is unlikely to coincide with a pusher pulse making the start time 
ambiguous (but known within one push). 
In order to average out this error. all ATDs in this work are created by summing a 
minimum of ten individual ion mobility experiments. As can be seen above, this 
approach has been shown to be a valid one. It is , however, not an ideal situation and it 
would obviously be better to know the start time of the ions accurately. 
Fortunately, the circuit described above to allow increased data resolution uses the pusher 
pulse to trigger the ion mobility pulse. Using this circuit will therefore allow us to 
accurately determine the start time of the ions. 
2.6.2.3 Data Acquisition 
The data sets created by Masslynx operating in IMS mode are extremely large, often as 
much as ten times larger than an equivalent ToF MS only data set. This is because each 
IMS file contains an extra dimension of data - namely arrival time - for each scan. 
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These large data sets require a lot of processing power when they are transferred to the 
acquisition computer from the TDC on the embedded PC. The computer has 1 Gb of 
RAM but even this relatively large processor is slowed considerably by an long IMS 
acquisition. 
Currently experiments are limited to twenty minutes in duration with a maximum mlz 
range of 1000. For experiments requiring longer acquisitions or a wider mlz range it is 
necessary to create a number of files. While this is not a major problem when running 
standard IMS experiments, it does present a problem for planned experiments using LC-
IMS-MS (c.f. Clemrner2 ) where long run times will be required. 
One possible solution to this problem is reducing the size of the data sets created. In the 
current set-up an IMS experiment is 200 scans. Typically all ions of interest have 
reached the detector within 40 scans, there are therefore 160 scans per experiment that 
are not needed. The software will therefore be modified to allow the number of scans per 
experiment to be reduced thus creating smaller data sets. 
An obvious practical solution to this problem in the interim is the addition of extra RAM 
to the acquisition computer. To this end it will be upgraded to 2 Gb RAM. 
2.6.2.4 Data Processing 
An obvious bottle neck in the experimental method is the transferring of data from the 
Masslynx files into a format which allows the extraction of arrival times. Currently this 
involves the creation of several ASCII files of ATD data (one per ion of interest, per data 
file) followed by extraction of data taken under the same conditions. This data are then 
summed, plotted and fitted to obtain arrival times. The arrival times are then plotted and 
a mobility is calculated. This process takes around twenty minutes per ion (longer when 
multiple raw data files are required). 
130 
2. The M0QT0F - a new ion mobility mass spectrometer 
To attempt to speed this process up some Excel data templates have been created, these 
however, require a degree of editing for every data set and do not save much time. 
Ultimately it is hoped that Waters will make their ion mobility viewer software available. 
This software is designed to work with Masslynx files and creates multi-dimensional 
plots of arrival time, mass, ion intensity and retention time. This software should make 
data visualisation and processing much easier. 
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2.7 Conclusions 
The MoQToF is a unique instrument that represents the first reported integration of a 
linear ion mobility device into a commercial mass spectrometer with no loss in the 
original  functionality. As an IMS-MS-MS instrument it has the capability of gaining 
complimentary structural information from ion mobility, mass spectrometry and tandem 
mass spectrometry. 
Through experiments on a number of test compounds - ubiquittin, cytochrome C and 
lysozyme - the instrument has been shown to produce ion mobility measurements (i.e. 
cross sections) comparable with those published by other groups. 
Among the more appealing aspects of modifying a commercial instrument is the prior 
knowledge of its performance one has. The Micromass Q ToF I mass spectrometer has 
been shown previously by us 4 and others21 22  to be extremely useful for the study of 
proteins under native' conditions. Whilst this has mot proved an easy task to date the 
potential exists - thanks in part to the modification of the quadrupole - to study come 
very large complexes using this instrument. 
The change from the commercial instrument to the modified ion mobility instrument has 
brought about many changes not only in the physical instrument but in its performance as 
a mass spectrometer. Table 2.4 below summarises the performance of the instrument 
before and after the modifications. 
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Q-T0F I MoQToF 
Cell Chamber Pressure 
n/a I x I0 	mBar 
(no gas in cell) 
Cell Chamber Pressure 
n; a 1 x 10 	mBar 
(3.5 Torr He in cell) 
Analyser Chamber Pressure 
6 	10 -6 mBar I x 10 -6 mBar 
(no gas) 
Analyser Chamber Pressure 
na 1 x 10 	mBar 
(3.5 Torr He) 
ToF Chamber Pressure 
3 x 10' rnBar 2 x 10 -7 mBar 
(no gas) 
ToF Chamber Pressure 
n a 5 x 10 - mBar 
(3.5 Torr He) 
Quadrupole Mass Range 2 to 4500 niz 2 to 32. 000 m/z 
Quadrupole Resolution --500 —250 
ToF Mass Range Ito 5000 nil to 100. 000 m'z 
ToF Resolution 8000 8000 
Transmission Efficiency 
n  3% 
(MS mode, 3.5 Torr H e )* 
Transmission Efficiency 
n  500 
(IMS Mode, 3.5 Torr H e )* 
IMS Reso l u tion ** n/a 20 
IMS Pressure Range n a 4 Ton 
IMS Temperature R ange *** n  300 K to 600 K 
Table 2.4: Instrument specifications before and after modifications. *as  compared to ion 
transmission prior to upgrade; **calculated  for +8 cytochrome C at Vd = 60 V. P = 3.5 T, T = 305 
K: ***fl-  lines require repair before low temperature experiments can be carried out. 
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3. -Defensins: Insight from Mass Spectrometry 
This chapter will focus on the use of mass spectrometry based techniques to study a 
category of anti-microbial peptides known as 13-defensins. 
To protect themselves from infection by micro-organisms, mammals have developed an 
extremely complex defence mechanism with several levels of defence. The first 
mechanism of defence against infection is the innate immune response - a non-specific 
response to infection. An important part of innate immunity is represented by a broad 
category of peptides known as anti-microbial peptides' (AMPs) and an important sub-
category of AMPs are defensins 2 . 
Defensins are found in a wide range of organisms including humans, mice, plants and 
penguins. They are small (-3 0-45 amino acids), cationic and cysteine rich. Broadly 
speaking, they are active against a wide variety of pathogens: gram-negative and gram-
positive  bacteria as well as fungi. Defensins are also reported to exhibit chemotactic 
activity i.e. they can attract or activate specific blood cells such as T-cells across a 
concentration gradient by acting on specific receptors. Human 13-defensin 3 (HBD-3) for 
example has been shown to attract immature dendritic cells by acting through the CCR6 
chemokine receptor'. 
The genes that express defensins are largely found on chromosome 	In mammals, 
they are expressed in a number of tissues but are most abundant in the epithelial tissues of 
various organs' 6 . 
One of the more interesting features of defensins is their lack of sequence homology 
across the series apart from the presence of (typically) six cysteine residues. This 
variability of sequence is thought to be due to the huge evolutionary pressure applied to 
the peptides by the constantly changing nature of the pathogens from which the 
organisms must be protected 7 . 
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Mammalian defensins are divided into two categories, a-defensins and 13-defensins, based 
on their gene location, sites of expression and the connectivities of the intra-molecular 
disulphide bonds formed between the six, conserved cysteine residues. These canonical' 
disulphide connectivities are shown in figure 3.1. It is worth noting that these 
connectivities hold for all defensins that have been isolated from tissue thus far but it has 
not been proved that all defensins conform to this pattern. 
a-defensins: ••CyslCys2Cys3CysCys5"Cys6" 
I 	 I 
13-defensins: CyslCys2CysCysCys5 ... Cys . .. 
Figure 3.1: Canonical disulphide connectivity of a and 13-defensins. 
The exact purpose of these disulphide bonds and their topology is not clear. Several 
groups have shown that removing the disulphide bonds by reduction has little or no effect 
on activity("" L)  . Lu has shown that changing the topology of the disulphides in HBD3 has 
no effect on anti-microbial activity but does have an effect on the ability of the peptide to 
chernoattract in that only canonically bonded HBD-3 exhibits chernotactic properties 8 . 
Klüver et a? conducted a systematic study of HBD-3 by synthesising a number of 
variants of the peptide with different disulphide connectivities, sequence length, net 
charge and hydrophobicity. They showed that varying the disulphide topology of the full 
length peptide or removing the disulphides altogether had little effect on anti-microbial 
activity. It was also demonstrated that small fragments of HBD-3 can exhibit anti-
microbial activity. 
From the work on varying sequence length, hydrophobicity and charge, the authors 
demonstrate a qualitative relationship between hydrophobicity, charge and anti-microbial 
activity from which they were able to categorise the peptides into three groups: (i) 
peptides with low net-charge and moderate hydrophobicity are active anti-microbial 
agents; (ii) peptides with low hydrophobicity and positive net-charge are anti-microbially 
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active and cytotoxic to eukaryotic cells; (iii) peptides with high charge and low 
hydrophobicity are anti-microbial agents that exhibit no cytotoxic effects on eukaryotic 
cells. 
The mechanism of anti-microbial activity of defensins is not well understood but several 
studies indicate that the defensins molecules bind to negatively charges cytoplasmic 
membranes and disrupt their integrity somehow bringing about leakage of intercellular 
components and inhibition of DNA, RNA and protein synthes i s2 OIU 2 . 
The interaction between the peptides and membranes is not clear; two models have been 
suggested 10 : 
I . 	Pore (Barrel Stave) Model - in this model, the peptides form oligomeric pores 
that span the membrane allowing leakage. This model is supported by the 
structural studies of defensin which show the presence of oligomers. 
ii. Carpet Model - in this model, the defensins bind to negative components on the 
cell membrane neutralising them. This neutralisation disrupts the integrity of the 
membrane leading and allow it to be permeabilised. 
Figure 3.2 is a pictorial representation of the two models. 
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Figure 3.2: The carpet and barrel stave (pore) models of membrane permeation. A - peptide 
accumulates at the cell surface and binds to negative membrane components: B - the peptide 
neutralises the areas of the membrane destabilising it: C - the membrane disintegrates: A' - 
peptide oligomers form on the membrane surface: B' - the oligomer(s) insert into the membrane 
forming a pore. 
High resolution structural characterisation of defensins has been performed using both 
XRC 1314 and 	 -.16.17 These studies have identified a common defensin-fold' based 
on the structure of human a-defensin-3 18 . The fold consists of a core of three anti-
parallel 13-sheets constrained by the intra-molecular disulphide bonds. 13-defensins 
additionally exhibit an a-helix region towards the N-tenriinus. Figure 3.3 15 shows the 
NMR structure of HBD-2 with the 13-sheet core (blue arrows) and N-terminal alpha-helix 
(red helix); disulphide bonds are shown in yellow. 
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, w 	--/ 
Figure 3.3: NMR structure of human -defensin-2 (HBD-2). The defensin-fold' of a 3-sheet 
core (blue arrows) and N-terminal a-helix (red helix) is clearly evident. 
Recent work at Edinburgh has focussed on the characterisation of a number of 3-
defensins from both humans and rnice 61920 . This work takes many forms and is part of a 
large collaboration between several groups from the School of Chemistry, the Medical 
School and the Medical Research Council and externally Cambridge University and 
University College London. Through this work we endeavour to characterise defensins 
structurally (via NMR. MS and TMMS), learn about their biological activity (by anti-
microbial testing and chemotaxis assays), learn how to produce and extract peptides 
(through various methods) and attempt to discover how they function in vitro. 
In our previous work' 920, mass spectrometry has been the core technique for structural 
characterisation of 13-defensins. This work aims to extend that work to include mass 
spectrometry-based mode-of-action studies. 
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The peptides featured in this work were all produced by solid phase synthesis techniques; 
the sequences were obtained for genome mining to identify 3-defensin sequences 7 . 
Further to this a number of rationally designed peptides have been synthesised in order to 
aid our understanding of the importance of sequence, disulphide bonding and 
dimerisation. The sequences and anti-microbial activities of the peptides studied here can 
be found in appendix 3. 
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3.1 Accurate Mass of -defensins 
Upon obtaining a new defensin, it is important to confirm the peptide has been produced 
correctly and contains the correct number of disulphide bonds. To do this high-
resolution, accurate mass measurements have been performed on all peptides using a 
9.4T ESI-FTICR-MS (Bruker Daltonics, Billerica). Combining these measurements with 
isotope modelling allows for precise determination of the oxidation state of each cysteine 
residue (and hence determination of the number of disulphide bonds present). Modelling 
individual charge state isotope from raw data or uncharged isotope distributions from 
deconvoluted data can yield the same information - both are shown here. 
3.1.1 Experimental 
Peptides are obtained from two sources: (i) synthetic peptides from Albachern Ltd. 
(Glandsmuir, UK) produced by solid phase methodologies; (ii) synthetic peptides from 
Dr. Derek MacMillan (UCL, London). Ubiquitin (a calibrant peptide) was obtained from 
Sigma Aldrich Ltd. (Milwaukee, WI, USA). 
For mass spectrometry measurements the peptides were dissolved in 49.5:49.5:1 
MeOH:H20:CH3COOH at 20-50iM and ionised by ESI (250j.il min', 3-4kv) or nano-
ESI from goldlpalladium coated tips (Proxeon Biosystems) or via a nano-mate (Advion 
Ltd.). 
3.1.2 Defrl 
The peptide Defri (defensm related peptide 1) is a variant of MBD8 found in black 6 
mice. In Defri, the first cysteine residue has been replaced by a tyrosine leaving only 
five cysteines and hence opening the possibility of the formation of an intermolecular 
disulphide bond. Previous work on this peptide has shown it to exist as a covalently 
bound dimer of mixed disulphide topology' 9 . The peptide was shown to be extremely 
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active against a wide variety of micro-organisms although this activity fell greatly on 
reduction of the intermolecular disulphide bond. 
Work on defensins by other groups has shown that different disulphide connectivities can 
be separated by a long HPLC gradient 8 . In order to test if this was possible for DefrI it 
was synthesised again and separated on an extremely long gradient (20% orgainic to 30% 
organic over 60 mm) collecting 16 fragments across the peak in the hope each fragment 
would contain, predominantly, one connectivity. In order to confirm the oxidation state 
of the disulphides in the fractions a representative selection of the more abundant 
fractions was analysed by FTICR-MS. These were fractions 13, 14, 15, 23, 25 and 26. 
The spectra were calibrated externally using ubiquitin. 
DPVTYIRNGGkQY IGLRHKIG GSPFK.:.1K 
Figure 3.4: Monomer sequence of DefrI. Cysteine residues are highlighted in red, the Cys to 
Tyr mutation is highlighted in blue. 
The sequence of the monomer of Defri is shown in figure 3.4 with the point of the 
cysteine to tyrosine mutation highlighted in blue. 
3.1.2.1 Results 
By modelling the predicted isotope distribution for Defrl dimer with four intramolecular 
and one intermolecular disulphide bonds using the X-Mass software (Bruker Daltonics, 
Billerica), it was possible to confirm that each of the peptides tested was fully oxidised 
(all five disulphide bonds in tact) as expected. Figure 3.3 shows the ±7 charge state of 
Defri with the predicted isotope distribution overlain (red triangles). 
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Figure 3.5: Isotope distribution of--7 Defri fraction 23. 
There is good mass agreement between the theoretical spectrum and the experimental 
spectrum but the intensities match poorly. This mismatch is most likely due to space-
charge effects 2 ' which have been reported to affect ion intensities and mass accuracy in 
FTMS measurements 2 . The deconvoluted mass measured for this peptide was 7566.91 
Da as compared to a theoretical mass of 7566.98 Da for Defri dimer with all disulphide 
bonds intact - a mass accuracy of 9ppm. The same result was obtained for each fraction 
studied and it was therefore concluded that each fraction obtained was fully oxidised. 
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3.1.2 DEFBI07 
DEFBI07 is a five cysteine containing human 3-defensin (figure A3.1, appendix 3) 
obtained from genome database mining 7 ; it is the orthologue of the murine 13-defensin, 
defbl3. Unlike Defri, DEFB 107 is found to be completely inactive against  all pathogens 
tested 20 . 
Low resolution mass spectrometry of DEFB 107 showed it to have a mass 304 Da higher 
than expected. This mass increase corresponds to the addition of a glutathione (a tn-
peptide of sequence ECG) capping group on present on one of the cysteines. To confirm 
this accurate mass measurement was performed as described previously. 
3.1.2.1 Results 
Figure 3.6 shows the deconvoluted FTICR mass spectrum of DEFBI07 with the 
predicted isotope distribution for DEFB 107 with two intramolecular disulphide bonds 
and a disulphide bound glutathione group. Again there is excellent agreement between 
.j 	 . __ 1__ 	 11. 
uic wu1cL1L,aI iiias aiiu uic jiicaswcu I11aS, IUI LIIIS Sp..L1U1Ii ilicic is atso execuciiL 
agreement between the predicted abundance and the measures abundance. 
3.1.3 Other Defensins studied 
A number of other -defensins have been studied by FTICR-MS during the course of the 
work. Table 3.1 shows the measured mass for each peptide, the number of disulphides 
present and the corresponding theoretical mass for a fully oxidised peptide (all 
disulphides formed). 
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Peptide Theoretical Mass Measured Mass Comment 
8pprn. monomer. 
Defbl4 5 L 3.7176 5183.6768 
3 disulphides 
4.5ppm. dimer. 
DefbI4 lCvs 10058.7923 10058.7461 
I disulphide 
I Oppm, monomer.  3
HBD-3 5154.4594 5154.5086 
disulphides 
3ppm, monomer. 
HBD-2 Biotin 45-5 3.2125 4553.1995 3 disulphides. 
biotin affinity tat 
Table 3.1: Theoretical and measured masses of 13-defensins. The masses shown are of the most 
intense peak in the spectrum. 
There is good agreement between measured mass and theoretical mass demonstrating the 
strength of FTICR-MS as an accurate mass technique for peptides of this size. 
Additionally, isotope modelling was performed for each of the spectra generated for these 
peptides allowing confirmation  of the assigned cysteine oxidation states. 
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3.2 Mapping Disulphide Connectivity of -Defensins 
As discussed in the mtroduction to this section, the topology of the disulphide bonds in I-
defensins appears to have no effect on anti-microbial activity but can be important for 
chemotactic activity. It is therefore important to fully characterise the disulphide 
connectivities of the peptides studied. 
Digestion of peptides by proteolytic enzymes followed by MS analysis is a widely used 
technique in the identification of peptides. In the case of this work it is important to 
cleave the peptide between the cysteines while leaving the disulphide bonds in tact. It 
has been shown previously that using trypsin or a combination of trypsin and 
chymotrypsin can be used to successfully mass map defensins 19 . Trypsin cleaves after 
basic residue (i.e. K and R) and chyrnotrypsin cleaves after aromatic residues (F, W and 
Y). After digestion the peptides obtained can be analysed by MS and the masses 
obtained matched with theoretical peptide masses. 
3.2.1 Experimental 
Peptides were obtained as previously described. All other chemicals were obtained from 
Sigma-Aldrich (Milwaukee, WI). 
Enzymatic digestion of the peptides (500 jig/ml) was performed with tiypsin (25 jig/ml) 
in 50mM TRIS-HCI buffer pH 5. The reaction was allowed to proceed at 37°C for 4hrs 
before termination with 0.01% TFA. 
The resulting peptides were purified and concentrated using Cl 8 Zip Tips (Millipore, ) 
eluting into 20 p1 of CH 3 CN:H 20:CH3COOH (49.5:49.5:1) prior to analysis by nano-ESI 
MS on a Q-T0F I (Waters Micromass Technologies, Manchester, UK) using 
gold/palladium coated tips (Proxeon Biosystems, Denmark). 
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3.2.2 Results: DEFBI07 
DEFB 107 presents an interesting challenge as the position of the capping group must be 
determined along with the topology of the two disulphide bonds. This was achieved 
using trypsin digestion with MS and MS/MS analysis. Figure 3.6 shows the sequence of 
defb 107 with the sites of tryptic cleavage highlighted in red. 
RALIS MEGHC I EAEC 2 LTFEV lGGC 3 .AELAFC4C 5 KN. 
Figure 3.6: Deth 107 sequence 
Table 3.2 shows the observed peptides obtained from this procedure (the masses 








R 174.11 174.09 
2 ALISK 530.34 530.33 
3 MEGHC 1 EAEC2LTFEVK 1722.71 1722.74 
4 [IGGCR] [AELAPFC 4CR] [Git] 1787.75 1788.21 
5 NR 28 8.15 Not observed 
Table 3.2: Identified tryptic digest peptides for DEFB 107. Square brackets indicate the presence 
of disulphide bonds. 
Clearly fragment 4 could have the disulphide bond between cysteine 3 and cysteine 4 
with the capping group on cysteine 5 or the disulphide bond between cysteine 3 and 
cysteine 5 with the capping group on cysteine 4 - the two corresponding peptides are 
indistinguishable on mass grounds only. To determine which of these topologies was 
observed. CID was performed on ±4 full length DEFBI07 - the obtained dissociation 
fragment ions are listed in table 3.3. 
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Fragment Sequence Theoretical Mass Measured Mass 
b3 RAL- 340.22 340.20 
b4 RALI- 453.30 453.31 
b9 RALISKRME- 1085.34 1085.60 
hi! RAL.ISKRMEGH- 1279.53 1279.65 
hI 2 RALISKRMEGHC- 1382.68 1382.66 
b13 RALISKRMEGHCE- 1511.79 1511.65 
y4 [-CKNR][Glt] 822.24 822.28 
yl I [RAELAPFCCKNR][Glt] 1250.49 1250.67 
[\4 ± 4H] 
[RALIS KRMEG H C EAEC LTFEV 
KIGGCRAELAPFCCKN R][Glt] 
4572.38 4572.37 
Table 3.3: Identified CID fragments from -4 DEF13I07. 
The important fragments here are fragments y4 and yl 1. vii confirms the presence of 
the glutathione group on the final two cysteine residues; y4 has the sequence 
[CKNR][G1t] indicating the presence of the glutathinne group on cysteine 5. 
By combining the data from peptide mass mapping and CID measurements it is clear that 
the peptide has the connectivity C1-C2, C3-C4, C5-Glt. This is of course a non-
canonical connectivity, the structural consequences of this topology will be discussed in 
section 4.1. 
3.2.3 Results: Defb14 
DefbI4 is the murine orthologue of the human 13-defensin HBD3. It has been shown to 
be active against a wide variety of pathogens. The peptide studied was produced 
synthetically by Albachem. The disulphide connectivity of this peptide was determined 
by digestion with trypsin. The peptide sequence is shown in figure 3.7. 
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FLPNTLRKFFC I RI RGGRC 2AVLNC3LG kEEQIG RC4SNSGR KCcC6 RKK K 
Figure 3.7: Defb14 sequence with trypsm cleavage sites highlighted in red and chymonypsin 
cleavage sites highlighted in blue 
Analysis of the resulting peptides by MS revealed two/three dominant topologies, the 
peptides identified by each digestion are shown in table 3,4. The data includes several 








1 FLPK 503.31 503.32 
2 TLR 388.24 388.34 
3 K 146.11 146.08 
4--9 [FFC 1 R][C4SNSGR] 1191.50 1191.45 
5 IR 287.20 287.21 
6 GGR 288.15 288.18 
7 [C 2AVLNCLGK] 917.45 917.47 
7+11 [C 2AVLNC 3 LGK]{C 5 C 6 K] 1295.57 1295.86 
8 EEQIGR 730.36 730.29 
10 K 146.11 146.08 
11 [C 5 C6K] 378.12 378.52 
12 K 146.11 146.08 
13 K 146.11 146.08 
14 K 146.11 146.08 
1+2* FLPKTLR 873.55 873.65 
TLRK 516.35 516.97 
3_49* [KFFC 1 R][C4 SNSGR] 1319.61 1319.96 
4.59* [FFC 1 RIR][C4 SNSGR] 1461.69 1461.33 
[C 2AVLNCLGKEEQIGR] 1630.91 1630.78 
Table 3.4: Tr;psm digest masses for DeIb14. Square brackets indicate the presence of disulphide 
bonds. * indicates the presence of a missed cleavage. 
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The data reveals one clearly defined connectivity of C 1 -C4, C2-C3, C5C6 (indicated by 
fragments 4+9, 7 and 11 respectively) and at least one other topology of connectivity C 1 -
C4, C2-05. C 3 -C6 and/or connectivity C 1 -C4. C2-C 6. C 3-0 5 (indicated by peptides 4±9 and 
7+11). Due to the low abundance of peptide 7+11 further experiments such as CID were 
unable to be performed in order to fully characterise this peptide. 
It is noteworthy that the C 1 -C4 peptide occurs in all three identified topologies suggesting 
this disulphide bond is favoured in this peptide while the other disulphide bonds are more 
variable and may perhaps scramble in the folding process. Unfortunately we are unable 
to obtain information on the synthesis and folding strategies employed by Albachem 
when preparing this peptide as this information is viewed as being commercially 
sensitive. Were this information available, it might be possible to explain why these non-
canonical connectivities were obtained. 
Once again, there is no evidence of a canonically bonded defensin present in the sample: 
unlike DEFB107 , however, Defb14 is extremely active despite the nature of the 
disulphide bridges - this is consistent with the findings of Lu 8 and of Klüver9 for HBD3. 
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3.3 Defensin Membrane Interactions 
As discussed previously, the mode of action of 13-defensins is not well understood; it is 
known to involve disruption and permeabilisation of the cell membrane of invading 
pathogens leading to content leakage and eventual necrosis. There are two proposed 
modes of action for -defensins (and AMPs in general): 
Carpet Model: where many molecules accumulate on the cell surface 
eventually disturbing the integrity of the membrane. 
Pore/Barrel Model: where the peptide oligomerises and forms at 
multimeric pore which permeates the cell membrane to allow leakage. 
In reality AMPs may work by one, both or neither of these mechanisms and much work 
is required to filly, or even partially, understand their mode of action. 
The peptide DEFB 107 presented itself as an interesting choice for the study of mode of 
action At flrst sight it would seem an unlikely candidate for this type of study because it 
is inactive. However, this inactivity can be exploited for examination of peptide-
membrane interaction; the hope being the peptide is capable of interacting with a cell 
membrane in a similar way to active defensins but is unable to disturb the integrity of the 
membrane. 
An experiment was devised, based on the work of Demmers et a1234 who elegantly 
demonstrated how to determine which parts of peptides are incorporated in cell 
membranes using hydrogen/deuterium exchange mass spectrometry. 
The basic experiment is as follows: the peptide of interest is mixed with a solution of 
lipid at a high lipid to peptide ratio. The resulting solution is used to form peptide 
containing vesicles known as proteoliposomes. The parts of the peptide which interact 
favourably with the lipids (e.g. alpha helices) are enclosed by the lipid bilayer and are 
therefore unavailable to solvent. By performing HID exchange on these proteoliposomes 
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it is possible to determine how much and which parts of a peptide are incorporated in the 
membrane. 
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3.3.1 Experimental 
DEFBI07 was obtained from Albachem Ltd. (Glansmuir, UK). The lipid. 1,2-
dimyristoyl-sn-giycero-3-phospocholine (DMPC), trifluoroacetic acid (TFA), 2.2,2-
trifluoroethanol (TFE). ethanol, ammonium acetate, deuterium oxide (1320) and methanol 
were all obtained from Sigma Aldrich (Milwaukee, WI). 
250 ig of DEFBI07 (1mg/mi in water) was freeze dried under vacuum to produce a 
lyophilised powder. This powder was dissolved in a small amount (250 gil) of TFA 
which was removed with a stream of nitrogen. The peptide was then redissolved in TFE 
(250 Ml)  and dried under nitrogen once more. The dried peptide was taken up once more 
in TFE (1mg/mi) and mixed with a solution of DMPC in methanol (Smg/ml) to give a 
peptide to lipid ratio of approximately 1:25. The resulting solution was vortexed 
vigorously at 40°C (i.e. above the glass transition temperature of DMPC) before drying 
under nitrogen (again at 40°C). The resulting film was taken up in imi of methanol and 
the vortexing and drying process was repeated. The mixed film produced was dried 
under vacuum for 24hrs prior to hydration at 40°C in 250 1.11  of 10mM ammonium acetate 
cniiitinn - crivinci n finu1 npntidp rcn'entritinn cf 1 mo/rn! 
-- -- 
In order to produce vesicles from this solution a process known as extrusion is carried 
out. This involves passing the peptide/lipid solution through a 0.1 im membrane (Avanti 
Polar Lipids Inc., Birmingham, AL) several tens of times forcing the lipids to form 
vesicles or in this case, proteoliposomes (once more this is carried out at 40 0C). 
Prior to H/D exchange the solution is incubated at 40°C for 30 mm. It is then diluted 50 
times in 10 mM deuterated ammonium acetate solution. At selected time points - 
ranging from 3 mm to 2 days - aliquots of this solution were taken and analysed by nano-
ESI-MS on a Q-T0F (Micrornass, Manchester, UK) using gold/palladium tips (Proxeon 
Biosystems. Denmark). 
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As a control solutions of DEFBI07 were analysed at the same concentration from 10mM 
ammonium acetate and from lOniM deuterated ammonium acetate (ensuring the same 
final concentration of deuterated solvent was present - 98%). 
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3.3.2 Results 
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Figure 3.9: Q-T0F mass spectra of DEFB 107 obtained from three different solutions: (A) 
DEFBI07 in 10mM AmAc (Average Mass = 4572.05 Da): (B) DEFB107 proteoliposomes in 
dAmAc 1 hour after incubation (Average Mass = 4638.14 Da, —66 exchanged); (C) DEFB 107 in 
IOimM dAmAc 10 minutes after incubation (Average Mass = 4649.98 Da. —78 exchanged) 
Figure 3.9 shows mass spectra obtained for DEFB 107 flown from 10mM ammonium 
acetate (AmAc), deuterated 10mM ammonium acetate (dArnAc) ten minutes after initial 
incubation in deuterated buffer and for DEFB 107 proteoliposomes flown from deuterated 
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Figure 3.10 is a plot of mass increase against time incubated in dAmAc for DEFB 107 
proteoliposomes. The data clearly shows that there is an instant (<3  minutes i.e. the 
shortest possible analysis time) increase in mass to —66 hydrogens exchanged; the 
number of exchanged hydrogens does not increase beyond this number, even after two 
days incubation time. 
Mass Increase vs. Time for DEFBI07 Proteoliposomes 
Incubation Time (Mm) 
Figure 3.10: Graph of mass increase vs. incubation time for DEFB 107 flown from 
dAin.Ac. The red line indicates the maximum possible mass increase (i.e. 78 Da) for the 
peptide. 
Returning to figure 3.9, spectrum C shows an average of 78 hydrogens exchanged for 
DEFB 107 in dAniAc after 10 min incubation - this corresponds to the exchange of all 
available hydrogens (backbone and sidechain) indicating the molecules is completely 
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solvent accessible. It is clear therefore that the lipid is protecting part of the peptide from 
the solvent indicating part of the peptide is enclosed by the membrane. 
In an attempt to ascertain which part(s) of the peptide was protected from the solvent, 
CID was performed on the 4+ charge state of the peptide flown from proteoliposomes in 
dAmAc. At fairly low collision energy (--35 V), loss of the fully exchanged glutathione 
capping group was seen - indicating it was fully solvent exposed [data not shown]. Due 
to this group's proximity to the C-terminus of the peptide, this suggests the C-terminus of 
the peptide is also fully solvent exposed. Further identification of fragment ions in this 
spectrum proved to be extremely difficult due to the huge number of possible fragment 
ion masses for a partially exchanged peptide. 
Using this evidence, it is postulated that the N-terminus of the peptide is the part that 
interacts with the membrane. Examining the sequence (figure A3.1, appendix 3) reveals 
that the first 11 residues of the peptide are unrestrained by disulphide bonding (in 
comparison to the rest of the peptide). Three of the first four residues (Ala-2 , Lys3 and 
11e4) are aliphatic residues with low hydrophobicities - i.e. residues that should interact 
favourably with a lipid bilayer. These residues are flanked by basic residues (ArgI and 
Lys6/Arg7) which could interact favourably with the polar head groups of the lipids. If 
we count the number of exchangeable hydrogens in the section of the peptide before 
Lys5, the total number is 11, this is very close to the number of protected hydrogens seen 
in the experiment (12). 
A plausible explanation for the reduced exchange seen for the peptide in the presence of 
the artificial vesicles is that the first five or six residues insert into the bilayer. 
Structural studies of the peptide using molecular modelling and ion mobility (see section 
4.1) indicate the N-terminal section is a potential helix: this is in keeping with structural 
findings for other f3-defensins where the section of the peptide before the first cysteine is 
invariably shown to be helical' 31 . Similarly, the N-termini of other defensins for which 
the structure has not been solved (including those peptides studied in this work) is almost 
W. 
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always aliphatic and hence likely to interact favourably with a membrane. It is therefore 
reasonable to suggest that the N-terminal section of -defensins is the section of the 
peptide involved in membrane disruption. 
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3.4 Defensin - Glycosaminoglycan Interactions 
With such a large array of AMPs combining to fight off bacterial infection it is not 
surprising to learn that bacteria have developed their own defence mechanisms with 
which to fend off AMPs. For example, Burkholderia cenocepacia has been shown to be 
extremely resistant to attack by defensins; closer examination of the structure of the 
bacteria shows a mutation to its lipopolysaccharide (LPS), neutralising its negative 
charge, eliminating the possibility of an electrostatic interaction between the peptide and 
LPS26 . 
Another reported defence mechanism involves the release of glycosaminoglycans 
(GAGs) 27 . On entering an organism the pathogens Pseudornonas aeruginosa. 
Enterococcusfaecalis and Streptococcus pvogenes are reported to release enzymes which 
degrade epithelial proteoglycans to release dermatan sulphate (a GAG). It has been 
shown that dermatan sulphate binds to and inactivates AMPs and therefore the increase in 
GAG concentration brought about by the protease, reduces the effectiveness of the host's 
AMPs. 
One such GAG is heparin, a highly sulphated polysaccharide comprising repeating 
disaccharide units. The most common disaccharide repeating unit consists of a 2-0- 
sulphated iduronic acid and a 6-0-sulphated, N-sulphated glucosamine, IdoA(2S)-
GIcNS(6S). It has been shown 27  that 13-sheet containing a-defensins bind to and are 
inactivated by GAGs and that the sulphate groups typically found on heparin are 
important factors in the binding. 
A number of authors report the presence of heparin binding domains - stretches of amino 
acid sequence to which heparin can bind. Cardin and Weintraub 28  propose XBBBXXBX 
and XBBXBX (where X is a hydrophobic or uncharged residue and B is a basic residue) 
while Sobel et a1 propose XBBBXXBBBXXBBX and TXXBXXTBXXXTBB (where 
T represents a turn) as additional binding domains. It is worth noting that these 
consensus sequences are not always found on heparin binding peptides and it may be 
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more relevant to examine the spacing between amino acids in order to identify a binding 
domain 30;  Margalit et a!31 report a distance of 20 A between basic residues as a 
prerequisite for heparin binding. 
The exact relation between heparin binding and anti-microbial activity is not known, 
indeed it could merely be coincidence that cationic AMPs such as defensins bind to 
anionic heparin. However, if heparin binding is indeed related to anti-microbial activity, 
the nature of the interaction may help in the design of new, novel AMPs. 
In order to study the heparin binding propensity of the 3-defensins studied in this work a 
mass spectrometry based binding assay was developed. 
3.4.1 Materials and Methods 
Peptides were obtained as described previously. The heparin chosen (a disaacharide) was 
obtained from Dextra Laboratories (Reading. UK) 
For the binding assay, we peptides and saacnariue were ootn aissoiveu in water at 
1mg/mi and mixed in various peptide:heparin ratios (2:1, 1:1, 1:2, 1:4) before dilution in 
10mM ammonium acetate (Sigma Aibrich, Milwaukee. WI) solution to give a final 
peptide concentration of 20 IJM. 
The resulting solutions were allowed to equilibrate at room temperature for 20 minutes 
before analysis by nano-ESI-MS and MS/MS on a Q-T0F I (Waters Micromass 
Technologies, Manchester, UK). 
3.4.2 Results 
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Figure 3.11 shows an example mass spectrum obtained for the peptide Defri mixed 1:2 
with the saccharide. A9 as phase dissociation constant, Kd, can be determined by 
evaluating the amount of free protein ([P]), free ligand ([L]) and complex ([PL]) present 
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Figure 3.11: Mass spectrum of Deft i and heparin mixed 1:2 from in 10111\1 
AmAc. The peaks labelled in blue correspond to ions of the free peptide while 
the peaks labelled in red correspond to ions of the defensin:saacharide complex. 
Looking at figure 3.11 the amount of complex seen is clearly charge state dependent. 
There is complex present for the ±5 to ±7 charge states but none for the +8 charge state 
and the ratio of complex to free protein varies from charge state to charge state. 
There are a number of possible reasons why no complex is seen for the higher charge 
state, the two most apparent are: (i) the saccharide is interacting with basic groups on the 
protein therefore preventing them from becoming charged in the electrospray process - 
the maximum charge state available to the complexed protein is therefore reduced 
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relative to the free species: (ii) the complex is unstable at higher charge states and 
dissociates. The question then arises: should Kds  be determined from deconvoluted data 
or from individual charge states? 
Deconvoulted data clearly gives a representation of the whole sample rather than any 
individual charge state , however, it takes into account protein ions for which there is no 
corresponding complex and may therefore skew the data towards a higher Kd value. 
Calculating the Kj from one individual charge state will allow for lower Kds  to be 
assigned - perhaps closer to the solution phase value - by choosing the charge state for 
which the complex is most abundant relative to the free protein. 
For this work it was decided that all Kd values should be determined based on 
deconvoluted data on the assumption that it is better representative of the solution as a 
whole. 
K,j values are determined using equation 3.132  where [Li ] is the initial ligand 
concentration and ([Li-[PL])  is the free ligand concentration i.e. free ligand 
concentration is equal to initial concentration minus the amount of ligand involved in the 
complex. 
[P]([L1_ ] - [PL]) K d = 
	[FL] 	Equation 3.1 
[P] and [PL} are calculated by summing the intensities of the complex and the free 
protein and setting that equal to the initial protein concentration i.e. 20 1kM.  [P] is then 
equal to [P]/([P] ± [FL]) * 20 jiM and [FL] is [PL]/([P] ± [PL]) * 20 jiM. 
While it is possible to determine Kds  based on individual measurements, it is better to 
base the values on data obtained from several spectra using different protein:ligand ratios. 
This allows a plot of [PL]/[P] against ([L]-[PL]) to be produced. The gradient of the 
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straight line fitted to the data will be equal to the inverse of the dissociation constant. 
This method was used in this work where ever possible. Figure 3.12 shows a plot of 
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Figure 3.12: Plot of the molar ratio of complex and free protein against free ligand 
concentration for Defri. The values were obtained at three protein:ligand ratios: 2:1, 
1:1 and 1:2. 
In the case of figure 3.12, the complex was evaluated at three peptide:heparin ratios: 2 to 
1. Ito 1 and Ito 2. The values obtained are plotted and a gradient of 0.0433 is obtained 
(note the excellent R 2 value obtained). 
Using the gradient of the line, the Kd of heparin and Defri is 23 tiM. 
This procedure was repeated for a number of different -defensins. Table 3.5 shows the 
gas phase dissociation constants measured for the various 3-defensin-heparin complexes 
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along with their anti-microbial activity (minimum inhibitory concentration - MIC) 
against P. Aeruginosa. 
Peptide K (tiM) MIC (jiM) 
DefblO7 No binding >22 (no killing) 
Defrl 23 0.79 
Defri YSC 10 13.5 
Defrl lCysAla 40 0.82 
Defri ICysSer 37 0.81 
Defbl4 30 0.29 
Defb14lCys* 19 0.15 
Defbl4 DIP  l* 23 0.58 
Defbl4 DIP2 No binding >20 (no killing) 
Defb14 DIP3 No binding >20 (no killing) 
Table 3.5: Gas phase dissociation constants of selcted 3-defenisns binding to heparin 
disaacharide along with MIC against P. Aeruginosa. Peptides marked with * had their 
Kds evaluated at only one peptide:ligand ratio. 
Upon examination of the data shown above it is immediately apparent that there is a 
qualitative relationship between heparin binding and anti-microbial activity: highly active 
peptides bind more tightly (i.e. have lower Ks) than less active and inactive peptides - 
which do not bind at all. This presents the assay as a potential high throughput activity 
screen. 
To investigate the effect of the heparin binding on anti-microbial activity, the anti-
microbial assays were run again in the presence of heparin for a selected group of 13-
defensins at a 1:2 peptide:ligand ratio. Table 3 .6 shows the results against P. Aeruginosa 
(a gram-negative bacteria) and S. Aureus (a gram-positive bacteria). 
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Peptide 
MIC - PA 
(iM) 
MIC - PA wI 
heparin (jiM) 
MIC - SA 
(jiM) 
MIC - SA wI 
heparin (jiM) 
Defrl 0.79 >6.6 (no killing) 0.83 >6.6 (no killing) 
Defrl lCvsAla 0.85 0.43 1.6 3.4 
Defbl4 0.29 4.8 0.6 >9.6 (no killing) 
Defbl4 lCvs 0.15 0.15 0.31 2.5 
Defol4 DIPI 0.61 0.61 1.2 4.8 
Heparin 
No killine No killinu No killinu No killing 
control 
Table 3.6: Anti-microbial activities of selected defensins against P. Aerugino.vu (PA) and S. 
Aureus (SA) in the presence and absence of heparin disaacharide 
It is interesting to note that the two'natural' defensins studied (Defri and Defb14) show 
partial or complete loss in activity in the presence of heparin whereas the designed 
peptides lose little or no activity in the presence of the saccharide. 
It is noteworthy that the effect of heparin is much more pronounced for the activity 
against the gram-positive bacteria studied. This is thought to be due to the different cell 
membrane structures of each type of bacteria 33 . Figure 3.13 shows a schematic 
representation of each type of bacteria. 
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Figure 3.13: Schematic representation of gram-negative (left) and gram-positive membranes. 
Gram-positive bacterial membranes are compri sed of a thick peptidoglycan layer 
followed by a cell membrane. Gram-negative bacteria have an outer membrane followed 
by a much thinner peptidoglycan layer in the periplasmic space between the outer 
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In order for a defensin to reach the cell membrane of a gram-positive bacterium, it first 
must traverse only the peptidoglycan layer to reach the cell membrane of a gram-
negative bacterium a defensin must also pass through the outer membrane. It is therefore 
possible that during the more complex path the molecule must take in order to reach a 
gram-negative cell membrane, the bound heparin can be lost through interaction with the 
cell membrane. For this reason, in the presence of heparin the peptide can remain active 
against gram-negative bacteria at lower concentration than against gram-positive bacteri a. 
If we take this hypothesis to be correct then we must assume that the two 'natural' 
defensins better protect the heparin from interactions with the membrane components 
hence heparin has a more pronounced effect on their activity. Further insight into this 
will be provided by ion mobility in section 4.4. 
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3.5 Conclusions 
Studying 3-defensins with MS can yield many different pieces of information from the 
relatively simple structural data provided by an accurate mass measurement to the more 
complex and difficult to interpret mode of action data obtained from a binding assay. 
From the accurate mass data shown above, it is clear that the synthetic peptides are being 
produced correctly and have the correct number of disulphide bonds. The formation of 
these disulphide bonds and the resulting connectivity is , however, a more complex issue. 
The two peptides studied in detail above did not posses canonical disulphide 
connectivity. This suggests a failing in the synthesis/refolding strategies employed in the 
production of these peptides. Current work within the project is focussing on new 
synthetic strategies (selective capping of cysteines etc.) to produce canonical disulphide 
connectivity Defbl4. The fact remains, however. Defb14 with 'incorrect' disulphide 
bonding is a highly active anti-microbial agent 6 - this is of course in agreement with the 
work of Lu and others 8 ' 9 . However, it is interesting to note that Defhl4 ic 
chemotactically active  - this is in opposition to the findings of Lu's work on HBD3 (the 
human othologue of Defbl4) where he found canonical disulphide bonding was a 
requirement for chemotaxis 8 . 
The work carried out on membrane interaction provides good evidence for the n-terminus 
of 3-defensins being important for antimicrobial activity. Armed with this information it 
is possible to rationalise the differences in activity of other defensins studied. Defri 
exists as a covalently bound dimer with five disulphide bonds and is a potent AMP its 
six cysteine analogue Defri Y5C exists as a non-covalent dimer with three intramolecular 
disulphide bonds and is seen to be nearly twenty times less active. If one examines the n-
termini of these two peptides they are obviously globally similar, however, the n-
terminus of Defri is less restrained by disulphide bonding than that of Defri Y5C - the 
first cysteine in Defri is residue 11. in Defrl Y5C it is residue 5. The less constrained n- 
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terminus of Defri may be able to present a structure favourable for membrane interaction 
and may also be able to penetrate the membrane more deeply than Y5C. 
Clearly the artificial vesicles used in this work represent a vastly simplified model of a 
bacterium. Bacterial membranes are vastly complex structures comprised of a mixture of 
lipids, carbohydrates and proteins. The first interactions between these membranes and 
3-defensins are reported to be between the basic residues of the peptide and anionic 
structures on the surface of the cell such as lipopolysaccharide (LPS), techoic acid and 
sialic acid 34.  Indeed it has been shown that B. cepacia with mutated LPS is highly 
resistant to attack by J3-defensins 19 (also appendix 3, Table A3.1). It is therefore 
important to consider the interactions with these membrane components when 
considering the mode of action of-defensins. 
The heparin binding assay described above has been shown to be a good qualitative assay 
for ranking anti-microbial activities of peptides. It has also been shown that some 
defensins are inactivated in the presence of heparin. The nature of the interaction may 
therefore be important in understanding how f3-defensins work and will be studied in 
more detail by ion mobility and molecular modelling. 
Ultimately it would be desirable to extend this work on J3-defensin binding to include 
interactions with bacterial membrane components such as LPS and teichoic acid. 
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4. Ion Mobility Studies of -Defensins and Defensin-
Related Peptides 
As stated in chapter 3, producing correctly folded defensins with the correct disulphide 
topology is difficult. Understanding  this - coupled with a wish to understand the 
defensin related peptides produced - drives our desire to characterise the peptides studied 
here with structural techniques. 
Most structural characterisation of 13-defensins has been carried out using NMR and XRC 
although some mass spectrometry based studies have been published"'. Thus far only 
three human J3-defensin structures have been solved: HBD-1 (NMR 3 and XRC4 ): HBD-2 
(NMR and XRC): and HBD-3 (NMR only'). The three structures were shown to share 
a common topological fold consisting of a core of three anti-parallel f3-sheets with an N-
terminal a-helix. Additionally, HBD-2 was reported to exist in two different quaternary 
structures: a non-covalent dimer and a non-covalent octamer composed of four dimers. 
This latter form was taken as good supporting evidence for the pore formation model of 
defensin activity (see section 3). 
It is interesting to note, however, that static light scattering studies by Sawai et a15 and 
size exclusion studies by Bauer et a17 show HBD-2 to exist as a monomer in solution. 
The latter authors suggest that the conditions used in the crystallisation process (e.g. high 
concentration) favour oligomerisation and the XRC studies do not therefore report on the 
solution behaviour of the peptide. 
Given the number of defensins studied here, it is unfeasible to determine the structures of 
all the peptides studied using NMR or X-ray crystallography. It is * however, possible to 
study a number of these peptides by ion mobility mass spectrometry using the MoQToF. 
This chapter will focus on the structural characterisation of a number of t3-defensins, 
defensin related peptides (DIPs) and of defensin-heparin complexes. Due to the 
challenges associated with obtaining reliable structures from molecular modelling there 
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are only a small number of model structures presented here. IMMS measurements will 
be used here primarily to examine differences in defensin conformations under different 
conditions such as different disulphide connectivities. This may give some insight into 
the importance of the disulphide bonds and their connectivity. 
The heparin binding experiments will be used to investigate the structural change on 
binding heparin - can this be related to the degree of inhibition seen? 
While most of the work discussed in this chapter has been carried out on the MoQToF, 
certain experiments have also been carried out in UCSB and therefore are useful for 
quality control purposes. 
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4.1 DEFBI07 
Mobility measurements of the peptide DEFBI07 have previously been performed at 
UCSB2 , this peptide is therefore an ideal test and calibration compound for our defensin 
studies. 
4.1.1 Experimental: Large Apertures 
Initial experiments were carried out with large aperture orifices in place - 2 mm diameter 
at the front of the cell, 1.67 mm diameter at the rear - allowing experiments to be carried 
out at 1.75 Torn 
The experiments were therefore performed at 1.6 Ton of He at 305 K with injection 
voltage (V) = 35.5 V. DEFB 107 was analysed at 40 xM in 49:50:1 
H20:MeOH:CH3COOH using ESI with 3.2 kV capillary voltage and 75 V cone voltage. 
Measurements were performed at Vd = 35 V. 30 V. 25 V. 20 V. 15 V and 10 V with 60 ps 
pusher period. Arrival times, mobilities and cross sections were obtained as described in 
section 2.3. 
Table 4.1 shows the cross sections obtained from this method for the three observed 
charge states (+5, +6 and +7) along with cross-sections measured in previous work. 
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—5 657 A2 768 A2 14 0 
±6 694 A2 819 A2 15% 
712 A 2 865 A_ 18 0 0  
Table 4.1: DEFB1O7 cross sections from MoQToF vs. UCSB. 
Clearly the cross sections are being significantly underestimated under these conditions 
with a larger underestimation occurring at higher charge. 
One possible explanation for this is that the ions are being injected with too high energy 
and are not reaching a constant drift velocity until a short distance into the cell. Under 
the conditions described above, the ions have the following kinetic energies: +5 - 177.5 
eV ±6-213 eV; ±7 —248.5 eV. This means a ±7 ion of DEFBI07 will have higher 
velocity upon entering the cell than a ± 6 ion which will in turn have a greater velocity 
than a ±5 ion. If the hypothesis is correct that the ions are not drifting' for the entire 
length of the cell then it follows that the +7 ion will take the longest to reach a constant 
drift velocity and hence be underestimated by the largest degree. 
To test this hypothesis, the experiment was repeated at Vi nj = 20.5 V. The cross sections 
obtained were as follows: ± 5 ion found to be 689 A (underestimation by 10%); +6 was 
found to be 722 A2 (12%) and +7 was found to be 745 A2 (14%). Once more, there is a 
large underestimation of the cross-section. The MoQToF values are , however, closer to 
those measured previously suggesting the hypothesis is valid. 
Assuming the ions begin to drift within the first few millimetres of the drift cell (i.e. the 
pressure is sufficient to allow them to reach a constant drift velocity), it should be 
possible to bring the measured values into calibration by adjusting the drift length used in 
the mobility calculation. For the data shown in table 4. 1, setting the drift length to 4.72 
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cm for +5,4.70cm for +6 and 4.62 cm for +7 gives cross sections of 767 A, 817 A2 and 
868 A2 respectively all within less than 0.5% of the UCSB values 2 . 
While it is possible to apply this sort of calibration to any data collected using the 
MoQToF, it is not ideal to have such an obvious unknown in our experiment, especially 
given the charge state dependence of the error. 
The experiment was therefore repeated at higher pressure. 
4.1.2 Experimental: Small Apertures 
The large aperture orifices were replaced with 1mm aperture orifices thus allowing higher 
pressures to be reached in the cell. 
The above experiment was repeated with 3.4 T He in the drift cell at 305 K with 34.8 V 
injection voltage. Measurements were taken at Vd = 60 V, 50 V, 40 V, 30 V. 25 V and 
20 V with 60 is pusher period. 
The experiment was performed three times under these conditions. ±5  and +6 charge 
states were observed for all experiments while +7 and +8 charge states were observed on 
two occasions with the ±4 charge state observed in one repeat. Table 4.2 summarises the 
results obtained. 
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4.1.3 Results 
Charge 
Cross Section (MoQToF) Cross 
Section 
(UCSB) 
1 2 3 average 
—4 na n/a 627A'  627 A 648 
±5 742 A 743 A 2 753 A2 746 A 766 A2 
±6 808 A2 825 A 2 801 A2 811 A2 819 A 2 
+7 855A2 874A2 n/a 864A2 865A 2 
±8 920 K 955 A 2 n/a 938 A 2 n/a 
Table 4.2: DefblO7 cross sections from M0QToF Measurements were obtained at 3.5 Torr from 
49:49:2 HO:MeOH:CHCOOH solution. 
As can be seen, there is good reproducibility across all charge states and good agreement 
with previous results. Figure 4.1 shows a plot of cross section versus charge for 
flFFJ4 I (17 ijcino 	cp('tirnc rht 	h, 	 th 	 d't. 	.'., ,,-. - - - - - - 	
-- .-.t -. .---.--.--..---.---.-, .---- - -- J .-. '- 0 	 - '-'C - '•-' 	 .,fl4_' 	 II LII 	 4t_J 4¼- 
4.2. 
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Charge State 
Figure 4.2: Plot of average cross section against charge for Defb 107. All values are M0QT0F 
data apart from +3 which is UCSB data. Errors are ± one standard deviation where appropriate 
and ± 3% otherwise. 
It can be seen from figure 3.1 that there is a steady increase in cross section from +4 to 
+8. The transition from +3 to +4 shows a comparatively small increase in collision cross 
section, perhaps indicating an unfolding transition between ±4 and +5. 
4.1.4 Molecular Modelling 
In order to characterise the types of structures seen in this work, molecular modelling 
calculations were performed using the AMBER 99 force field within the Amber 8.0 
program suite s'. The peptide with glutathione capping group was built in X-leap with four 
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different connectivities: the canonical disulphide connectivity and the three possible 
connectivities with the glutathione group attached to the final cysteine. 
All amino acids were held at their physiological charge states apart from the histidne and 
the glutarnic acid on the capping group which were both neutralised. This gave the 
modelled peptide a net charge of ±2. 
The peptide was modelled using a simulated annealing approach to yield minimised gas 
phase structures: dynamics are perforned at 800 K for 30 ns before cooling exponentially 
to 0 K. The resulting structure is then minimised. This minimised structure is then used 
as the starting point for the next set of dynamics and so on until 100 structures have been 
generated. 
The collision cross section for these structures was then calculated using the projection 
approximation. Table 3.3 shows the average cross sections obtained for the 20 lowest 
energy structures and all structures obtained for each disulphide topology. 
Connectivity 
Average Cross Section 	- 
(20 lowest energy structures) 
Average Cross Section 
(all structures) 
2-4 3-6 5-Gh 596 A2 608 A 
24 3-5 6-GIt 582 A2 607 A 
2-5 3-4 6-Git 592 A 2 609 A 
2-3 4-5 6-GIt 614 A 620 
Table 3.3: Collision cross sections of for different disulphide topologies 
of ±2 DEFB 107 found from low energy calculated geometries. 
Figure 4.2 shows two representative low energy structures of DEFBI07 obtained from 
this method. Figure 4.2-A shows a structure obtained for the canonical' connectivity; 
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M,6-61t 
Figure 4.2-A: Low energy molecular modelling structure of canonical DEFB 107 
B 	CVS3-CYS6 
C. 
: 	 Y 
(YS-Glt 	
CYS2-CYS4 
Figure 4.2-B: Low energy molecular modelling structure of DEFBIO7 with the experimentally 
observed disulphide topology. In both figures the polypeptide backbone is represented by a light 
blue ribbon, and the cysteine and glutathione residues are shown as CPK structures. 
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41.5 Discussion 
While it has not been possible to obtain experimental data for a - charge state of 
DEFB 107, the cross section for such a species may be extrapolated from figure 3.1. 
Clearly, given the variability of the measurement and the similarity of the calculated 
cross sections, the measured geometries could correspond to any of the modelled 
topologies. However, the large increase in cross section seen from ±4 to ±8 (-50% 
increase) may reveal something about the disulphide connectivity. 
The increase in collision cross section seen for ubiquitin 9 between the ±4 and +8 charge 
states is approximately 50% i.e. comparable to that seen here for DEFB 107. Ubiquitin 
does not posses any disulphide bonds and is therefore relatively unrestricted in the 
conformations it can adopt. If we then assume that DEFB 107 must be similarly 
unrestricted it is clear that the disulphide bonding topology present for this peptide cannot 
greatly restrain it conforrnationally. Of the four topologies modelled it is clear that the 2-
3, 4-5, 6-GIt topology is the most unrestricted by disulphide bonding given that the 
disuiphide bonds present are between adjacent cysteine residues. Ihis is of course the 
connectivity observed for this peptide by the mass mapping procedure described in 
section 3.2.2. 
While this method does not give absolute confirmation of the disulphide topology seen 
for this peptide it does represent a potential method for reducing the number of 
possibilities. 
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4.2 Defrl 
As discussed previously, Defri is a five cysteine containing defensin related peptide 
which forms a covalently bound dimer between the penultimate cysteine of each 
monomer. In order to fully understand the activity of the peptide a number of variants of 
this peptide have been created: 
Defri dimer: the original peptide containing four intra-molecular disulphide 
bonds and one intermolecular disulphide bond. 
Defri Git: a partially reduced form of Defri wherein the intermolecular 
disulphide bond has been reduced and the cysteine has been capped with a 
glutathione group. 
Defri Red: fully reduced Defri i.e. no disulphide bonds present 
Defri Y5C: Defri with residue 5 (tyrosine) replaced by a cysteine with three 
intra-molecular disulphide bonds. 
	
V. 	Defri lCys: Defrl with all bar the penultimate cysteine replaced with alanine. 
Exist as a covalently bound dirner. 
The disulphide connectivity of Defri (and by inference DefrI GIt) has been shown to be 
a mixture of non-canonical topologies. The connectivity of DefrI Y5C has been shown 
to be canonical. There is only one possible connectivity for Defrl ICys. 
Each of these peptides will be studied by TM-MS in the hope of revealing the influence of 
the disulphide bonds on the conformations adopted by defensins. 
4.2.1 Experimental 
All peptides were analysed at 40 p.M from 49:50:1 H 20:MeOH:CH 3COOH using ESI 
with typical capillary voltages of 3.25 kV and typical cone voltage of 65 to 80 V. For 
Defri ICys a pusher period of 63 us  was used; for Defri Red and Defrl GIt a pusher 
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period of 70 jis was used and for Defri Y5C a pusher period of 65 us  was used. As there 
was insufficient Defri to obtain mobility data on the MoQToF, the data reported here are 
from the analogous Bowers instrument at UCSB'. 
For the data obtained on the MoQToF, measurements were performed at 3.5 Ton of He 
at 305 K with an injection voltage of 40 V. Measurements were taken at Vd = 60 V. 50 
V, 40 V, 30 V and 25 V. For Defri, data was recorded at 5 Ton of He at 300 K with V inj 
= 42 V. Measurements were taken at Vd = 90 V, 60 V, 45 V. 30 V and 20 V. 
4.2.2 Results 
Table 4.4 shows measured cross sections for all peptides studied. 
Peptide  
Charge Defri Defri Git Defri Red Defri \5C Defri 1Cs 
3 - 513A 551A 523A 2 - 
4 - 59 	\ 581 A - 
642  A 652 A2 605 A2 - 
6 1071A - 735A1 - - 
7 1242A2 - - - 1332A 
S 1342A2 - - - 1401 A 
9 1430 A2 - - - 1520 








1566 A 2 
1620A 11 
Table 4.4: ExDerimental cross sections of Defri and related Denudes. 
4.2.3 Discussion: Defri Dimers 
As no reliable computational structures are available for these peptides. we will focus 
here on differences between the patterns seen for each peptide. 
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Comparison of Defri. Defri iCys and Defri Y5C will provide insight into the influence 
of intra-molecular disulphide bonds on conformation. Unfortunately, non-covalent 
dirners were not observed for any of three monomers studied despite previous evidence 
that Defri Y5C exists as a non-covalent dimer. Cross sections for the DefrI Y5C dirner 
were therefore estimated by doubling the cross section seen for the monomer species. 
While this is clearly not a valid method for calculating the cross section of a non-covalent 
dimer, it is instructive to illustrate the influence of the inter-molecular disulphide bond. 
Figure 4.3 shows a plot of cross section vs. charge state for these three peptides. 
















Figure 4.3: Collision cross sections of Defri related dimers at different charge states. Defri 
and Defrl 1 Cys are experimentally determined values for covalently bound dimer species 
while DefrI Y5C cross sections are extrapolated values for a covalently bound dimer. 
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Clearly for any one charge state, Defri is a more compact ion than Defri ICys and the 
putative Defri Y5C dimer is more compact than both species. 
If we first examine the Defri and Defri iCys data we can see that for the lower charged 
species. the two molecules can be seen to behave fairly similarly, showing a similar 
increase in cross section with charge: for ±7 to +9 Defri increases by 15% while Defri 
ICys increases by 14%. However, at +10 the cross section of Defri was seen to flatten 
while the cross section of Defri ICys was seen to continue to increase fairly linearly with 
charge. 
We can interpret these data in terms of the influence of intra-molecular disulphide bonds 
which conformationally restrict Defri in comparison to Defri lCys. In lower charge 
species this influence is only apparent in terms of the slightly larger cross section 
measured for DefrI lCys (5% to 8%) as would be expected for a less restrained peptide. 
This finding is similar to that shown for Lysozyme by Valentine et all(' where they 
showed the disulphide reduced form to present a considerably larger cross section than 
the disulphide intact form. 
The apparent drop in cross section from +9  to +10 for DefrI is perhaps more interesting, 
the peptide has reached its most extended form at +9. Up until the +9  charge state, the 
increase in cross section can be explained in terms of coulombically driven unfolding of 
the secondary and tertiary structure of the peptide. For Defri I Cys, this process is 
allowed to continue with the addition of a tenth and then eleventh charge; the presence of 
the intra-molecular disulphide bonds in Defri does not allow this unfolding to continue. 
It is tempting to interpret the slight drop in cross section as a structural rearrangement of 
the peptide with the addition of the tenth charge. It is also possible that the drop in cross 
section is merely an experimental error, the cross sections measured at +9 and +10 are 
within 2% of each other, a reasonable estimate of the experimental error. Without 
reliable molecular modelling structures it is not possible to confirm which hypothesis is 
correct. 
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Turning to the Defrl Y5C data, the cross sections obtained for the putative dimer are 
smaller than those obtained for Defri with the difference more pronounced at higher 
charge (--3 0NO at 4-6, 20% at +8 and 15% at ±10). This difference highlights two important 
factors: firstly the influence of a third intermolecular disulphide bond; secondly - and 
more clearly - the difference between a covalently bound dimer and a non-covalently 
bound dimer. 
From ±6 to +10 for Defri there is an increase in cross section of 30%, for Defrl Y5C the 
increase is only 16% indicating Defri Y5C is a more restrained peptide than Defrl. 
Looking at the sequence, this is unsurprising. The first cysteine - and hence disulphide 
bond - in DefrI Y5C is residue 5 with the final cysteine occurring one residue from the 
end; this means almost the entire peptide is within the disulphide restrained region. 
Defri . however, has no cysteine until residue 12 meaning a far larger proportion of the 
peptide is unrestrained by disulphide bonds - this is supported by the far greater increase 
in cross section seen for Defrl. 
The large difference in cross section between these two species is not only due to an extra 
intra-molecular disulphide bond, the inter-molecular disulphide bond in Defrl must also 
have some influence over this. To explain this fully it is first necessary to examine the 
data obtained for the three monomer species. 
4.2.4 Discussion: Defri Monomers 
Figure 4.4 is a plot of cross section against charge for Defri Git, Defri Red and Defri 
Y5c. 
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Collision Cross Sections of Defri Monomers 
01111 








-.- Defri Git 
Defri Y5C 




	 ri 	61 	 [3] 
Charge 
Figure 4.4: Experimental collision cross sections of Defri Git, Defri Red and Defri Y5C 
At this stage it is worth reiterating the differences between these three peptides: Defrl Git 
is a monomer of Defri with two intra molecular disulphide bonds with a mixture of 
connectivities (two or three) and a glutathione capping group on the penultimate cysteine; 
Defri Red is a monomer of Defri with no disulphide bonds i.e. all the cysteines present 
are reduced; Defri YSC is a mutant of Defri in which the fifth residue - a tyrosine - has 
been replaced with cysteine. it contains three disulphide bonds of canonical connectivity. 
It is immediately apparent that Defrl Red and Defri Y5C behave in a very similar way. 
For Defri Red the cross section increases by 5 1,10 between +3 and ±4 and by 12% between 
+4 and +5; for Defrl Y5C the cross section increases by 39/o between +3 and ±4 and by 
12% between +4 and ±5. This indicates that intra-molecular disulphide bonds are not 
influencing the degree of charge driven unfolding seen for Defri Y5C at these charge 
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states. We do see, however, that the cross sections obtained for DefrI Red are around 8% 
larger than those measured for Defi Y5C indicating that the disulphide bonds confer a 
more compact structure on the peptide. This is of course in good agreement with what 
was seen for Defri and DefrI I Cys. 
The data obtained for Defrl IGlu show slightly different behaviour for this peptide. It 
shows a larger increase from +3 to +4 (16%) followed by a slightly smaller increase 
between +4 and +5 (8%). This is perhaps best explained with reference to DEFB107 
which also contains a glutathione capping group. For DEFB 107, we saw from modelling 
that the glutathione group had a great influence on the structures adopted with the peptide 
folded around the capping group. The large increase in cross-section between +4 and +5 
measured for DEFB 107 can be attributed to a loss of the interaction between the peptide 
and capping group. It is therefore tempting to assume Defrl iGlu behaves similarly: the 
lowest charged species interacting strongly with the glutathione group and hence giving a 
smaller cross section than Defri YSC; moving from +3 to +4 the interaction is lost cross 
section increases, it then unfolds with charge in a similar fashion to the other two species 
studied. 
The presence of the glutathione group makes it difficult to directly compare DefrI Git 
with DefrI Y5C and Defrl Red (and hence gain insight into the influence of the 1-5 
disulphide bond in Defrl Y5C) but if the data are normalised to cross section per residue 
(i.e. the cross section is divided by the number of residues present), Defri Y5C and Defri 
Red are seen to give similar values for their +4 and +5 charge states perhaps indicating 
that the more compact geometry seen for Defrl Y5C can be as easily inferred by two 
disulphide bonds as it can by three. Table 4.5 summarises this normalised data for the 
three monomer peptides. 
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Peptide 
Charge Defri Git Defri Red Defri V5C 
13.9 ± 0.4 16.2 ± 0.5 15.4 ± 0.5 
16.1 ± 0.5 17.1 ± 0.5 15.8 ± 0.5 
17.4 ± 0.5 19.2 ± 0.6 17.8 ± 0.5 
±6 - 21.6±0.6 - 
Table 4.5: Normalised cross sections for Defri monomers. All values are obtained by 
dividing measured cross section by number of residues and are in A 2 per residue. 
From the above work, we would not necessarily expect to see the great difference 
between the cross sections of Defri and a DefrI Y5C dimer. The larger cross sections 
observed for Defrl must therefore be related to the inter-molecular disulphide bond. For 
a non-covalent dimer, the interactions between the two monomers must be between the 
peptide backbones and/or the side-chains. In order to maintain a stable dirner there are 
usually several important interactions and therefore the two monomers are quite 
restrained. For a covalently bound dirner, the only reqiiire1 interartion between the two 
monomers is the covalent linker, in this case the disulphide bond. Each Defri monomer 
will therefore be able to flex and rotate about the intermolecular disulphide bond 
allowing it to fonTi a more open structure hence the larger cross section measured. 
While comparing cross sections of peptides at different charge states gives a good 
indication of the over degree of flexibility of each peptide, it is also worth quantifying 
this for each individual charge state. This can be done by comparing the widths of the 
ATDs obtained for different peptides under the same conditions - a wider peak indicating 
a more flexible molecule. Table 4.6 shows the widths of the ATDs obtained for the 
Defri monomers. The data were obtained by measuring the full width at half height 
(FWHH) of each peak obtained at Vd = 60 V. 
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Peptide 
Charge Defri Gil Defri Red Defri Y5C 
+3 124±4is 118±4ts 75±2us 
+4 88±3us 106±3us 65±2us 
+5 90 	us 101±3us 60±2us 
--6 
- 77±2us - 
Table 4.6: FWHH of ATDs of Defri monomers at Vd = 60 V. 
For any one peptide, it is expected that the peak width should decrease with increasing 
charge - more highly charged species spend less time in the drift cell than lower charged 
species hence there is less peak broadening due to diffusion. This trend holds for all ions 
studied. It is interesting to note however, there is a comparatively large drop in peak 
width from ±3 to ±4 for Defri GIt indicating a change in conformational flexibility or the 
presence of multiple unresolvable conformations. The +3 to ±4 transition has been 
assigned as a point at which there is a large conformational change for this species, these 
data would seem to support that finding. 
The general trend from these data is that Deft! Red is more flexible than Defri Glt which 
is in turn more flexible than Defrl Y5C. This seems logical from what we know about 
the peptides in that conformational flexibility is related to the number of intra-molecular 
disulphide bonds present - zero, two and three respectively. 
Defri is a mutant form of the murine defensin MBD-8 found in black 6 mice'. MBD-8 
has six cysteine residues and is therefore an orthologue of Defr! Y5C; the sequences of 
these two peptides are shown below. 
Defri Y5C: 	*DPVTCIRNGGICQYRCIGLRHKIGTCGSPFKCCK 
MBD-8: 	NEPVSCIRNGGICQYRCIGLRHKIGTCGSPFKCCK 
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The sequence alignment between Defri Y5C and MBD-8 reveals the presence of three 
mutations in the N-terminus of Defri Y5C as compared to MBD-8: (i) the loss of N-
terminal asparagine 1; (ii) glutamate 2 to aspartate; and (iii) serine 5 to threonine. 
The NMR structure of MBD-8 has previously been determined by Bauer et a17 who 
demonstrated it to have the 'defensin fold' described previously in this section. Given 
the large degree of sequence homology between the peptides it is reasonable to assume 
the Defri Y5C and MBD-8 will have very similar solution structures. The gas phase 
collision cross sections of Defrl Y5C can therefore be compared to the NMR structure of 
MDB-8; a collision cross section was calculated for the 20 solution phase structures of 
this molecule using the Mobcal program 11 . 
Using trajectory methods' 2.13  the average collision cross section calculated was 666 A2 
(ranging from 625 to 701 A) as compared to cross sections of 523 A2 , 538 A2 and 605 
A2 for the +3. ±4 and +5 charge states of Defrl Y5C i.e. the solution structure of MDB-8 
has a larger cross section than one might expect for Defri Y5C 
figure 4. shows the NMR structure of MDB-8'. The core of the peptide containing the 
regions of defined secondary structure can be seen to be restricted by the disulphide 
bonding. The five N-terminal residues , however, are unrestrained by these interactions 
allowing this section of the peptide a larger degree of conformational freedom than the 
rest of the peptide - this region of the peptide can be seen to be unrestrained in the NMR 
structures. As this is the region where the mutations occur in Defri Y5C a change in the 
flexibility of this region may account for the smaller than expected cross section. 
It is also worth remembering that MBD-8 contains one more residue than Defri Y5C, to 
better compare the two molecules the cross section calculated for MBD-8 will be mass- 
normalised to Defri Y5C. This gives a normalised collision cross section of 646 A2 for 
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Figure 4.5: NMR structure of MBD-8. The figure shows the position of the six cysteine 
residues, the disulphide bonds connecting them and the areas of defined secondary structure: the 
three anti-parallel n-sheets of the core and the helical N-terminal section. 
To test estimate the importance of the unrestrained region of the peptide on the overall 
cross section, the S n-terminal residues were removed from the structures and the cross 
sections were recalculated giving an average value of 588 A2 . This value is comparable 
to the cross sections measured for Defrl Y5C suggesting an interaction between the n-
terminal section and the core of the peptide in the gas phase structure. 
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4.3 Defbl4 
Defbl4, the murine orthologue of HBD-3 14, was synthesised in a number of different 
forms in order to fully study its physical, chemical and biological properties. A number 
of the peptides created were studied by IMMS on the MoQToF: 
Defbl4: full length Defbl4. fully oxidised containing 3 disulphide bonds of the 
topology described in section 3.2.3. 
Defbl4 ICys monomer: full length defbl4 with all but the penultimate cysteine 
mutated to alanine. 
	
Ili. 	Defbl4 Ala: full length Defbl4 with all cysteines mutated to alanine 
iv. 	Defbl4 DIPI: the first 23 residues of Defbl4 Ala. 
V. 	Defbl4 DIP2: the final 23 residues ofDefbl4 Ala 
Vi. 	Defbl4 DIP3 monomer: the final 23 residues ofDefbl4 ICys monomer. 
Experiments were performed on each of these peptides. 
4.3.1 Experimental 
All peptides were analysed at 40 iM from 49:50:1 H 2O:MeOH:CHCOOH using ESI 
with typical capillary voltages of 3.25 kV and typical cone voltage of 65 to 80 V. For the 
full length peptides a pusher period of 70 .is was used; for the short defensin inspired 
peptides (DIPs) a pusher period of 60 is was used. 
Measurements were performed at 3.5 Ton of He at 305 K with an injection voltage of 35 
V. Measurements were taken at Vd = 60 V. 50 V, 40 V. 30 V and 25 V. 
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4.3.2 Results 
Table 4.7 shows the experimental collision cross sections obtained for the various DefbI4 













+3 - - - 465 A2 444 A 434 A - 
+4 709 A2 - - 546 A2 486 A 491 A2 666 A2 
+5 751 A 2 916A2 - - 585 A2 80A2 758A2 
+6 881 A2 962 A2 979 A2 - - - 827 A 2 
+7 1008 A 2 1018 A2 1070A - - - 971 A 2 
±8 - 1105 A 2 1170A - - 	 - 
Table 4.7: Experimental cross sections ofDeIbl4 and related peptides. 
4.3.3 Discussion: Full Length Peptides 
Figure 4.6 is a plot of cross section against charge state for the three full length peptides 
studied here. 
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Defb14 Cross Sections 
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Figure 4.6: Plot of experimental cross sections of full length Defbl4 and related peptides 
analysed from 49:49:2 H:O:MeOH:CH3COOH. The dotted line represents the average cross 
section of HBD-3 taken from the NMR structures. 
The data shown here shows Defb14 behaves in a similar fashion to Defri in that the 
disulphide intact form (Defbl4) unfolds with charge in a similar fashion to the no-
disulphide form (Defbl4 Ala) i.e. fairly linearly with charge. Once more the presence of 
intra-molecular bonds can be seen to give rise to a more compact form of the peptide. 
The behaviour of Defbl4 ICys is perhaps more interesting. In terms of atomic structure 
it is practically identical to Detb14 Ala, the only difference being the presence 
substitution an —SH for an H at residue 40. For this reason, it would be expected that the 
two molecules would behave in a similar fashion. This hypothesis holds at lower charge 
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states (+5 and ±6) but at higher charge DefbI4 iCys behaves more like Defb14. This is 
an interesting finding and suggests the presence of the —SH group allows the molecule to 
form different intra-molecular interactions allowing it to adopt more compact gas phase 
structures. This perhaps gives us some insight into the different behaviour of this 
molecule in vivo; Defbl4 lCys was shown to be active chemotactically while Defbl4 Ala 
is significantly less active. It is thought that in order for chemotaxis to occur the peptide 
must adopt a specific conformation, this does not occur for Defbl4 Ala but does for 
Defbl4 ICys - further study of these two peptides by IMS and molecular modelling may 
allow us to discover the structural importance of the Ala to Cys substitution. 
It is interesting to note that despite the presence of two, distinct disulphide bonding 
topologies for Defbl4, there is only one resolvable conformer obtained from the ion 
mobility measurement. This is of course in agreement with the data obtained for Defri 
where one conformation is observed despite the presence of more than one disulphide 
bonding topology. Once more, it may be interesting to examine the peak widths of each 
of the three full length species. Table 4.8 shows the peak widths of these three species at 
Vd =60 V. 
Peptide 
Charge DefbI4 Delb14 lCs DefbI4 Ala 
+4 85±3us - - 
+5 75±2s 73±2ts - 
+6 72±2.ts 86±3.ts 53±2ps 
±7 82±3j.ts 90±3is 56±2p.s 
±8 
- 
79±3 [is 63±2us 
Table 4.8: AID peak widths for full 1entth Dcfb14 nentides. 
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For Defbl4, the ATD peak width decreases with charge from +4 to +6 before increasing 
again. The ATD widths measured are larger for Defbl4 than for Defbl4 Ala i.e. Defb14 
occupies a greater amount of conformational space than DefbI4 Ala. The presence of 
intra-molecular disulphide bonds in Defbl4 confers a more compact geometry on Defbl4 
in comparison to Defbl4 Ala and one might assume the disulphide bonds would restrict 
the molecule more leading to narrower peaks. If we take this to be the case, then the 
width of the ATD must be due to the presence of multiple conformers of similar collision 
cross section. In section 3.2.3, it was shown that Defbl4 exists in two different 
disulphide topologies, these may result in two slightly different gas phase structures 
giving rise to a more diffuse ATD. The TM resolution of the MoQT0F is around 20, this 
is clearly too low to separate any possible multiple conformers seen here but by studying 
the same system on a high resolution ion mobility instrument it may be possible to 
separate two disulphide topoisomers. 
For comparison, the average cross section of the 20 NMR cross sections of HBD-3 is 
included in figure 4.6. This is 883 A2 , very close to the value measured for +6 Dethl4. 
Clearly the two species are not directly comparable due to the difference in sequence and 
disulphide topology but the agreement does suggest the measurement is valid. 
4.3.4 Discussion: Defb14 DIPs 
Figure 4.7 is a plot of collision cross sections obtained for DIP1. DIP2 and DIP3. 
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Defb14 DIP Collision Cross Sections 
2 	 3 	 4 	 5 
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Figure 4.7: Cross Section vs. charee Diot for DefbI4 DIPs 
The data shows that the two c-terminal peptides (DIP2 and DIM) are more compact than 
DIP I, the n-terminal peptide. The cross sections of all three peptides increase fairly 
linearly with charge. 
For the full length Defbl4 peptides. it was shown that Defbl4 ICys behaved differently 
to Defbl4 Ala despite there only being a minor change to the side chain of one amino 
acid. For DIP2 and DIP3. the same change has been made i.e. Ala to Cys. In contrast to 
what was shown for the full length peptides. DIP2 and DIP3 give virtually identical cross 
sections for all coincident charge states (within 2.5%). This suggests that the interaction 
which causes a change in the behaviour of Defbl4 ICys is between the cysteine residue 
and the n-terminus of the peptide. 
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Figure 4.8 shows a mass spectrum obtained for DIP3 from the conditions described in 
section 4.3.1. 
Figure 4.8: Mass spectrum of DIP3 from 49:49:2 H 20:MeOH:CH 3COOH. The poor signal-to-
noise seen for the spectrum illustrates the loss of transmission seen for the IMMS configuration. 
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There is clear evidence for the presence of both monomer and dimer species in this mass 
spectrum. As DIP3 has a reduced cysteine residue it is tempting to assume the dimer 
present is covalently linked, , however, if harsher source conditions are used (higher cone 
voltage etc.) the dimer dissociates easily suggesting a non-covalent dimer; the mass data - 
although not high enough resolution or mass accuracy for absolute confirmation - would 
seem to support this assertion. 
Figure 4.9 shows a plot of the cross sections obtained for the DIP3 monomer, dimer and, 
for clarity, the cross sections for a putative dimer of DIP3 obtained by doubling the cross 
sections obtained for the +2 and +6 monomers. 
DIP3 Cross Sections 
1000 
-•- Defb14 DIP3 









L 500 - o 
400 
2 	3 	4 	5 	6 
Charge 
Figure 4.9: Cross sections of DIP , monomer and dimer from 4*4*2 H-O:\leOH:CI-LCOOH. 
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We can see that, in contrast with the Defri dimer data shown previously, the dimer cross 
sections obtained for DIP3 are more compact than twice the monomer cross section. This 
supports the assertion that the DIP3 dimer is non-covalent as oppose to covalent the 
apparent drop in cross section being due to multiple interactions between each monomer 
as oppose to the single, covalent interaction required to keep Defrl in dimer form. This 
is analogous to the drop cross section seen by \Vyttenbach et all-5 for the Bradykinin 
dimer, which can only be held together by non-covalent interactions. 
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4.4 Conclusions 
Ion mobility studies of a number of different defensin molecules and related peptides 
have been presented. This represents the first concerted effort at studying the structures 
of these species in the gas phase. 
Thanks to previous studies at UCS13 2 , DEFB107 was an ideal test molecule for these 
studies. Initial experiments at lower buffer gas pressures demonstrated the importance of 
reaching a constant drift velocity on entering the cell. At these lower pressure the ions do 
not start to 'drift' until they are several millimetres into the cell; this causes the drift time 
to be reduced and hence the measured cross-section is underestimated. Repeating these 
experiments at higher pressure gave good agreement with previous results indicating the 
ions drift for the entire length of the cell and hence validating the MoQT0F as a tool for 
these studies. 
A number of Defri related peptides were studied yielding important information about 
the importance of disulphide bonds on conformational flexibility. From the dimer studies 
we see that the presence of an intermolecular disulphide bond in Defri and Defri I Cys 
(forming a covalent dimer) allows a more extended conformation to be adopted than 
might be expected for a non-covalent dimer. This indicates that at the charge states 
studied the interactions between the monomers are dominated by the covalent 
intermolecular bond it is only at the lowest charge state (+6) that non-covalent 
interactions can be seen to have an influence on the conformation. 
The influence of intramolecular disulphide bonds is illuminated by all the Defri species 
studied. Defrl Y5C has three intramolecular disulphide bonds - it forms the most 
compact monomer gas-phase ions. Defri Red has no disulphide bonds - it forms the 
most extended monomer gas phase ions. Similarly. Defri (two intramolecular disulphide 
bonds per monomer) forms more compact ions that Defrl ICys (no intramolecular 
disulphide bonds). The presence of intramolecular disulphide bonds constrains the 
molecules. 
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Examining these findings in the wider context of the biological activity of these 
molecules is important. From previous studies 1 we know the intermolecular disulphide 
bond is vital for the anti-microbial activity of Defri (reduced Defrl is virtually inactive); 
in contrast the data shown in Appendix 3 (table A3.1) shows that the intramolecular 
disulphide bonds are not necessary necessary for its anti-microbial activity (Defri iCys is 
as active as Defrl). It is postulated therefore that the flexibility allowed by the 
intermolecular disulphide bridge is an important feature of the biological activity of the 
molecule. 
The studies of Defbl4 and related peptides reveal the influence of very minor changes in 
sequence on gas phase structure. Once more the influence of intramolecular disulphide 
bonds was demonstrated - Defbl4 being more compact than the mutants Defbl4 ICys 
and Defbl4 Ala. However, it is change imparted by a cysteine to alanine mutation that is 
most intriguing. Defrl ICys has a cysteine residue at position 40, in Defbl4 Ala this 
residue is replaced by alanine. For the lower charge atates studed this had little or no 
influence on the structure, however, for higher charge states (+7  and +8) it was shown 
that the presence of the cysteine allows a more compact conformation to be adopted. 
Further study of this using only the c-terminal half of Defbl4 Ala and Defb14 ICys 
(Dethl4 DIP2 and Defb14 DIP3 respectively) showed the cysteine residue to have to 
influence on the cross-section of these species (i.e. DIPs 2 and 3 have essentially the 
same cross-sections at all charge states studied). This indicates that there must be an 
important interaction between the c-terminal cysteine and the n-terminal half of Defbl4 
which allows a more compact geometry to be maintained for Defbl4 lCys compared 
with Defbl4 Ala. Once more this is echoed in a biological context where Defbl4 ICys 
has been shown to be chemotactically active while Defbl4 Ala is not 14 . 
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5. Defensin - Glycosaminoglycan Interactions by IMMS 
In section 3.4. a method was presented in which the binding of a GAG. heparin, to 1-
defensins was studied using MS. For a number of the Defbl4 related peptides the study 
has been extended to also include ion mobility data. The use of IMMS to study 
complexes has been discussed previously in section 1.3.2.5. 
These studies were performed to gain insight into the conformational effect of heparin 
binding to a defensin or DIP. For clarity this study has been restricted to Defb14 and 




The experiment was also carried out with Defbl4 Ala and Defbl4 DIP2; no binding was 
n~Nc pru ~-fi frr thc 	t-c nnA th. rciiltc 	thrcrsr. rittc 4rrs,-, 4c 
5.1 Experimental 
Samples were prepared as described in section 3.4.1 using a 1:2 peptide:heparin ratio. 
IM-MS spectra were obtained using ESI with a typical capillary voltage of 3.25 kV and 
cone voltages of 65 to 85 V. 
For Defb 14 a pusher period of 67 .ts  was used, for Defb 14 1 Cys a pusher period of 60 1.ts 
was used and for Defbl4 DIP  a pusher period of 65 is was used. 
Measurements were performed at 3.5 Torr of He at 305 K with an injection voltage of 35 
V. Measurements were taken at Vd = 60 V. 50 V, 40 V, 30 V and 25 V. 
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The experiment was also performed using Defri Y5C, DIP2 and Defbl4 Ala, however, 
no binding was seen to occur for these species. 
Molecular modelling of the Deth14 DIPI - heparin complex was carried out in the 
Amber Suite of programs. The two molecules were built in X-Leap and minimised via a 
short simulated annealing run generating ten low energy structures. The two molecules 
were then placed together and 100 low energy structures were generated using the 
simulated annealing protocol outlined in section 4.1.4. 
5.2 Results 





Charge iCys DIPI 
+lHep +2Hep 
+lHep +lHep 
-- 	+3 - - 	 - 511A 
±4 726A - 	 - - 
+5 757 A2 762 A2 	 - - 
±6 - - 	 1006A 2 - 
Table 5.1: Experimental collision cross sections of heparin complexed with Defb14 and related 
peptides. 
5.3 Discussion 
The data obtained are best viewed in terms of the differences in cross section between the 
uncomplexed peptide and the complex. 
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Defb14 Complex Cross Sections 
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Figure 5.1: Plot of cross section against charge for De1b4 and Defbl4 heparin complexes. 
Figure 5.1 shows the cross sections obtained for Defbl4 and the observed Defb14 
complexes. The complex was observed in +4 and ±5 charge states with evidence of one 
and two heparin molecules binding for the +5 charge state. 
For the +4  charge state, the complex gives a collision cross section of 726 A 2 around a 
2.5% increase in cross section in comparison to the free peptide. This increase in cross 
section is to be expected as the complex will contain 55 more atoms than the free 
peptides although a larger increase in cross section may have been expected as previous 
work on a similar heparin derived disaccharide showed it to have a cross section of —630 
A2 . This suggests that there is some comformational tightening of the peptide structure 
on binding the heparin. 
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This hypothesis is lent more weight by the cross sections measured for the +5 complex: 
the free peptide has a cross section of 751 A2 while the peptide with one heparin bound 
has a cross section of 757 A2 and the peptide with two heparin bound has a cross section 
of 762 A2 - increases of 0.8% and 1.5% respectively. These are extremely small changes 
in cross section for such a large change in the make up of the species studied (for the 
Defbl4 + I heparin species, the saccharide represents 18% of the mass of molecule). 
This strongly suggests the peptide is highly conformationally restricted by the heparin. 
Another explanation is that the presence of heparin brings about a significant 
rearrangement of the molecule resulting in a similar cross section.. 
If we again examine the peak widths of the ATDs of each ion studied here we see the 
conformational space occupied by the ion is reduced for the defensin-heparin complexes 
(i.e. the ATDs for the complex ions are sharper than those seen for the free peptide). At 
Vd = 60 V: +4 DefbI4 ATD has a FWHH of 98 .is, the complex ATD has a F\VHH of 76 
is; +5 Defbl4 ATD has a FWHH of 82 .is, the + I heparin and ±2 heparin ATDs have 
FWHH of 68 s and 72 is respectively. 
This conformational tightening and stabilisation of the peptide by heparin is analogous to 
the work of Guo et al l on metallothionein complexes whereby they observed a decrease 
in cross section of metallothionein with increasing numbers of ligand bound. This was 
interpreted in terms of peptide stabilisation by the ligand. 
Figure 5.2 shows a plot of collision cross section versus charge for Defbl4 ICys and its 
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Defbl4 ICys Complex Cross Sections 
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Figure 5.2: Cross sections of Defb14 ICys and Defb14 ICys - heparin complex. 
The cross section measured for the +6 complex was 1006 A2 an increase of —5% 
compared to the cross section measured for the free peptide. The peak widths of these 
species at Vd = 60 V were 103 [is (free peptide) and 92 J.is (complex), once more 
indicating conformational restriction of the peptide by the saccharide. Figure 5.3 shows 
the ATDs obtained for these two species at Vd = 60 V. 
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Figure .3: AIL)s of L)etb14 iCys and Detb14 lCys +I heparin at 60 V drift voltage. 
Figure 5.4 shows a plot of collision cross section as a function of charge state for DIPI 
and the DIPI-heparin complex. The complex was only observed in the +3 charge state, 
this - perhaps coincidentally - corresponds to the net charge of the DIP3-heparin 
complex in solution with the peptide having seven positive charges and the saacharide 
four negative charges. The complex cross section is 511 A2 , approximately 10% larger 
than the cross section of the free peptide. While this is the largest relative increase in 
cross section seen for the three peptides studied it is still a remarkably small increase in 
cross section, especially when considering the disaccharide constitutes 19% of the 
complex by mass. It is noteworthy that the increase in cross section on binding heparin 
of 46 A2 seen here is extremely close to that seen for Defbl4 ICys where an increase of 
44 A2 was observed. 
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Figure 5.4: Collision Cross Sections of DIP] and DIPI -heparin comrlex. 
Once more we see a reduction in the ATD width for the complex suggesting a 
conformational stabilisation of the peptide by the heparin: for the free peptide at Vd = 60 
V the ATD FWHH was 92[is; for the complex under the same conditions the ATD 
FWHH was 73 is. 
In section 3.4.2 it was shown that the presence of heparin greatly reduced the activity of 
Defbl4 against both gram-negative and gram-positive bacteria but had a far less 
pronounced effect on the activity of the other two peptides. It was proposed that the 
difference seen here was due to a different degree of protection of the heparin from being 
lost to the cell wall. 
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Kd values measured for each of the three peptides differ by less than a factor of two and 
are therefore essentially identical i.e. the peptide-heparin interaction is equally as strong 
for each peptide studied. If the difference in activity in the presence of heparin is indeed 
related to how easily the heparin can be lost - hence returning the peptide to its original, 
active form - then the difference between each species is not governed by 
thermodynamic control. 
In terms of increase in cross section on binding heparin it was shown that DIP] increased 
the most, followed by Defbl4 iCys with Defbl4 showing the least increase in cross 
section, even with two heparin molecules bound. The relatively small increase in cross 
section seen for each species suggests a conformational tightening of the peptide on 
binding heparin. This conformational tightening presumably better protects the peptide-
saacharide interaction from disruption by cell membrane components. 
As the largest degree of conformational tightening is seen for Defbl4 it is not surprising 
that the presence of heparin has the greatest effect on the activity of this peptide against 
both gram-negative and gram positive bacteria. The similar degree of conformational 
tightening seen for DIPI and Detb14 ICys suggests both peptides protect the heparin-
defensin interaction to a similar degree - this is broadly supported by the similar trends in 
activity of these peptides in the presence of heparin. 
In order to gain further insight into the interaction it was clear that molecular modelling 
should be carried out. The complexes of the full length Defbl4 peptides and heparin are 
very large systems and the position of the charges on each peptide is non-trivial (Defbl4 
has 14 basic residues where a charge can be carried; data were obtained for --4 to ±7 
charge states). Modelling of these systems will therefore require a great deal of work 
both experimentally and computationally before reliable structures can be generated. 
DIPI, however, is a far smaller system and the observed complex charge state 
corresponds to the net charge of the complex in solution thus allowing the complex to be 
modelled using the solution charges on the peptide and saccharide. 
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Figure 5.5 shows a gas-phase simulated annealing structure obtained for the free peptide 
in its solution charge state i.e. ±7. 
Figure 5.5: Simulated annealing structure of ±7 DIP 1. 
While it is worth noting that this species is not observed experimentally. DIP] is clearly 
an unstructured peptide at this charge state. The theoretical cross section for this 
structure is 677 A2 . 
Figure 5.6 shows a low energy gas phase structure obtained for the ±3 charge state of the 
DIPI-heparin complex. This theoretical cross section of this system obtained using the 
exact hard sphere scattering 2 algorithim in Mobcal 3 . is 524 A2 . This agrees very well 
with the experimental value of 511 A2 . 
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9Phe 
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Figure 5.6: Simulated annealing structure of DIP 1-heparin cornple. The blue ribbon structure 
represents the peptide: the stick structure represents the saacharide. 
As suggested by the mobility data, the addition of the heparin to the defensin brings about 
a conformational tightening of the peptide. The peptide wraps around the heparin 
enclosing it. The interaction causes the formation of a helical region towards the N-
terminus of the peptide between residues 9 and 17. The primary interactions between the 
peptide and saacharide are ionic interactions between the protonated basic groups on the 
peptide and the deprotonated acidic groups on the saccharide along with hydrogen 
bonding  interactions between the peptide and saccharide. 
Comparing this structure to the solution structure of HBD-3 4 (the human orthologue of 
Defb14) reveals a remarkable similarity between the two structures. Figure 5.7 shows an 
NMR structure of HBD-3 (Schibli et aT). 
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Figure 5.7: Solution phase structure of HBD-3 solved by NMR spectroscopy. The peptide shows 
the characteristic defensin fold' consisting of a core of three 3-sheets and an N-terminal helical 
section. 
It can be seen that the key structural motifs of the N-terminal section of HBD-3 are 
mirrored by the DIP] - heparin complex. Both structures contain a helix towards the N-
terminus followed by a turn; the C-terminus of DIP3 maps quite closely onto the first 
sheet of HBD-3. The heparin molecule takes the place of the second and third 3-sheets of 
HBD-3. Clearly, the presence of the heparin induces a defensin fold' in DIP] - a 
remarkable discovery. 
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5.4 Conclusions 
In chapter 3 there was shown to be a link between heparin binding and defensin activity, 
further to this it was demonstrated that the presence of heparin has a profound effect on 
the anti-microbial activity of a number defensins. In this chapter. ion mobility studies of 
heparin binding to Defbl4, Defbl4 ICys and Defbl4 DIP  were presented. 
Upon addition of a heparin molecule to a peptide, the collision cross-section was seen to 
increase. The absolute increase in cross-section was seen to be comparable for Defbl4 
iCys and Defbl4 DIPI (-45 A) while it was seen to be much smaller for Defbl4, even 
for the complex between Defbl4 and two heparin molecules . The increases in cross 
section seen for all species observed was much less than might be expected, this is 
indicative of more compact gas phase conformations being adopted on heparin binding - 
this is especially pronounced for Defbl4. 
Relating this to anti-microbial activity in the presence of heparin (table 3.6) we see that 
Defbl4 ICys and Defbl4 DIPI behave similarly showing no ehnnge in activity against 
gram-positive bacteria and a small decrease in activity against gram-negative bacteria; 
Defb 14, however, shows a marked decrease in activity against both gram-negative and 
gram-positive bacteria in the presence of heparin. In other words the peptide which is 
most restrained by the heparin is most affected by its presence. 
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6. Ion Mobility of Other Systems 
Work in the group extends beyond the study of -defensins to include a number of 
different molecules from small peptides such as LHRH 1 to large protein complexes such 
as cyclophillin-cyclosporin. Past work in the group has primarily involved the use of 
mass spectrometry as a probe of these molecules 2 ' 3 . In the future further insight into 
these systems will be provided by performing TM-MS experiments on the MoQT0F. 
This chapter will focus on some initial work carried out on three different systems: Trp-
Cage, a 'mini-protein' with a well known structure; Melittin a small peptide present in 
honey bee venom and Calmodulin, a small calcium binding protein. 
217 
6. Ion Mobility of Other Systems 
6.1 Trp-Cage 
Trp-cage 4 is the smallest peptide known to have a defined fold. It has 20 residues and 
has been shown to fold spontaneously into its native structure 4 . In the native structure, 
the Trp6 residue is 'caged' by Glyl 1, Prol2. Pro18 and Pro 19 with a stabilising salt 
bridge between Lys8, Asp9 and Argl6. It is a designed peptide based on extendin-4 a 39 
residue peptide originally isolated from the Gila Monster lizard. 
It has been shown using a fluorescence based technique 6 that the structure of the +2 ion 
of this peptide is stable up to -420 K and the structure of the ±3 ion is stable up to -360 
K. In this section, four different mutants of Trp-cage will be studied using IMMS with 
temperature dependent measurements performed on one of these mutants. 
The solution phase structure of wild type Trp-cage is shown in figure 6.1 g . 
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lob 
Figure 6.1: NMR structure of wold-typr Trp-cage. The folded peptide contains an N-terminal a-
helix (purple), a single 310 helical turn (orange) and a PPII helix (pink). It has a tightly packed 
hydrophobic core stabilised primarily by prolirie (aliphatic) to trvptophan (aromatic) interactions. 
6.1.1 Experimental 
Four different Trp-cage mutants were synthesised using solid phase synthesis techniques, 
the sequences are shown in figure 6.2. 
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Figure 6.2: Sequences of Trp-cage wild tvp and mutants. Mutations are labelled in blue. 
The four variants studied are the wild type (WT), a Lys to Arg mutant (K8R), an Arg to 
Lys mutant (R16K) and a Arg to Lys, Lys to Arg mutant (double mutant - DM). 
The four species were studied on the MoQT0F under the same conditions: 3.5 Ton He, 
305 K. V = 40 V with 63 lis pusher period. Solutions were prepared at 40 iM in 50:50 
MeOH:H 2O and ionised using ESI with 3.5 kV capillary voltage and 70 V cone voltage. 
Measurements were taken at Vd = 60 V, 55 V, 50 V, 45 V. 40 V. 35 V and 30 V. 
Further experiments were performed on DM at 3 40 K. 375 K and 395 K. 
6.1.2 Results 
Figure 6.3 shows a typical mass spectrum obtained for WT under these conditions. Note 
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[M+2H]2+ 
Fiture 6.3: ESI mass snectrum of Trp-cape WT. 
Table 6.1 shows the measured cross sections for each species at 305 K. 
Peptide 
Charge WT K811 	 RI6K DM 
IM±2H1 2 -378, 386A 380A 382A 
IM+3HI 3 401 A2 412 A2 394A2 - 
(M+2H+Na] 3 403 A2 406 A 392 A2 393 A2 
[M+2H±K1 3 400 A2 401 A2 	394 A2 390 A 
Table 6.1: Collision cross sections of four different Trn-cae mutants. 
For the high temperature studies of DM, only the ±2 species was obtained with sufficient 
intensity to accurately assign arrival times. Table 5.2 shows the cross sections obtained 
for ±2 DM at the four temperatures studied. 
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Temperature 305 K 340 K 	375 K 395 K 
Cross Section 382 A 380 A 378 A 378 A 
Table 6.2: Collision cross sections of-2 TrD-caee DM at 4 different temneratures. 
6.1.3 Discussion 
The mass spectrum shown in figure 6.2 is a fairly typical mass spectrum for any of the 
four species studied in that the dominant species of the spectrum is the +2 and the +3 
species ions are dominated by the singly sodiated peak with the fully protonated being the 
weakest of the three seen (i.e. triply protonated; doubly protonated and single sodiated; 
and doubly protonated and singly pottassiated). 
While this is unusual for larger peptides and proteins it is not unexpected for smaller 
peptides which tend to have less basic groups and therefore less sites for protonation. All 
four mutants have two basic groups (K and R, K and K or R and R) each and these are 
assumed to he the cites of nrotontion for the --) snerie 	cir the - 'A cnpr-iec the fii1 
- 	 ---- 
protonation site is less clear, however, it is clear thatthis site must interact more 
favourably with the alkali metal cations than with a proton hence the adduct species 
dominate. 
Turning to the mobility data, it can be seen that for all four mutants the ±2 species is 
smaller than the +3 species. 
Generally the cross sections measured for the three different ±3  species (fully protonated; 
one sodium and one potassium) for each mutant are the same regardless of the third 
charging group. K8R is a slight anomaly here as the cross section decreases marginally 
from protonated to sodiated to potassiated. 
Looking across the different peptides we see that for the +2 ion, the cross sections are 
essentially identical - within 2% - for all four mutants. This trend holds less well for the 
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±3 ions where the cross sections generally go as: K8R > WT > RI6K - DM. The 
variation is small - less than 5 1 ' across the series - but consistent. 
For the first three mutants the trend would seem to go with the number of arginine 
residues: arginine has a bulkier side chain than lysine; the largest cross section was 
measured for the species with the most arginine residues and the smallest for the one with 
the least. Going by this trend, however, one might have expected Trp-cage DM to have 
the same cross section as Trp-Cage WT as they both contain one arginine - this does not 
happen. This then suggests that the presence or absence of an arginine at residue 8 is a 
more important factor for the structures measured. 
To better understand the results seen here, extensive computational studies are under 
way, examining the gas phase structures and stability of the different Trp-cage mutants. 
Here we will show a computed structure for ±2 Trp-cage WT. 
The process used to produce the computational structures is as follows: the +2 peptide 
was built using the AMBER8 molecular mechanics package' with the pan -n99 force field 
using the co-ordinates obtained from the NMR structure 4 . The structure was then heated 
sequentially to 350 K (50 K steps, 20 ps duration). Molecular dynamics of the resulting 
structures were then run for 10 ns at 350 K. Figure 6.4 shows a computed structure of ±2 
Trp-cage WT with charges located on the two basic residues. 
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Figure 6.4: Molecular mechanics structure of +2 Trp-cage WT at 350 K. The N-terminus of the 
peptide is to the left with the c-terminus to the right of the figure. Note the retention of the N-
terminal helix. 
The calculated cross section for this peptide at the end of the molecular dynamics run was 
387 A2 in excellent agreement with the measured cross section of 378 A2 for this 
structure. 
For Trp-cage DM, the results at each of the four temperatures studied were essentially 
identical suggesting that, as suspected, the ±2 charge state of this mutant is thermostable 
up to 395 K. Ideally the experiment would have been performed at a number of higher 
temperatures in order to study the thermal unfolding of the peptide. This was not 
possible due to the failure of an internal solder at higher temperature. 
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6.2 Melittin 
Melittin is a small, cationic peptide that is the major component of honey bee (Apis 
mellifera) venom. It shows a number of biological activities including increasing cell 
permeability and haernolysis 9 : the activity it shows is thought to be directly related to its 
interaction with and perturbation of lipid bilayers' ° . 
Previous work by a number of groups has shown melittin to exist it two forms: in 
aqueous solution it adopts a random coil structure; in a membrane environment it adopts 
a helical 	 thought to involve the formation of a tetramer 12 . The helical 
structure has also been shown to form in 	and high salt concentration' 3 . The 
methanol monomer structure' 0 shows melittin to exist as two a-helices with a 'kink' 
between them at Pro 14. The sequence of melittin is shown in figure 6.5. 
10 	 20 
GIGAVLKVLT TGLPALISWI KRKQQ-CONH2 
Figure 6.5: Melittin Sequence 
Current work at Edinburgh is focussed on trying to understand the influence of the 
environment on the structure adopted by melittin. The peptide is being studied at various 
concentrations and pHs, in different buffers of varying concentration and in different 
solvents. These experiments are primarily being carried out using HD exchange mass 
spectrometry in both the solution and gas phases. 
The molecule has also been studied by CD 	 a technique by which 
the degree of helicity of a peptide or protein can be determined. Figure 6.6 shows CD 
spectra of nielittin under different solvent conditions from 100% MeOH to 2% MeOH. 
'H.V. Florance, unpublished results 
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Wavelength I nm 
Figure 6.6: CD spectra of melittin. 
It can be seen that the helical content of the solution increases with increasing methanol 
concentration. From 2% to 27% methanol, the peptide exists as primarily random coil; at 
52% there is evidence of some alpha-helical structure; the degree of helicity then 
increases with methanol content to a maximum at 100% methanol. An increase in 
helicity has been similarly demonstrated for increasing phospholipid concentration. 
Clearly solvent composition has a strong influence on the solution phase structures 
adopted by melittin. The question then arises: can the solution phase structure be 
preserved into the gas phase? Ion mobility mass spectrometry is clearly the ideal way to 
answer this question. 
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6.2.1 Experimental 
Melinin was obtained from Sigma Aldrich (Milwaukee, WI). All solvents were obtained 
from Fisher Scientific (Loughborough, UK). 
The peptide was prepared at 40 !IM  in the following solvent conditions: 
l00% H20 
75:25 HO:MeOH 
50:50 H 20:MeOH 
25:75 WO:MeOH 
V. 100% MeOH 
vi. 50:50 MeOH:lOniM ammonium acetate pH 6.8 
Each of these solutions was analysed on the MoQToF using ESI with a capillary voltage 
of 3.5 kV, a cone voltage of 60 V to 80 V and 35 V injection energy. Measurements 
were taken at 3.5 Torr He with a pusher period of 60 j.ts. Data were recorded at Vd = 60 
V,50V,40V,35V,3OV and 25V. 
6.2.2 Results 
A typical mass spectrum obtained for melinin is shown in figure 6.7. The dominant 
charge state seen for all solvent conditions studied here is +4, +3 is seen under all 
conditions but +5 is only apparent at low methanol concentrations (0% and 25% MeOH). 
This suggests that in high aqueous conditions melittin has more exposed basic groups 
than it does in high organic conditions allowing higher charge states to be accessed under 
these solvent conditions. This finding is in good agreement with the CD data presented 
above. 
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The mass spectrum also shows the presence of the Y 13 fragment ion of melittin. This 
fragment is produced by nozzle skimmer dissociation. At high methanol concentration, 
the +2 fragment is the dominant species while the ±3 ion is the dominant fragment 
species at high aqueous concentration. Once more, the data suggests the molecule is less 




Fiiure 6.7: ESI mass snectrum of melittin. 
Table 6.3 shows the collision cross sections measured for melittin under each solvent 
condition. 
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±3 544A 5437 523 A 530 A 2 566A 516A - 
+4 584 A 576 A 572 A2 561 A2 587 A2 578 A 
+5 605 A2 	602 A2 - - - - 
V1 3 +2 340 A 339 A2 328 A 2 332 A- 350 A2 332 A 2 
\' 13 3 59 k 2 	351 A 2 - "3_37A 2 356 A 362 A 
Table 6.3: Collision cross sections of melittin from different solvent conditions. 
6.2.3 Discussion 
The trends in these data do not reveal a clear shift in cross section with solvent 
concentration that would indicate a large structural change caused by the transition from 
random coil to a-helix. Figure 6.8 shows the variation of the ±3, ±4 and Y 1 3 ±2 cross 
sections with increasing methanol concentration. 
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Melittin Cross Section Variation with % Methanol 
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It can be seen that there is a weak trend followed by each species where the cross section 
decreases slightly from 0% to 50% methanol before increasing to a maximum at 100% 
methanol. Interpretation of this trend is best related to molecular modelling structures 
obtained by the simulated annealing method outlined in section 4.1.4. Figure 6.9 shows 
the cross sections calculated for the crystal structure of rnelittin 12, a structure obtained 
Experiment vs. Theory for 1-3 Melittin 
00" 
	
10 	010  kllr-, 
Z/Vv\ 	4 
Figure 6.9: Experimental and theoretical cross sections of +3 melinin. 
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from performing molecular dynamics on the crystal structure at 300K and two minimised 
simulated annealing structures of the ±3 charge state - one compact structure and one 
extended structure. The simulated annealing structures were obtained by performing 
calculations in the solution phase using generalised born solvent (GB) to represent the 
presence of water. The figure also shows the experimental cross sections obtained for ±3 
melittin from 100% H20 and 100% MeOH with error bars representing ±1- 3%. 
It is immediately apparent that the extended GB structure is not sampled by the 
experiment, the more compact GB structure, however, is in good agreement with the 
cross section obtained for 100% water. This structure represents the loss of almost all a-
helix content of the peptide compared to the crystal structure. From the CD data we 
expect this to be the case. This suggests that for the low methanol content experiments, 
the solution phase conformation is preserved into the gas phase. This is perhaps 
unsurprising, as melittin is fairly unstructured in aqueous solution. 
The larger cross section seen for 100% MeOH is more difficult to interpret in terms of the 
structures shown in figure 6.9. It is clearly more extended than the structure seen for 
100% water but not as extended as the crystal structure. This suggests some sort of 
intermediate structure. Comparing the crystal structure to the compact GB structure we 
see that the cx-helices have unravelled and the molecule has collapsed in on itself to create 
a more compact geometry. The structure seen from 100% methanol could therefore 
represent a state where some of the helical structure is lost on transferring the molecule to 
thegas phase, the unravelling of the helix then allows a more compact geometry to be 
adopted. 
If this is the case then it should be expected that part of the molecule will be more 
extended than other parts. From previous CID work' it is known that the +2 Y 13 
fragment is a dissociation product of the +3 ion of the full peptide. The presence of the 
fragment ion therefore allows us to determine the degree of foldedness of the c-terminus 
of the peptide. 
H.V. Florance & P.E. Barran, unpublished data 
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Returning to table 6.3 we see for 100% H2O the +2 Y 13 fragment has a cross section of 
340 A2 , 62% of the cross section of the ±3 full length peptide. For 100% MeOH the ±2 
fragment has a cross section of 332 A 2 , 59% of the cross section of the +3 full peptide. 
For both it is clear that the n-terminus is more unfolded than the c-terminus. The cross 
sections obtained from each solvent are comparable (within 3%) and can be assumed to 
represent globally similar structures. 
Examining the structure obtained for the compact GB calculation, there can be seen to be 
some retention of the helix in the n-terminus, it is lost entirely in the c-terminus. This 
agrees nicely with the data obtained for the Y13 fragment. 
It is proposed therefore that in 100% MeOH, melittin exists in a crystal-like alpha helical 
structure; on transfer to the gas phase, the peptide gains three charges - one on the n-
terminus, two on the c-terminus. The presence of two charges on c-terminal half of the 
peptide cause it to lose its helicity. the n-terminal helix is at least partly maintained. To 
fully test this hypothesis, further molecular modelling must be performed. 
Clearly for 100% MeOH, the solution structure is not transferred to the gas phase. 10 
achieve this it may be necessary to use nano-electropsray ionisation. This technique 
allows a more gentle transfer from the solution to gas phase increasing the chances of 
efficiently sampling the solution structure, it may also allow access to the +2 charge state 
of melittin which may be more'native-like'. 
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6.3 Calmodulin 
Calmodulin (CaM) is a calcium binding protein expressed in all eukaryotic cells. It is a 
148 amino acid protein which has been shown to bind four calcium ions 17.  CaM is 
involved in a huge number of processes within the body including  cell growth, nitric 
oxide synthesis and immunosupression' 8 . Most of these processes involve the binding of 
CaM to one or more other proteins within the body, the binding is often calcium 
dependent e.g. calmodulin will bind to and activate the enzyme nitric oxide synthase only 
when calcium is present 19 . The sequence is shown in figure 6.10 with the calcium 
binding regions highlighted in blue. 
10 	 20 	 30 	 40 	 50 
ADQLTEEQIA EFKEAFSLFD KDGDGTITTK ELGTVMRSLG QNPTEAELQD 
60 	 70 	 80 	 90 	 100 
MINEVDADGN GTIDFPEFLT MMARKMKDTD SEEEIREAFR VFDKDGNGYI 
110 	 120 	 130 	 140 
SAAELRHVMT NLGEKLTDEE VDEMIREADI DGDGQVNYEE FVQMMTAK 
Figure 6.10: Sequence of calmodu]in. 
Apo CaM (i.e. calmodulin without calcium present) is comprised of two globular 
domains joined by a flexible linker; each domain consists of two helix-loop-helix metal-
binding motifs known as EF hands ('. The binding of calcium to these sites induces a 
structural change in the molecule in which the anti-parallel helices in the domain linking 
region become parallel and form an a-helical linker region 21 . The NMR structures of the 
apo2° and hoIo 21 (i.e. with four calcium ions) forms of CaM are shown in figure 6.11. 
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Figure 6.11: The solution NMR structures of Apo-CaM (A) and Holo-CaM (B). 
The large change in conformation from apo to bob should be easily observable by ion 
mobility; this section will focus on some preliminary work to probe this structural 
change. 
6.3.1 Experimental 
CaM was obtained from the research group of Dr. Simon Daff (Edinburgh. UK). It was 
desalted and purified on a PD1O column, lyophilised and brought up in 10mM 
ammonium acetate, pH 6.8 (Sigma Aldrich, Milwaukee WI) to a concentration of 150 
tiM. 
The resulting solution was incubated at room temperature overnight with 5 mM calcium 
acetate (Sirna Aldrich. Milwaukee, WI) to allow the CaM to become fully holo (i.e. bind 
four Ca). This solution was then diluted down in 49:49:2 HO:MeOH:CHCOOH to a 
final concentration of 40 PM 
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The solution was analysed on the MoQToF with a capillary volatage of 3.5 kV and a 
cone voltage of 75 V. The cell was held a 3.5 Ton He, 305 K using an injection energy 
of 40 V. Measurements were taken at Vd = 60 V, 50 V, 40 V and 35 V. A pusher period 
of 98 lis was used. 
6.3.2 Results 
Figure 6.12 shows a typical mass spectrum obtained for the bob-CaM sample. 
The addition of acid to the sample denatures the protein. The species observed in the 
mass spectrum are therefore of higher charge than might have been expected for a holo-
CaM spectrum. Further to this, the most abundant ions present correspond to Apo CaM; 
for all species there is evidence of CaM + I Ca 2 ; for ±7 and +8 there is evidence of CaM 
± 2Ca2 ; for ±7 there is evidence of CaM ± 3Ca2 . Clearly the CaM is no longer holo but 
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Table 6.4 shows the cross sections measured for all observed species 
Charge CaM + 0Ca CaM + 1Ca2 CaM + 2Ca 2 CaM + 3Ca 2 
±7 
1526A2 
1750 A 2 
1575 A 2 
1805 A2 
1390A 
1786 A 2 
(1371 A - ) 
±8 
1655A2 
2068 A - 
1762A2 
2088 A- 
(1882 A- ) - 
±9 
1660 A2 




+10 1963A 1912A2 - - 
+11 2434A 2 2285A2 - - 
+12 2895 A2 2830 A2 - - 
±13 2999 A2 2998 A2 - - 
±14 3093 A 2 3072 A2 - - 
+15 3270 A2 3254 A2 - - 
+16 3333 k 2 - - - 
Table 6.4: Experimental collision cross sections for camodulin. Data in brackets were calculated 
using only two arrival times. all other data were calculated using four arrival times. 
6.3.3 Discussion 
Figure 6.13 is a plot of cross section against charge for all observed species. 
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Camodulin Cross Sections 
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Figure 6.13: Collision cross sections of CaM with 0 (open squares), 1 (open circles), 2 (open 
triangles) and 3 Ca 2 (open star). The dashed line represents the calculated cross section for the 
crystal structure of apo CaM. 
For the lower charge states there are two resolvable conformations, at higher charge there 
is only one resolvable conformer. Focussing first on the +7 to ±9 charge state of the 0 
Ca2 CaM we see that the two conformers are separated by -13% at +7  increasing to 
-20% for the ±8 and ±9 charge states. The +8 and ±9 charge states give similar cross 
sections for both the compact and extended form (within —2%) indicating similar 
conformations for each charge state. For the +7  ion the measured cross sections of both 
geometries is less than the calculated cross section for the crystal structure of apo-CaM 
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(1870 A). For the +8 and +9  ions the crystal cross section lies between those measured 
for the two conformers. 
For the +10 charge state the cross section measured lies between the two values measured 
for the +9 ion perhaps indicating that the measured value here is the average of two 
unresolvable conformers. At higher charge - +11 to ±14 - where only a single confonner 
is present we see the expected increase in cross section with charge. 
Turning now to the CaM + I Ca data it can be seen that the measured cross sections for 
most charge states are similar to those found for the 0 Ca 2 CaM with some exceptions: 
for ±7 to  ±9  we see for the compact form, the +lCa 2 CaM species presents a larger 
conformation than the 0Ca 2 form. This pattern is not repeated for the more extended 
conformer indicating the calcium has a greater influence on the conformer adopted by the 
more compact fonm For the ±11 ion we see the +1 Ca is —6% smaller than the 0Ca 2 ; 
this difference comes in the middle of the largest increase in cross section with charge for 
the apo-CaM - 32% from ±10 to ±12 c.f. 6% from ±12 to +14 - perhaps indicating that 
the presence of the calcium partially restrains the peptide. 
For the +2Ca2 data it can be seen that once more the addition of a second calcium has a 
different effect on the more compact conformer as compared to the extended conformer. 
For the more extended conformer of +7 CaM ±2Ca we see that once more the calcium 
bound form has a similar cross section to the calcium free form. The cross section 
measured for the more compact form of this ion , however, is --9% smaller than that 
measured for the 0Ca form. This indicates a large conformational change on 
binding/losing a second Ca-  . Only a single resolvable conformer was present for the +8 
ion of CaM ± 2Ca; the cross section measured form this lies between the two values 
measured for the Apo form indicating this is an average cross section of two species. 
Interestingly, the cross section obtained for 7+ Cam +3Ca 2 is very close to that measured 
for the more compact ±2Ca conformer; this was the only observed conformer for this 
species. 
240 
6. Ion Mobility of Other Systems 
As discussed above, CaM has four binding sites split evenly between two domains. This 
means that for CaM +2Ca 2 there are two possibilities for the location of the calcium 
ions: (i) both ions on the same domain; (ii) one ion on each domain. 
Previous work has shown that the binding in each domain of CaM is cooperative 22 i.e. if 
one site on a domain binds calcium then the second site on this domain will also then 
bind calcium. However, we see from this work and that of others that ESI produces CaM 
with odd numbers of calciums. If the cooperativity in solution holds (i.e. CaM in solution 
has either: 0 Ca; 2 Ca on the same domain; or 4 Ca) then the +ICa 2 and ±3Ca 2 
species observed must be produced in the ionisation process. It is therefore possible that 
using ESI, one may sample both combinations (described above) of calcium binding for 
CaM +2Ca. 
For CaM ±3Ca 2 one domain must have calcium in both binding sites therefore inducing 
the associated conformational change in one domain. As the cross section measured for 
this species is close to that of the more compact ±2Ca ion then it is clear that this 
species can be assigned to an ion with both ions bound in the same domain. If we then 
assume that the more extended form of CaM seen for +2Ca corresponds to a form of 
CaM with the calcium bound in different domains then we have a plausible explanation 
for the two conformers seen at lower charge. If we hold this hypothesis to be true then 
the presence of two conformers for the 0Ca 2 and +1Ca forms of CaM at low charge 
suggests these ions are formed from the +2Ca 2 species, presumably in the ionisation 
process or in the region between the source and the drift cell. 
Ultimately it will be desirable to extend these experiments to include the fully holo form 
of CaM. This was not possible due to the source problems outlined in section 2.6.1. 
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6.4 Conclusions 
In this chapter ion mobility studies of three different systems were presented. 
Four different mutants of Trp-cage - a synthetic 'mini-protein' - each varying from the 
next by the number, and position of the basic residues. At room temperature these 
mutations were seen to have a very minor affect on the cross sections observed. 
Measurements of Trp-cage DM were also taken at higher temperatures revealing the 
molecule to be have a stable conformation up to 395 K, in good agreement with 
computational studies. 
Melittin has previously been shown to adopt a helical structure in methanol and a random 
coil structure in aqueous solvent. In order to understand the influence of solvent on gas 
phase structure, ion mobility data was obtained using varying amounts of methanol. 
While there are clearly observable trend in the cross-sections observed for the various 
species they are weak ones. 
The cross sections observed at low methanol content gave good agreement with the 
compact generalised born solvent (aqueous environment) structure generated by 
simulated annealing - indicating this structure maintained upon transfer to the gas phase. 
This structure, as expected. has no a-helical content 
The cross-sections obtained from 100% methanol are more extended than this but more 
compact than the calculated cross section of the crystal structure (completely helical) 
which is thought to be representative of the methanol solution structure. This suggest a 
degree of collapse of this structure, probably a loss of some of the a-helical structure. Ion 
mobility measurements of the Y fragment of melittin (the c-terminal half of the 
molecule) show it to account for more than half of the cross section of the full length 
peptide. It is therefore concluded that the n-terminal half of melittin retains some helical 
content on entering the gas phase whilst the c-terminal half largely loses its helical 
structure. 
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Ion mobility studies of calmodulin provided a wealth of structural information on species 
carrying 0 to 3 calcium ions and 7 to 16 positive charges. At lower charge states (Z < 10) 
the protein was seen to adopt more than one conformation: a compact conformation - 
thought to have at least one domain in a 'native' conformation; and an extended 
conformation - with both domains 'disordered'. At higher charge. a single conformation 
is observed. 
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In this work. the development of a new ion mobility mass spectrometer - The MoQToF 
has been described. The MoQToF is a modified Micromass Q-ToF 1 with a linear 
mobility cell between the source hexapole and quadrupole mass analyser. The instrument 
has been shown to be a reliable IMMS instrument capable of accurately reproducing 
mobility measurements on a number of previously studied molecules (sections 2.5 and 
4.1). 
Some improvements to the apparatus' software, electronics, ion optics and to the cell 
itself are still required in order for the instrument to work as expected (section 2.6) but 
initial results are promising. 
Studies of 3-defensins using IMMS and mass spectrometry have also been presented. 
FTICR-MS has been shown to be a reliable technique for determining the oxidation states 
of the cysteines in the peptides and hence determine the number of disulphide bonds in 
the molecule (section 3.1). Using MS based methods, the disulphide bonding topologies 
of two 13-defensins - DEFB 107 and Defbl4 - have been determined (section 3.2). 
In section 3.3 the interaction between DEFB 107 and an artificial membrane has been 
shown to involve the N-terminal section of the peptide. In published t3-defensin 
structures', the N-terminal section of the peptide has been shown to be helical - an ideal 
structure for membrane interaction. We believe this to support the carpet model of anti-
microbial activity2 . Using this model it is proposed that the N-terminus binds to the 
membrane, anchoring the peptide to the cell surface; when this occurs at high enough 
concentration the cell membrane integrity is disrupted, causing lysis. It would be 
desirable to extend this work in the future to include studies of more peptides and 
crucially more complex artificial membranes containing a variety of lipid and 
carbohydrate components allowing a better approximation of bacterial membranes. 
244 
7. Conclusions 
In section 3.4 a heparin-defensin binding assay is presented. Measured dissociation 
constants are seen to provide a qualitative scale of defensin activity in that more active 
peptides bind more strongly to heparin. It has also been shown that the presence of 
heparin can inhibit the activity of some of the peptides studied indicating a possible 
method of pathogen defence against anti-microbial peptides 3 . 
In chapter 5 the interaction has been studied in more detail using molecular modelling 
and IMMS. The binding of heparin has been shown to stabilise the defensin molecules 
IMMS studies of a number of J3-defensins and relate peptides have been presented in 
chapter 4. This work primarily concentrates on the differences between related peptides. 
It reveals the influence of disulphide bonding on molecular flexibility. Generally 
speaking, disulphide bonds restrain the peptides. This may have implications in tenns of 
their purpose. It has been reported that the presence of disulphide bonds can lead to 
increased protection against proteolysis 4. We see that peptides without disulphides are 
less conformationally restrained; these peptides in general are more likely to degrade 
when left at room temperature. 
In section 4.1 an TMMS study of DEFB 107 is presented 4, this work reveals that the 
combination of molecular modelling and IMMS to be promising as a method to discover 
disulphide topologies by analysing the flexibility of the molecule. While this technique 
will never allow absolute confirmation of a connectivity, it may allow some topologies to 
be eliminated. 
Chapter 6 presents some preliminary studies of three different systems: Trp-cage; 
melittin; and calmodulin. Much further work is required to fully understand these 
systems , however, initial results are promising. 
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Appendix 1: MoQToF Drawin 
Figure A1.3: Instrument layout 1. 
249 







Figure A 1.4: Instrument layout 2. 
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Appendix 1: MoQToF Drawings 
Figure A1.6a: First half of cell voltage power supplies circuit diagram. This circuit controls the 
voltages applied to the drift cell (Cl & C2). 
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Figure A1.6b: Second half of cell voltage power supplies circuit diagram. This circuit controls 
the voltages applied to the drift cell (Cl & C2). 
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Appendix 1: MoQToF Drawings 
Figure .41.12: Pulser modification circuit. The pulse from the pusher is fed into the clock 
(Ipm_counterO) which is set to output a pulse after a set number of inputs (e.g. 200 pushes). The 
output pulse from the clock s then fed through a buffer to the pulse generator. 
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Annendix 2: Amino Acid Structures and Masses 







Alanine Ala A 89.0933 
Asparagine Asn N 132.1182 
Cysteine Cys C 121.1593 
Glutarnine Gin Q 146.1450 
Glycine Gly (3 75.0665 
isoleucine lie 1 131.1737 
Leucine Leu L 13 1.1737 
Methionine Met M 149.2129 
Phenylalanine Phe F 165.1909 
Proline Pro P 114.1232 
Serine Ser S 105.092' )
Threonine Thr 1 119.1191 
ipwpi1aJI 
.._..-._i..  lip 
Tyrosine Tyr Y 181.1899 
Valine Val V 117.1469 
Aspartic Acid Asp D 133.1023 
Glutaniic Acid Glu E 147.1291 
Arginine Arc, R 174.2026 
Histidine His H 155.1561 
Lysine Lys K 146.1886 
Table A2.1: Table of amino acid codes and molecular weights. 
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Appendix 2: Amino Acid Structures and Masses 
Amino acid back-bone s1c1ure 
R 
II  H 	
NH3 
0 
R -Groups  
Glycirie (Gly, G) —H OH 





Vaine (Val, V) CH 
\ Cysteine (Cys, C) —CH 
CH. Methionine (Met, M) —CH 2CH 2SCH. 
CH 3 
/ Asparagine (Asn, N) 
—CHCNH 
II 
Leucine (Leu, L) —CHC1 0 
CH 3 
Glutamine (GIn, 0) 
—CHCHCNH 
CH2CH. o 
Isoleucine (lie, I) —CH 
\ 
Aspartic acid (Asp, D) —CH 2CO 2H 
Glutamic Acid (Glu, E) —CH 2CH 2CO,H 
Lysine (Lys, K) 
Phenylalanine (Phe, F) —CH 2_Q 
- 
 (CH 3)-NH 3 
NH; 
Arginine (Arg, R) —(CH2)N--- 
NH2 
Tyrosine (Tyr, Y) 
_—CH-G_-_0H H 
'NH 
Histidine (His, H) 
N 
—CH2--Ji1 
Tptophan (Trp, W) 
Proline (Pro, P) ( 	' H 
Serine (Ser, S) CH2OH 
4 	 1 
Table A2.2: Amino acid side chains. 
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ix 3: 3-Defensin Seuences and Activities 
Appendix 3: 13-Defensin Sequences and Activities 
Defri: DPVTY IRNGG ICQYR CIGLR HKIGT CGSPF KCCK 
Defri Y5C: DPVTC IRNGG ICQYR CIGLR HKIGT CGSPF KCCK 
Defri iCys: DPVTA IRNGG IAQYR AJGLR HKIGT AGSPF KCAK 
DEFB107: RALIS KRMEG HCEAE CLTFE VKIGG CRAEL AFCCK 
Defbl4: FLPKT LRKFF CRIRG GRCAV LNCLG KEEQI GRCSN 
SGRKC CRKKK 
Defb14 ICys: FLPKT LRKFF ARIRG GRAAV LNALG KEEQI 
GRASN SGRKC ARKKK 
Defb14 Ala: FLPKT LRKFF ARIRG GRAAV LNALG KEEQI GRASN 
SGRKA ARKKK 
Defb14 DIP1: FLPKT LRKFFARIRG GRAAV LNA 
Deth14 DIP2: AcNH-LNALG KEEQI GRASN SGRKA ARKKK 
Deth14 DIP3: AcNH-LNALG KEEQI GRASN SGRKC ARKKK 
HBD-2: VFGGI GDPVT CLKSG AICHP VFCPR RYKQI GTCGL 
PGTKC CKKP 
HBD-3: GlINT LQKYY CRVRG GRCAV LSCLP KEEQI GKCST 
RGRKC CRRKK 
Figure A3.1: Sequences of 13-defnsins studied. 
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Appendix 3: -Defensin Sequences and Activities 
Peptide 
Anti-microbial Activity (pig/ml) 
P. aeruginosa B. cepacia S. aureus 
Defrl 6 >100 12.5 
Defri Reduced 50 >100 >100 
Defl Y5C 50 >100 >100 
Defri ICys 6 nla nia 
Defb14 1.5 >100 3.13 
Defb14 Reduced 1.5 nla n/a 
Defb14lCys 1.5 >100 3.13 
Defbl4Ala 1.5 nia 3.1 3 
Defbl4 DIP l 1.5 n/a 3.13 
Defbl4DIP2 >50 n/a >50 
Defbl4DIP3 >50 n/a >50 
HBD-3 1.5 >100 3.13 
Table A3.1: Anti-microbial activities of3-defensins against three selected pathoens: P. 
aeruginca (gram negative): B. cepacia (gram negative, highly dcfènsiu iesisial!L); S. aureus 
(gram positive). 
264 
